
<html lang="en"     class="pb-page"  data-request-id="86e02790-7c58-4f72-8109-db0f61782e25"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00885;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A–E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium" /></meta><meta name="dc.Creator" content="Fatma&#xA;H.  Al-Awadhi" /></meta><meta name="dc.Creator" content="Bowen  Gao" /></meta><meta name="dc.Creator" content="Mohammad A.  Rezaei" /></meta><meta name="dc.Creator" content="Jason C.  Kwan" /></meta><meta name="dc.Creator" content="Chenglong  Li" /></meta><meta name="dc.Creator" content="Tao  Ye" /></meta><meta name="dc.Creator" content="Valerie J.  Paul" /></meta><meta name="dc.Creator" content="Hendrik  Luesch" /></meta><meta name="dc.Description" content="Five novel modified linear peptides named brintonamides A–E (1–5) were discovered from a marine cyanobacterial sample collected from Brinton Channel, Florida Keys. The total synthesis of 1–5 in add..." /></meta><meta name="Description" content="Five novel modified linear peptides named brintonamides A–E (1–5) were discovered from a marine cyanobacterial sample collected from Brinton Channel, Florida Keys. The total synthesis of 1–5 in add..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 17, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00885" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00885" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00885" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00885" /></link>
        
    
    

<title>Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A–E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00885" /></meta><meta property="og:title" content="Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A–E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0011.jpeg" /></meta><meta property="og:description" content="Five novel modified linear peptides named brintonamides A–E (1–5) were discovered from a marine cyanobacterial sample collected from Brinton Channel, Florida Keys. The total synthesis of 1–5 in addition to two other structurally related analogues (6 and 7) was achieved, which provided more material to allow rigorous biological evaluation and SAR studies. Compounds were subjected to cancer-focused phenotypic cell viability and migration assays and orthogonal target-based pharmacological screening platforms to identify their protease and GPCR modulatory activity profiles. The cancer related serine protease kallikrein 7 (KLK7) was inhibited to similar extents with an IC50 near 20 μM by both representative members 1 and 4, which differed in the presence or lack of the N-terminal unit. In contrast to the biochemical protease profiling study, clear SAR was observed in the functional GPCR screens, where five GPCRs in antagonist mode (CCR10, OXTR, SSTR3, TACR2) and agonist mode (CXCR7) were modulated by compounds 1–7 to varying extents. Chemokine receptor type 10 (CCR10) was potently modulated by brintonamide D (4) with an IC50 of 0.44 μM. We performed in silico modeling to understand the structural basis underlying the differences in the antagonistic activity among brintonamides toward CCR10. Because of the significance of KLK7 and CCR10 in cancer progression and metastasis, we demonstrated the ability of brintonamide D (4) at 10 μM to significantly target downstream cellular substrates of KLK7 (Dsg-2 and E-cad) in vitro and to inhibit CCL27-induced CCR10-mediated proliferation and the migration of highly invasive breast cancer cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00885"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00885">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00885&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00885&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00885&amp;href=/doi/10.1021/acs.jmedchem.8b00885" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6364-6378</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00810" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00929" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A–E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Fatma H. Al-Awadhi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fatma H. Al-Awadhi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fatma%0AH.++Al-Awadhi">Fatma H. Al-Awadhi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bowen Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bowen Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Xili, Nanshan District, Shenzhen, 518055, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bowen++Gao">Bowen Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mohammad A. Rezaei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohammad A. Rezaei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div><div class="loa-info-affiliations-info">Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohammad+A.++Rezaei">Mohammad A. Rezaei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason C. Kwan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason C. Kwan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason+C.++Kwan">Jason C. Kwan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chenglong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chenglong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chenglong++Li">Chenglong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tao Ye</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Ye</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Xili, Nanshan District, Shenzhen, 518055, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Ye">Tao Ye</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2780-9761" title="Orcid link">http://orcid.org/0000-0002-2780-9761</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valerie J. Paul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valerie J. Paul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Smithsonian Marine Station, Fort Pierce, 701 Seaway Drive, Fort Pierce, Florida 34949, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valerie+J.++Paul">Valerie J. Paul</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hendrik Luesch</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hendrik Luesch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +1-352-273-7738. Fax: +1-352-273-7741. E-mail: <a href="/cdn-cgi/l/email-protection#2448514157474c64474b540a5142480a414051"><span class="__cf_email__" data-cfemail="305c455543535870535f401e45565c1e555445">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hendrik++Luesch">Hendrik Luesch</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4091-7492" title="Orcid link">http://orcid.org/0000-0002-4091-7492</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00885&amp;href=/doi/10.1021%2Facs.jmedchem.8b00885" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6364–6378</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 June 2018</li><li><span class="item_label"><b>Published</b> online</span>17 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00885" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00885</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6364%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFatma%250AH.%2BAl-Awadhi%252C%2BBowen%2BGao%252C%2BMohammad%2BA.%2BRezaei%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.8b00885%26title%3DDiscovery%252C%2BSynthesis%252C%2BPharmacological%2BProfiling%252C%2Band%2BBiological%2BCharacterization%2Bof%2BBrintonamides%2BA%25E2%2580%2593E%252C%2BNovel%2BDual%2BProtease%2Band%2BGPCR%2BModulators%2Bfrom%2Ba%2BMarine%2BCyanobacterium%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6378%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00885"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1225</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00885" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A–E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fatma\nH.&quot;,&quot;last_name&quot;:&quot;Al-Awadhi&quot;},{&quot;first_name&quot;:&quot;Bowen&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Mohammad&quot;,&quot;last_name&quot;:&quot;A. Rezaei&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;C. Kwan&quot;},{&quot;first_name&quot;:&quot;Chenglong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Valerie&quot;,&quot;last_name&quot;:&quot;J. Paul&quot;},{&quot;first_name&quot;:&quot;Hendrik&quot;,&quot;last_name&quot;:&quot;Luesch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6364-6378&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00885&quot;},&quot;abstract&quot;:&quot;Five novel modified linear peptides named brintonamides A–E (1–5) were discovered from a marine cyanobacterial sample collected from Brinton Channel, Florida Keys. The total synthesis of 1–5 in addition to two other structurally related analogues (6 and 7) was achieved, which provided more material to allow rigorous biological evaluation and SAR studies. Compounds were subjected to cancer-focused phenotypic cell viability and migration assays and orthogonal target-based pharmacological screening platforms to identify their protease and GPCR modulatory activity profiles. The cancer related serine protease kallikrein 7 (KLK7) was inhibited to similar extents with an IC50 near 20 μM by both representative members 1 and 4, which differed in the presence or lack of the N-terminal unit. In contrast to the biochemical protease profiling study, clear SAR was observed in the functional GPCR screens, where five GPCRs in antagonist mode (CCR10, OXTR, SSTR3, TACR2) and agonist mode (CXCR7) were modulated by compounds 1–7&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00885&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00885" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00885&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00885" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00885&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00885" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00885&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00885&amp;href=/doi/10.1021/acs.jmedchem.8b00885" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00885" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00885" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00885%26sid%3Dliteratum%253Aachs%26pmid%3D30015488%26genre%3Darticle%26aulast%3DAl-Awadhi%26date%3D2018%26atitle%3DDiscovery%252C%2BSynthesis%252C%2BPharmacological%2BProfiling%252C%2Band%2BBiological%2BCharacterization%2Bof%2BBrintonamides%2BA%25E2%2580%2593E%252C%2BNovel%2BDual%2BProtease%2Band%2BGPCR%2BModulators%2Bfrom%2Ba%2BMarine%2BCyanobacterium%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D6364%26epage%3D6378%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Five novel modified linear peptides named brintonamides A–E (<b>1</b>–<b>5</b>) were discovered from a marine cyanobacterial sample collected from Brinton Channel, Florida Keys. The total synthesis of <b>1</b>–<b>5</b> in addition to two other structurally related analogues (<b>6</b> and <b>7</b>) was achieved, which provided more material to allow rigorous biological evaluation and SAR studies. Compounds were subjected to cancer-focused phenotypic cell viability and migration assays and orthogonal target-based pharmacological screening platforms to identify their protease and GPCR modulatory activity profiles. The cancer related serine protease kallikrein 7 (KLK7) was inhibited to similar extents with an IC<sub>50</sub> near 20 μM by both representative members <b>1</b> and <b>4</b>, which differed in the presence or lack of the N-terminal unit. In contrast to the biochemical protease profiling study, clear SAR was observed in the functional GPCR screens, where five GPCRs in antagonist mode (CCR10, OXTR, SSTR3, TACR2) and agonist mode (CXCR7) were modulated by compounds <b>1</b>–<b>7</b> to varying extents. Chemokine receptor type 10 (CCR10) was potently modulated by brintonamide D (<b>4</b>) with an IC<sub>50</sub> of 0.44 μM. We performed in silico modeling to understand the structural basis underlying the differences in the antagonistic activity among brintonamides toward CCR10. Because of the significance of KLK7 and CCR10 in cancer progression and metastasis, we demonstrated the ability of brintonamide D (<b>4</b>) at 10 μM to significantly target downstream cellular substrates of KLK7 (Dsg-2 and E-cad) in vitro and to inhibit CCL27-induced CCR10-mediated proliferation and the migration of highly invasive breast cancer cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer metastasis is considered the major cause of death among cancer patients. It is a complex multistep process that often starts when cancer cells penetrate the adjacent tissues, passing the basement membrane and extracellular matrix (ECM) to enter the vascular/lymphatic circulation. Once in circulation, cancer cells travel through and eventually exit by invading the basement membrane and ECM. They adhere at the new location and ultimately proliferate and produce secondary tumors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, understanding the mechanisms involved in metastasis is critical for the development of treatment strategies to limit tumor progression. The metastatic process involves the regulation of many factors, where the physical barrier represented by the basement membrane and ECM surrounding the cells is considered a critical rate-limiting step for cancer invasion and metastasis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One mechanism by which tumor cells overcome this physical barrier is mediated by the action of proteases, which are often upregulated to degrade ECM components or digest adhesive molecules, ultimately altering the tissue cohesiveness resulting in the dissemination of tumor cells. Among the various protease families, serine proteases have been extensively studied and reported to be aberrantly expressed and associated with invasion and metastasis of several cancers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> One example includes Kallikrein-related peptidases, consisting of 15 members of serine proteases with varying degrees of sequence homology (40–80%).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> They are secreted as inactive zymogens and later activated by the proteolytic cleavage of their pro-signal peptide via the action of other proteases or through autoactivation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Among the different members of this family of proteases, kallikrein 7 (KLK7) is a chymotryptic-like serine protease, originally named stratum corneum chymotryptic enzyme.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> It was initially identified in human skin extracts and functions in the shedding and desquamation of the skin via degradation of the adhesive molecules desmogleins and coreneodesmosomes.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Moreover, KLK7 transcripts and protein levels have been found to be overexpressed in several cancer types including ovarian, squamous cervical, breast, and pancreatic adenocarcinomas.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12">(8−12)</a></div><div class="NLM_p">In addition to proteases, recent studies report the involvement of G protein-coupled receptors (GPCRs) in cancer progression.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> GPCRs play important roles in regulating fundamental physiological functions essential to life, such as metabolism, neurotransmission, immune responses, and homeostasis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, their dysregulated activities have been linked to many diseases including diabetes,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> hypertension,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> heart failure,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and cancer.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Their vital role is reflected by the number of current GPCR drug targets, as ∼34% of all FDA approved drugs act at 108 unique GPCRs.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Several studies report the implication of GPCRs in regulating the metastatic process of various tumors, in particular GPCR linked chemokine receptors and their ligands.<a onclick="showRef(event, 'ref15 ref24'); return false;" href="javascript:void(0);" class="ref ref15 ref24">(15,24)</a> Chemokine receptors are overexpressed in various tumors and linked with poor prognosis. For example, the chemokine receptor type 4 (CXCR4) is one of the major chemokine receptors found to be expressed in ∼23 types of cancer cells,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> reported to be a regulator of breast cancer and involved in lymph node metastasis.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Other receptors include chemokine receptor type 10 (CCR10), which is expressed and plays a role in the metastatic cascade of adult T-cell leukemia/lymphoma (ATLL) and melanoma.<a onclick="showRef(event, 'ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref28">(24,28)</a> In human melanoma, the expression of CCR10 enhances the invasive ability of cancer cells resulting in their dissemination to lymph nodes.<a onclick="showRef(event, 'ref24 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref29">(24,29)</a> Therefore, targeting such receptors might provide a potential strategy for restricting tumor metastasis.</div><div class="NLM_p last">Marine cyanobacteria are a rich source of bioactive molecules with diverse activities. In addition to being prolific producers of protease inhibitors,<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> marine cyanobacteria often produce structurally diverse compounds that resemble endogenous ligands of GPCRs. Examples include the cyanobacterial fatty acid amides with cannabinoid receptor activity<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37 ref38">(33−38)</a> and recently the discovery of cyanobacterial fraction targeting serotonin receptor 2C.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Herein we describe the isolation, structure determination, and synthesis of five novel modified peptides and other structurally related analogues. Also, we report the biological evaluation of their dual protease and GPCR targeting activities and subsequently their effects on breast cancer migration.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Isolation and Sructure Eucidation</h3><div class="NLM_p">Samples of intertidal cyanobacterial mats (dominated by major filament types of Oscillatoriaceae) collected from Brinton Channel, near Summerland Key, Florida, were extracted with a mixture of EtOAc:MeOH (1:1) following freeze-drying. The nonpolar extract was then partitioned using different solvents, yielding 1.6 g of <i>n</i>-BuOH fraction, which was subjected to silica gel chromatography using a gradient system of increasing polarity (<i>i</i>-PrOH/CH<sub>2</sub>Cl<sub>2</sub>, MeOH) to afford 10 fractions. On the basis of the NMR profiles of those fractions, the fraction eluted with 50% <i>i</i>-PrOH/CH<sub>2</sub>Cl<sub>2</sub> showed characteristic resonances of modified peptides. Further purification of this fraction by reversed-phase HPLC resulted in the isolation of five novel compounds termed brintonamides A–E (<b>1</b>–<b>5</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cyanobacterial-derived brintonamides A–E (<b>1</b>–<b>5</b>) with the differences among structures <b>1</b>–<b>5</b> highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structures of those isolated compounds (<b>1</b>–<b>5</b>) were elucidated using a combination of 1D and 2D NMR experiments (<sup>1</sup>H NMR, <sup>13</sup>C NMR, COSY, TOCSY, HSQC, HMBC, and ROESY). The <sup>1</sup>H and <sup>13</sup>C NMR profiles of brintonamides A–E (<b>1</b>–<b>5</b>) were characteristic of modified peptides with typical chemical shifts of α-protons (δ<sub>H</sub>∼ 4–5 ppm), carbonyls (δ<sub>C</sub> ∼ 165–175 ppm), and exchangeable protons of amides (δ<sub>H</sub> ∼ 6–8). Also, <i>O</i>-methyl (δ<sub>H</sub> ∼ 3.73) and <i>N</i>-methyl (δ<sub>H</sub> ∼ 2.76–3.0) signals were apparent. Further analysis of 2D NMR spectra confirmed the presence of the following units in all of the isolated compounds (<b>1</b>–<b>5</b>): <i>O</i>-Me-Pro, <i>N</i>-Me-Phe, Ala, <i>N</i>-Me-Leu, Gly, and Pro. However, the compounds differ in their <i>N</i>-terminal unit. Those units were identified to be either 2-hydroxy-3-methylpentanoic acid (Hmpa), 2-hydroxyisovaleric acid (Hiva), <i>N</i>,<i>N</i>-Me<sub>2</sub>-Phe, or cinnamic acid. The sequence of these units was determined based on correlations observed in HMBC and ROESY spectra and further confirmed by MS-MS fragmentation (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S1</a>).</div><div class="NLM_p">HRESI/APCIMS of <b>1</b> suggested a molecular formula of C<sub>39</sub>H<sub>60</sub>N<sub>6</sub>O<sub>9</sub> (<i>m</i>/z 779.4321 for [M + Na]<sup>+</sup>, 757.4491 for [M + H]<sup>+</sup>). The analysis of both 1D and 2D NMR spectra (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S1</a>) suggested the presence of two amide NH signals (δ<sub>H</sub> 7.38 and 6.75), α-protons (δ<sub>H</sub> 5.65–4.02), one <i>O</i>-methyl singlet (δ<sub>H</sub> 3.71), two <i>N</i>-methyl singlets (δ<sub>H</sub> 2.99 and 2.84), and free OH (δ<sub>H</sub> 4.73). Furthermore, examination of 2D NMR spectra allowed the identification of Hmpa as a terminal unit connected to the following moieties: <i>O</i>-Me-Pro, <i>N</i>-Me-Phe, Ala, <i>N</i>-Me-Leu, Gly, and Pro, making the final structure of the linear peptide.</div><div class="NLM_p">HRESI/APCIMS of <b>2</b> suggested a molecular formula of C<sub>38</sub>H<sub>58</sub>N<sub>6</sub>O<sub>9</sub> (<i>m</i>/z 765.4172 for [M + Na]<sup>+</sup>, 743.4343 for [M + H]<sup>+</sup>), indicating one less methylene compared to <b>1</b>. Compound <b>2</b> exhibited similarity to <b>1</b> in terms of <sup>1</sup>H and <sup>13</sup>C NMR chemical shifts. Further examination of COSY, TOCSY, HSQC, HMBC, and ROESY data revealed the presence of the same units as in <b>1</b>, except for Hiva instead of Hmpa at the <i>N</i>-terminus (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S2</a>).</div><div class="NLM_p">HRESI/APCIMS of <b>3</b> exhibited molecular ion peaks at <i>m</i>/<i>z</i> 954.5311 [M + Na]<sup>+</sup> and 932.5504 [M + H]<sup>+</sup>, suggesting a molecular formula of C<sub>50</sub>H<sub>73</sub>N<sub>7</sub>O<sub>10</sub>. Analysis of <sup>1</sup>H NMR and edited-HSQC revealed similar chemical shifts to <b>1</b> and <b>2</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S3</a>). The major differences were the presence of an additional <i>N</i>,<i>N</i>-dimethyl unit (δ<sub>H/C</sub> 2.40, 41.3), the slightly downfield shift of the α-proton of the Hmpa moiety (δ<sub>H</sub> 4.72), and an additional aromatic group. Analysis of both COSY and HMBC spectra allowed the construction of the <i>N</i>,<i>N</i>-Me<sub>2</sub>-Phe residue, which is connected to the Hmpa unit by an ester linkage. The chemical shift of the α-proton of Hmpa in <b>3</b> is indicative of an ester compared to the chemical shift of free alcohol present in <b>1</b> and <b>2</b> (δ<sub>H</sub> 4.72 versus ∼4.29 and 4.14, respectively).</div><div class="NLM_p">HRESI/APCIMS of compound <b>4</b> in the positive mode exhibited a molecular ion peak at <i>m</i>/<i>z</i> of 909.4765 [M + Na]<sup>+</sup>, suggesting a molecular formula of C<sub>48</sub>H<sub>66</sub>N<sub>6</sub>O<sub>10</sub>. Analysis of <sup>1</sup>H NMR and edited-HSQC spectra revealed chemical shifts (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S4</a>) very close to <b>3</b>, and therefore, it is not surprising that the linear backbone of both compounds was also very similar. The major difference between <b>3</b> and <b>4</b> is the elimination of the <i>N</i>,<i>N</i>-dimethyl moiety from <b>4</b> resulting in an alkene (δ<sub>H/C</sub> 6.5/117.5 and δ<sub>H/C</sub> 7.7/146.1), which is connected to the aromatic ring based on correlations observed in the HMBC spectrum.</div><div class="NLM_p">HRESI/APCIMS of compound <b>5</b> exhibited a molecular ion peak at <i>m</i>/<i>z</i> of 909.4773 [M + Na]<sup>+</sup>, suggesting a molecular formula of C<sub>48</sub>H<sub>66</sub>N<sub>6</sub>O<sub>10</sub>. Compounds <b>5</b> and <b>4</b> have the same molecular weight, and analysis of <sup>1</sup>H NMR and edited-HSQC spectra revealed very close chemical shifts (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S5</a>). Examination of 2D NMR spectra confirmed the presence of the same substructures; however, analysis of <sup>1</sup>H NMR of both compounds suggested that <b>4</b> and <b>5</b> are isomers having different configurations of the cinnamic acid moiety. In compound <b>4</b>, the methine protons at the terminal unit displayed a larger coupling constant (<i>J</i> = 16.1 Hz), suggesting a <i>trans</i> configuration, whereas the methine protons in compound <b>5</b> displayed a smaller coupling constant (<i>J</i> = 12.6 Hz) indicative of <i>cis</i> configuration.</div><div class="NLM_p">It is important to note that some signals of brintonamides were observed as doubled signals, which are due to the presence of rotamers rather than impurities.</div><div class="NLM_p last">To assign the absolute configurations of the stereocenters present in brintonamides (<b>1</b>–<b>5</b>), portions of <b>1</b>–<b>5</b> (100 μg) were hydrolyzed using 6 N HCl (110 °C, 24 h) and subjected to enantioselective HPLC-MS analysis. The analysis revealed retention times corresponding to <span class="smallcaps smallerCapital">l</span>-Ala, <span class="smallcaps smallerCapital">l</span>-Pro, <i>N</i>-Me-<span class="smallcaps smallerCapital">l</span>-Leu, <i>N</i>-Me-<span class="smallcaps smallerCapital">d</span>-Phe, D-Hiva, and <i>N</i>,<i>N</i>-Me<sub>2</sub>-<span class="smallcaps smallerCapital">l</span>-Phe by comparison with authentic standards. The configuration of the Hmpa unit was established by chiral HPLC analysis under different conditions using CuSO<sub>4</sub> and was found to be (2<i>R</i>,3<i>S</i>)-Hmpa.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Total Synthesis of Brintonamides and Other Structurally Related Analogues</h3><div class="NLM_p">Because of the limited amounts of compounds <b>1</b>–<b>5</b> available for biological studies through isolation, the total synthesis was pursued, which provided sufficient material for further biological investigations. Synthesis also confirmed that our structural assignments were correct by comparison of the NMR spectra of the synthetic compounds with those of the natural products obtained through isolation. The synthesis commenced with the preparation of hexapeptide <b>9</b> by use of the standard Fmoc-based solid phase synthetic method (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Elongation of the peptide chain was accomplished by stepwise coupling of the required amino acids promoted by <i>O</i>-(7-azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU). After TFA-mediated cleavage of the peptide from the resin, esterification of the resulting acid <b>10</b> with tetramethylsilyldiazomethane afforded the corresponding peptide methyl ester <b>11</b>. Finally, removal of the Fmoc group from <b>11</b> followed by coupling of the resulting amine with acid <b>12</b> or <b>13</b> under HATU conditions furnished brintonamides A (<b>1</b>) (82% yield) and B (<b>2</b>) (84% yield), as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (for the detailed synthetic procedures, check the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Supporting Information</a>; all the synthetic samples were further purified by HPLC to give rise to samples with purity ≥95%).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Total Synthesis of Brintonamides A and B (<b>1</b> and <b>2</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Brintonamides C–E (<b>3</b>–<b>5</b>) and two structurally related analogues, dehydro-brintonamide D/E (<b>6</b>) and dihydro-brintonamide D/E (<b>7</b>), were prepared from brintonamide A (<b>1</b>) under Yamaguchi mixed anhydride conditions (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Compounds <b>6</b> and <b>7</b>, with different degrees of unsaturation, were designed to probe the contribution of the double bond and potential Michael acceptor in the cinnamic acid residue to activities in subsequent bioactivity studies. The esterification of acids <b>14</b>–<b>17</b> with brintonamide A (<b>1</b>) proceeded smoothly and cleanly to furnish brintonamides D (<b>4</b>), E (<b>5</b>), and compounds <b>6</b> and <b>7</b> in good yields (61–93%). Under identical conditions, however, brintonamide C (<b>3</b>) was obtained in only 39% yield.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Total Synthesis of Brintonamides C–E (<b>3</b>–<b>5</b>) and Analogues <b>6</b> and <b>7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biological Evaluation</h3><div class="NLM_p last">In our search for new anticancer agents with activity against the highly invasive triple negative breast cancer, we initially assessed the cytotoxicity against MDA-MB-231 cells. Complementary to this phenotypic assay, we employed biochemical and functional screening strategies against druggable targets that are linked to cancer but not necessarily through a cytotoxic mechanism. We focused on proteases because marine cyanobacteria are known to produce modified peptides with propensity to inhibit various proteases, some of which play a role in breast cancer metastasis as we have shown in our prior studies.<a onclick="showRef(event, 'ref30 ref31 ref40'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref40">(30,31,40)</a> Additionally, as marine cyanobacteria often produce modified peptides that resemble endogenous ligands of GPCRs, and because the GPCR targeting activity of cyanobacterial secondary metabolites is largely unexplored, we carried out a functional screen against a panel of GPCRs as an orthogonal platform. Our study aimed at investigating the full potential of brintonamides in targeting invasive breast cancer.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Antiproliferative Activity of Brintonamides against Invasive Breast Cancer cells</h3><div class="NLM_p">The cytotoxic activity of brintonamides (<b>1</b>–<b>7</b>) was evaluated against MDA-MB-231 breast cancer cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Brintonamides A and B (<b>1</b> and <b>2</b>) did not show any cytotoxicity, while treatment with brintonamide C (<b>3</b>) reduced viability by 50% only at the highest concentration tested (100 μM). Brintonamides D and E (<b>4</b> and <b>5</b>) exhibited weak cytotoxic activity with IC<sub>50</sub> values of 16.7 and 14.9 μM, respectively. It appeared that the cytotoxicity resulted from the incorporation of the Phe at the <i>N</i>-terminal end of the molecule, and the presence of the <i>E</i>-configured α,β-unsaturated carboxyl unit further enhanced the cytotoxic activity. Consequently, the synthetic analogues (<b>6</b> and <b>7</b>) were evaluated and were found to exhibit less potent cytotoxic activity than <b>4</b> and <b>5</b>. Compound <b>6</b> resulted in 50% viability at 32 μM, whereas <b>7</b> had an IC<sub>50</sub> of 60 μM. This preliminary SAR data suggests that role of the <i>N</i>-terminal residue in modulating the antiproliferative activity of these compounds (<b>1</b>–<b>7</b>), and the presence of a hydroxy acid with free OH at the <i>N</i>-terminus abolishes the activity.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antiproliferative activity of brintonamides (<b>1</b>–<b>7</b>) against MDA-MB-231 breast cancer cells. MDA-MB-231 cells were seeded (10 000 cells/well) in 96-well plates. Following 24 h incubation, the cells were treated with different concentrations of <b>1</b>–<b>7</b> or solvent control for 48 h. The cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay). Data is presented as mean ± SD, <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Protease Profiling Identifies Brintonamides as KLK7 Inhibitors</h3><div class="NLM_p">Because marine cyanobacteria are a prolific source of protease inhibitors, we thought to investigate whether brintonamides exhibit any antiproteolytic activity. To probe the activity and selectivity, brintonamides A and D (<b>1</b> and <b>4</b>) were profiled against a panel of 63 proteases in a dose–response format starting at 100 μM and the IC<sub>50</sub> values were obtained (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Compounds <b>1</b> and <b>4</b> were selected as representative brintonamides based on their structural differences at the <i>N</i>-terminus. We considered proteases that were inhibited with IC<sub>50</sub> values ∼20 μM or less as potential hits. Brintonamide A (<b>1</b>) exhibited inhibitory effects against the serine proteases chymotrypsin and kallikrein 7 (KLK7) with IC<sub>50</sub> values of 8.98 and 22.1 μM, respectively. Brintonamide D (<b>4</b>) exhibited a moderate inhibitory activity against three proteases in the low micromolar range (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1</a></a>), including the serine proteases KLK7 and chymase and the cysteine protease caspase 14. Despite the identification of several proteases as potential targets in the primary screen, we focused our studies on examining the inhibitory effects of brintonamides on KLK7 due to its established and growing significance in cancer metastasis.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41−44)</a> Despite the clinical significance of KLK7, there are few inhibitors reported in the literature with IC<sub>50</sub> values in the micromolar range.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> From nature, a depsipeptide produced by <i>Chondromyces</i> bacteria was found to elicit a KLK7-specific inhibitory activity with IC<sub>50</sub> value in the low nM range.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> From a clinical perspective, there are no tissue KLK7 inhibitors so far on the market. The only kallikrein inhibitor currently on the market is ecallantide, which was approved by the FDA in October 2008 for the management of hereditary angioedema (HAE). Ecallantide is a potent, specific, and reversible inhibitor of plasma kallikrein (<i>K</i><sub>i</sub> = 25 pM).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protease inhibitory activity of brintonamides (<b>1</b>–<b>7</b>). (A) Profiling brintonamides A and D (<b>1</b> and <b>4</b>) against a panel of 63 proteases. Heat maps represent % enzyme activities at 10 μM final concentrations of <b>1</b> and <b>4</b>. (B) Dose–response curves of the antiproteolytic activity of brintonamides <b>1</b>–<b>7</b> against KLK7 as a follow up study. The dose–response is presented as % fold inhibition against solvent control (DMSO). Data is presented as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values of Brintonamides A and D (<b>1</b> and <b>4</b>), and Positive Controls against Hits Identified in the Screen</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protease</th><th class="colsep0 rowsep0" align="center" char=".">kallikrein 7 (μM)</th><th class="colsep0 rowsep0" align="center">chymase</th><th class="colsep0 rowsep0" align="center" char=".">caspase 14 (μM)</th><th class="colsep0 rowsep0" align="center">chymotrypsin</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide A (<b>1</b>)</td><td class="colsep0 rowsep0" align="char" char=".">22.1</td><td class="colsep0 rowsep0" align="center">101 μM</td><td class="colsep0 rowsep0" align="char" char=".">50.3</td><td class="colsep0 rowsep0" align="center">8.98 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide D (<b>4</b>)</td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="center">23.2 μM</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="center">>100 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gabexate mesylate</td><td class="colsep0 rowsep0" align="char" char=".">20.4</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymostatin</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center">9.36 nM</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center">0.31 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IETD-CHO</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">7.28</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div></div><div class="NLM_p last">To validate KLK7 as a hit identified in the primary screen and to provide a preliminary SAR data, brintonamides A–E (<b>1</b>–<b>5</b>) along with the synthetic analogues (<b>6</b> and <b>7</b>) were tested in parallel against KLK7 in a dose–response format starting at 100 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). However, the compounds exhibited comparable IC<sub>50</sub> values lacking SAR against KLK7. We carried out enzyme kinetic studies to investigate the mode of inhibition of KLK7, which revealed mixed mode of inhibition characterized by decreasing <i>V</i><sub>max</sub> and increasing <i>K</i><sub>m</sub> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S2</a>). Molecular docking studies with the slightly most potent compound <b>4</b> suggested potential key interactions (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S3</a>). Brintonamide D (<b>4</b>) partially inhibited the cleavage of KLK7 downstream substrates, desmoglein-2 and E-cadherin, at 10 μM in a biochemical assay (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S4</a>); however, in KLK7, Dsg-2 and E-cad expressing MDA-MB-468 breast cancer cells (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S5</a>), compound <b>4</b> was unable to decrease Dsg-2 shedding despite inhibiting the migration of these cells similar to siRNAs targeting <i>KLK7</i> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S6</a>), suggesting that KLK7 is not sufficiently inhibited in a cellular context to cause the observed inhibitory phenotype on migration. The lack of cellular activity against KLK7, yet the promising inhibitory effects on migration indicated the involvement of other targets, which prompted us to apply an orthogonal functional screening platform to search for other potentially druggable targets predictive of the activity of brintonamides in breast cancer cells.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> GPCR Profiling Identifies Five Additional Targets for Brintonamides</h3><div class="NLM_p">To identify relevant cellular activities, brintonamides A and D (<b>1</b> and <b>4</b>) were profiled against a panel of 241 GPCR targets (agonist, antagonist, and orphan) at 10 μM final concentration using cell-based functional assays (unlike the enzyme biochemical assays used for protease profiling) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The screen was carried out using PathHunter β-arrestin assay technology (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B; <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GPCR profiling of brintonamides A and D (<b>1</b> and <b>4</b>) using cell-based functional screen. (A) Heatmap showing the profiling data of brintonamides A and D (<b>1</b> and <b>4</b>) against the gpcr<i>Max</i> and orphan panels of GPCR targets. (B) The GPCR assay principle based on the enzyme fragment complementation technology. (C,D) Scatter plots showing the % Activation or inhibition of 10 μM brintonamides A and D (<b>1</b> and <b>4</b>) against gpcr<i>Max</i> panel (agonist and antagonist modes). The hits identified in the screen with >50% activity or inhibitions are labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although profiling brintonamide A (<b>1</b>) did not show any hits (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,C), screening brintonamide D (<b>4</b>) at the same concentration (10 μM) revealed CXCR7 as the only hit in the agonist panel with 86% activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). CXCR7 is a chemokine receptor type 7, which has a role in mediating tumor development, migration, and angiogenesis.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Activating this receptor has a potential application in liver or lung fibrosis.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> In the antagonist panel, <b>4</b> modulated CCR10, TACR2, SSTR3, and OXTR activity with 98, 97, 77, and 76% inhibition, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The chemokine receptor type 10 (CCR10) is known to be expressed by melanocytes, plasma cells, and skin T cells.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> CCR10 has been reported to be involved in metastasis and T-cell mediated skin inflammation.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> Tachykinin receptor 2 (TACR2) is a receptor for tachykinin neuropeptide substance K (neurokinin A) that is involved in psychiatric diseases such as anxiety and depression.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> SSTR3 is a somatostatin receptor 3 which is expressed in the pancreatic islets. Somatostatin is known to suppress the production of pancreatic hormones such as insulin, and therefore SSTR3 is a potential target for the management of type 2 diabetes.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> Oxytocin receptor (OXTR) is known to be expressed by myoepithelial cells of the mammary gland myometrium and CNS.<a onclick="showRef(event, 'ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61 ref62">(59−62)</a></div><div class="NLM_p">When screened at higher concentration (20 μM), brintonamide D (<b>4</b>) displayed agonistic activity against CXCR7 with 91% activity. However, in the antagonist GPCR panel, several additional interactions between <b>4</b> and GPCR receptors were identified (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The top five hits identified were similar to those identified when screened at the lower (10 μM) final concentration but with higher % inhibitory activity, further validating these hits as targets of brintonamide D (<b>4</b>).</div><div class="NLM_p">Next, to validate the hits identified in the primary screens, all brintonamides <b>1</b>–<b>7</b> were tested in a dose–response manner starting at 20 μM, using an agonist and antagonist secondary screen against five targets (CXCR7, CCR10, OXTR, SSTR3, and TACR2) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">2</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> or EC<sub>50</sub> Values of Brintonamides (<b>1</b>–<b>7</b>) against the GPCR Hits Identified in the Primary Screen</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" char="." /></col><col align="center" char="." /></col><col align="center" char="." /></col><col align="center" char="." /></col><col align="center" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound/GPCR target</th><th class="colsep0 rowsep0" align="center" char=".">CCR10<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CXCR7<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">OXTR<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">SSTR3<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">TACR2<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide A (<b>1</b>)</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide B (<b>2</b>)</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide C (<b>3</b>)</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">10.46</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">6.11</td><td class="colsep0 rowsep0" align="center" char=".">5.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide D (<b>4</b>)</td><td class="colsep0 rowsep0" align="center" char=".">0.44</td><td class="colsep0 rowsep0" align="center" char=".">3.97</td><td class="colsep0 rowsep0" align="center" char=".">6.78</td><td class="colsep0 rowsep0" align="center" char=".">3.12</td><td class="colsep0 rowsep0" align="center" char=".">1.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brintonamide E (<b>5</b>)</td><td class="colsep0 rowsep0" align="center" char=".">2.71</td><td class="colsep0 rowsep0" align="center" char=".">5.92</td><td class="colsep0 rowsep0" align="center" char=".">5.76</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">4.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center" char=".">3.14</td><td class="colsep0 rowsep0" align="center" char=".">7.81</td><td class="colsep0 rowsep0" align="center" char=".">5.32</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">3.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td><td class="colsep0 rowsep0" align="center" char=".">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> agonist.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> antagonist (μM).</p></div></div></div><div class="NLM_p">Brintonamides A and B (<b>1</b> and <b>2</b>) did not show any activity against the tested GPCR targets, suggesting that the <i>N</i>-terminus residue is important for activity and the presence of a hydroxy group abolishes the activity. Brintonamide C (<b>3</b>), bearing <i>N</i>,<i>N</i>-Me<sub>2</sub>-Phe residue at the <i>N</i>-terminus, exhibited a moderate activity against the following GPCR targets: CXCR7, SSTR3, and TACR2 with IC<sub>50</sub> values in a low micromolar range (10.4, 6.1, 5.5, respectively). However, <b>3</b> did not show any activity against CCR10 and OXTR. The regioisomeric compounds, brintonamides D and E (<b>4</b> and <b>5</b>), containing a cinnamic acid moiety at the <i>N</i>-terminus, exhibited a moderate activity with IC<sub>50</sub>s in the low micromolar range. The <i>trans</i> isomer, brintonamide D (<b>4</b>), was the most potent analogue with submicromolar activity against CCR10 and was active against all five tested GPCR targets compared to the other brintonamides. The <i>cis</i> isomer, brintonamide E (<b>5</b>), exhibited comparable potency to <b>4</b> but was inactive against SSTR3, suggesting that the <i>trans</i> configuration is required for activity against SSTR3. The synthetic analogue <b>6</b>, bearing an alkane instead of alkene, exhibited comparable potency to brintonamide E (<b>5</b>) and was also inactive against SSTR3. The activity of <b>6</b> suggests that the activity of brintonamides D and E (<b>4</b> and <b>5</b>), bearing a potential Michael acceptor, is most likely not mediated by covalent interaction with the targets. Finally, the synthetic analogue <b>7</b>, containing phenylacetylene at the <i>N</i>-terminus, did not exhibit any activity against the tested GPCR targets, indicating that the presence of an alkyne abolishes the activity.</div><div class="NLM_p last">Because CCR10 emerged as the best hit in our GPCR profiling platform, inhibited with submicromolar IC<sub>50</sub> by brintonamide D (<b>4</b>), and due to its significance in cancer metastasis, we focused our studies on investigating the effects of CCR10 inhibition via brintonamides on cancer cell proliferation and migration.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling of CCR10 Interactions</h3><div class="NLM_p">To gain insight into the structural basis underlying the differences in the inhibitory activity of brintonamides against CCR10, we carried out molecular docking experiments. Because of the lack of available crystal structure for CCR10, we developed and utilized a homology model from δ opioid-type receptor templates (more details in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">The first visual inspection of the environment around brintonamide D (<b>4</b>) in the best selected model shows a highly charged binding pocket. There are nine arginine residues (ARG 151, 238, 243, 247, 318, 322, 337, 338, and 345) in the vicinity of analogue D (<b>4</b>), closer than 5.0 Å to it, which accounts for 27% of the arginine content in CCR10 protein; three of them form hydrogen bonds with the ligand, including Arg247, Arg322, and Arg345, with H-bond lengths between 2.2 and 2.4 Å. The binding site is characterized by a β-sheet, which was found to be relatively stable in the same subfamilies of templates but has movement across different families of GPCR structures. The residue Tyr227 in the middle of this β-sheet has π–π interaction with the aromatic ring on the modified side of brintonamide D (<b>4</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The perfectly parallel Tyr227 and phenyl group of <b>4</b> secures the ligand at the entrance of the binding site. This parallel stacking of aromatic rings seems to be the differentiator between the potency of the brintonamide ligands; only analogue D (<b>4</b>) is able to capture this key interaction, whereas the other compounds tend to engage with the other side of the binding pocket. In addition, the almost extended conformation of the ligand allows it to form three hydrogen bonds with the arginine residues in the deeper binding pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). These H-bonds are formed with arginine residues located on three adjacent helices. Several weaker H-bonds also exist with other arginine residues.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding conformation of (A) brintonamide D (<b>4</b>), (B) brintonamide E (<b>5</b>), (C) brintonamide A (<b>1</b>), and (D) brintonamide B (<b>2</b>) within CCR10 model. The interactions with key amino acid residues in the binding site are shown. The compounds are displayed as stick representation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In comparison, brintonamide E (<b>5</b>), which is the second most potent CCR10 antagonist, shows a completely bent conformation in a different environment (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). While it forms two H-bonds with Arg338, it is surrounded by a more diverse set of residues ranging from Arg151, 232, 337, and 338 on one side of the ligand to negatively charged Glu4 and 19, as well as the polar residues Gln8 and 83, Thr77, and Ser78, on the other side of the ligand. Interestingly, the two phenyl groups in compound E (<b>5</b>) are parallel-stacked and form π–π interactions. Analogue <b>6</b> with IC<sub>50</sub> value of the same order as brintonamide E (<b>5</b>) demonstrates a bent binding pose similar to its counterpart (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S7A</a>). It also captures the same two hydrogen bonds with the same residue, Arg338. For compound <b>7</b>, the triple bond linker rigidifies the phenyl ring and is expected to have entropic penalty compared to the previously discussed compounds. Because of its inflexibility at the modified side as well as its relatively long chain between the ester and phenyl groups, brintonamide <b>7</b> makes a very compact bent conformation to accommodate itself in the binding pocket, with perpendicular phenyl rings from its two sides coming together. No hydrogen bonding was observed for this analogue, presumably because of the mentioned spatial constraint (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S7B</a>).</div><div class="NLM_p">Brintonamides A and B (<b>1</b> and <b>2</b>) are different from other analogues in that they lack the aromatic ring at their modified side. Compound <b>1</b> occupies the same environment as analogue <b>4</b>, which is surrounded by high number of arginine residues (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). It also forms seven H-bonds with residues Arg151, Arg318, Arg322, and Arg337; nonetheless the absence of phenyl ring leads to its inability to interact with the key Tyr227 residue located on the characteristic β-sheet. This compound is in bent conformation, too (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Like brintonamide D (<b>4</b>), analogue B (<b>2</b>) is in extended form, while occupying the exact opposite side of the binding pocket compared to analogue D (<b>4</b>) is unable to form any H-bonds (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Finally, compound C (<b>3</b>) forms a hydrogen bond with Gln8 on the N-terminal part of CCR10 (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S7C</a>). While the presence of aromatic ring on the modified side of this analogue is supposed to potentially enable it to form π–π interactions with neighboring aromatic rings, the relatively bulky amine group next to it makes spatial hindrance, thus restricting the phenyl group to be at a small range of allowed rotamers. Therefore, it is expected to suffer from similar entropic cost as in the case of analogue <b>7</b>.</div><div class="NLM_p last">Our modeling studies resulted in the development of a model derived from δ opioid-type receptor templates that is consistent with the SAR experimental data obtained for brintonamides (<b>1</b>–<b>7</b>) and enabled understanding the structural basis for the antagonistic activity of brintonamides toward CCR10, which might explain the cellular effects in breast cancer cells.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> The Effects of CCR10 Inhibition on the Proliferation of Breast Cancer Cells</h3><div class="NLM_p">The role of CCR10 in promoting the proliferation of breast cancer cells was investigated using its ligand, CCL27. MDA-MB-231 cells (selected following the assessment of CCR10 expression in a panel of cancer cells; Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S8</a>) were stimulated with increasing concentrations of CCL27 under serum deprived conditions and the effect on proliferation was examined. Cell proliferation was increased in a dose-dependent manner in response to CCL27 stimulation, supporting a role of CCR10 activation in promoting the proliferation of breast cancer cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). As brintonamide D (<b>4</b>) had no cytotoxic effects up to 10 μM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), we investigated the ability of our CCR10 antagonist <b>4</b> in inhibiting the CCL27 induced proliferation of MDA-MB-231 cells. Our data revealed dose-dependent inhibition of CCL27 induced proliferation in response to <b>4</b>, with ∼10% inhibition of proliferation at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). Additionally, siRNA partial knockdown of CCR10 (50 nM, 60% knockdown) was found to reduce the proliferation by ∼10%, validating the effects of CCR10 in promoting proliferation in the highly aggressive triple negative cancer cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9</a>).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of targeting CCR10 on the proliferation of MDA-MB-231 cells. The effect of CCL27 (A) and brintonamides (B) on the proliferation of MDA-MB-231 cells. MDA-MB-231 cells were incubated for 48 h in the presence of different concentrations of CCL27, brintonamide A (<b>1</b>), or brintonamide D (<b>4</b>), and the effects were compared to the solvent controls. (C) Effect of brintonamides on the CCL27 induced proliferation of MDA-MB-231 cells. MDA-MB-231 cells (10000 cells/well) were pretreated with different concentrations of <b>1</b> and <b>4</b> for 2 h, followed by treatment with CCL27 (1 μg/mL) for 48 h. (D) The effect of CCR10 knockdown on the proliferation of MDA-MB-231 cells. MDA-MB-231 cells were incubated in the presence of 50 nM siCCR10 (60% knockdown efficiency; see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9A</a>), and the effect was compared to the negative control. Data is presented as mean ± SD, <i>n</i> = 3. The asterisks denote significance of <i>P</i> < 0.05 relative to solvent control using two-tailed unpaired <i>t</i> test (* denotes <i>P</i> ≤ 0.05, **** denotes <i>P</i> ≤ 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> The Effects of CCR10 Inhibition on the Migration of Breast Cancer Cells</h3><div class="NLM_p">To assess the effects of targeting CCR10 on metastasis, we evaluated the effects of brintonamides A and D (<b>1</b> and <b>4</b>) on the migration of MDA-MB-231 cells. Brintonamide D (<b>4</b>) inhibited the migration by 60% at 10 μM, whereas brintonamide A (<b>1</b>) was inactive (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). To link the migration inhibitory activity of <b>4</b> with the inhibition of CCR10 and potentially other GPCR hits, we carried out siRNA knockdown of the GPCR hits (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9</a>). Our data revealed ∼40% inhibition of migration by siCCR10 at 50 nM, whereas knocking down the expression of other target genes had no effect on migration (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), thus validating the role of CCR10 in mediating cancer progression and metastasis in invasive breast cancer.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of CCR10 antagonists and siCCR10 on the migration of MDA-MB-231 cells. (A) MDA-MB-231 cells were incubated for 48 h in the presence of 10 μM brintonamide A (<b>1</b>) and D (<b>4</b>), and the effect was compared to the solvent control. (B) MDA-MB-231 cells were incubated for 72 h in the presence of 50 nM siRNA (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9A</a>), and the effect was compared to the negative control. The graph represents the number of migrated cells in each treatment group. The asterisks denote significance of <i>P</i> < 0.05 relative to solvent control using two tailed unpaired <i>t</i> test (** denotes <i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Marine cyanobacteria are producers of structurally diverse modified peptides that are not necessarily cytotoxic but possess distinct pharmacological profiles and biological functions. In particular, linear modified peptides have been widely reported, some of which contain structural features that would allow the prediction of their activity such as the aspartic protease inhibitors grassystatins A–F<a onclick="showRef(event, 'ref31 ref63'); return false;" href="javascript:void(0);" class="ref ref31 ref63">(31,63)</a> bearing the Leu-derived statin unit, while others, such as brintonamides A–E (<b>1</b>–<b>5</b>), lack key structural feature which relates to a particular activity, hence hindering the prediction of their potential biological activity. We carried out the first total synthesis of these compounds (<b>1</b>–<b>5</b>) in addition to other analogues (<b>6</b> and <b>7</b>) which enabled rigorous biological evaluation and SAR studies. To aid the identification of the biological activity of brintonamides, we applied two screening approaches. Our initial protease profiling revealed inhibitory activity against KLK7; however, due to the weak enzymatic activity and lack of SAR among brintonamides, we applied for the first time GPCR profiling as an orthogonal platform, which enabled the identification of five additional targets. The best hit identified was CCR10, which was inhibited by submicromolar concentrations of <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Summary of the SAR data of brintonamides obtained from the hits identified in the screens. The graph represents the IC<sub>50</sub> or EC<sub>50</sub> values of brintonamides <b>1</b>–<b>7</b> against the hits identified in the target-based screens. The <i>x</i>-axis represents brintonamides <b>1</b>–<b>7</b>, while the <i>y</i>-axis represents IC<sub>50</sub> or EC<sub>50</sub> values. The GPCR targets modulated by an IC<sub>50</sub> or EC<sub>50</sub> values greater than 20 μM are displayed as transparent bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">CCR10 is a chemokine receptor encoded by the CCR10 gene, and its ligands are CCL27 and CCL28, known to be overexpressed and linked to poor prognosis in melanoma, cutaneous squamous cell carcinoma, and glioma.<a onclick="showRef(event, 'ref55 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref55 ref64 ref65 ref66">(55,64−66)</a> The chemokine receptors play critical roles in mediating tumor progression including proliferation and metastasis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Studies have shown that exposure of melanoma cells overexpressing CCR10 to CCL27 protects the cells from apoptosis,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and in glioma, downregulation of CCR10 was shown to significantly impair cell growth.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> As the metastasis process resembles leukocyte trafficking, which is regulated by chemokine receptors and their ligands, chemokines may play key role in regulating tumor cell migration and metastasis. Additionally, they are involved in organ selectivity and site-specific metastasis formation.<a onclick="showRef(event, 'ref14 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref14 ref67 ref68">(14,67,68)</a> It was reported that chemokine expression on specific sites enables directed migration of tumor cells expressing the corresponding receptors, enhancing their adhesive and invasive properties.<a onclick="showRef(event, 'ref14 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref14 ref67 ref68">(14,67,68)</a> The most studied example is CXCR4 and its ligand CXCL12, known to be highly expressed in breast cancer cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The metastatic pattern in breast cancer involves lymph nodes, lung, liver, and bone marrow, where CXCL12 was reported to be preferentially expressed. Hence, breast cancer cells overexpressing CXCR4 leads to targeting their migration to these organs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In vivo neutralization of CXCR4/CXCL12 interactions significantly reduced the metastasis of breast cancer cells to the lung and regional lymph nodes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Malignant melanoma, overexpressing CCR10, exhibits a similar metastatic pattern to breast cancer but with frequent metastasis to the skin where CCL27 is known to be overexpressed.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Despite the evidence supporting the involvement of chemokine receptors in metastasis, there are few studies focusing on the molecular mechanisms and signaling pathways by which chemokine receptors, in particular CCR10, mediate cancer progression and metastasis. One study reported that CCR10/CCL27 mediates proliferation and invasion in glioma via activation of the p-AKT signaling pathway.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Apart from melanoma and glioma, we show the expression of CCR10 in invasive breast cancer cells and that our novel CCR10 antagonist, brintonamide D (<b>4</b>), reduces the proliferation and migration of MDA-MB-231 cells. Our preliminary GPCR profiling data highlights the importance of the <i>N</i>-terminal residue in modulating the selectivity profiles (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Therefore, we utilized our SAR experimental data along with in silico modeling to understand the structural basis underlying the antagonistic activity toward CCR10. This will aid the future design of improved inhibitors through modifications of brintonamides’ scaffold and the <i>N</i>-terminal residue with the possibility of tuning the activity and selectivity toward CCR10 and other GPCR targets.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we demonstrated for the first time the discovery of cyanobacterial compounds with dual protease and GPCR modulatory activities, which may have a therapeutic potential in targeting invasive breast cancer. We believe that brintonamides are starting points for the development of not only protease inhibitors but selective GPCR antagonists. Given the significance of CCR10 in cancer progression and metastasis, future studies could be directed toward the design of improved small molecule antagonists of CCR10, which could be utilized as valuable probes to understand the downstream cellular pathways mediating the antimetastatic effects in breast cancer.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Experimental Procedures</h3><div class="NLM_p last"><sup>1</sup>H and 2D NMR spectra for the isolated compounds (<b>1</b>–<b>5</b>) in CDCl<sub>3</sub> were recorded on a Bruker 600 MHz Avance II spectrometer, using a 5 mm cryogenic probe for indirect detection (Bruker Cryoprobe TXI). The <sup>1</sup>H and <sup>13</sup>C NMR spectra for the synthetic compounds (<b>1</b>–<b>7</b>) in CDCl<sub>3</sub> were recorded on an Agilent VNMRS 600 MHz, 5 mm cold probe spectrometer. Spectra were referenced to residual solvent signals [δ<sub>H/C</sub> 7.26/77.0]. HSQC experiments were optimized for <sup>1</sup><i>J</i><sub>CH</sub> = 145 Hz, and HMBC experiments were optimized for <sup>1</sup><i>J</i><sub>CH</sub> = 7 Hz. HRESI/APCIMS data were recorded on an Agilent LC-TOF mass spectrometer equipped with an APCI/ESI multimode ion source detector in positive ion mode. ESIMS fragmentation data were obtained on an API 3200 triple quadrupole MS (Applied Biosystems) by direct injection with a syringe driver. LCMS data were obtained using API 3200 (Applied Biosystems) equipped with an HPLC system (Shimadzu). The optical rotation was measured using a PerkinElmer 341 polarimeter. The isolated compounds as well as the synthetic compounds were purified by HPLC, and the purity was confirmed by <sup>1</sup>H and <sup>13</sup>C NMR, and LC-MS to be ≥95%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Biological Material</h3><div class="NLM_p last">Samples of an intertidal cyanobacterial mat were collected over two years (2008–2009) from the surface of a rock seawall in Brinton Channel, near Summerland Key, Florida. The first collection was made May 4, 2008 (HL-CN2008-001), and then the sample was recollected during the week of May 21–30, 2009 (HL-CN2009-007) to obtain additional material. As is typical of many marine cyanobacterial mats, the sample contains multiple filament types. It is dominated by one filament type that is 5–7 μm wide and 8–15 μm long with square to rectangular cell shapes. The filaments have tapered ends, and no heterocysts are visible. Other common filament types in the mat include Oscillatoria-like discoid cell that are 10–12 μm wide and 2 μm long, with no heterocysts visible and both fine discoid filaments that are 2–3 μm wide and larger discoid filaments that are 25–30 μm wide. All filament types fit within the Oscillatoriaceae, a group of cyanobacteria currently under extensive revision. Voucher specimens are retained at the Smithsonian Marine Station at Ft. Pierce and are available for further investigation.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Extraction and Isolation</h3><div class="NLM_p">Samples from May 2008 were freeze-dried, and the solid material was directly extracted with EtOAc–MeOH (1:1). This nonpolar extract was filtered and concentrated in vacuo, then partitioned between hexanes and MeOH–H<sub>2</sub>O (80:20). The MeOH–H<sub>2</sub>O fraction was dried and further partitioned between <i>n</i>-BuOH and H<sub>2</sub>O. The <i>n</i>-BuOH-soluble fraction was dried and subjected to silica chromatography using a step gradient system of increasing <i>i</i>-PrOH in CH<sub>2</sub>Cl<sub>2</sub>. The material eluting with 10% <i>i</i>-PrOH was further purified by HPLC [column, YMC-Pack ODS-AQ, 250 mm × 10 mm; flow rate, 2.0 mL/min; PDA detection 200–800 nm] using a linear MeOH–H<sub>2</sub>O gradient (60–100% MeOH over 20 min, 100% MeOH for 20 min) to afford <b>1</b> (10 mg), <b>2</b> (0.9 mg), and <b>3</b> (1.3 mg) at <i>t</i><sub>R</sub> 18.7, 17.5, and 23.5 min, respectively.</div><div class="NLM_p">The freeze-dried sample from May 2009 was extracted directly with the nonpolar solvents EtOAc–MeOH (1:1) three times. The extract (18.6 g) was then partitioned between hexanes and 80% MeOH in H<sub>2</sub>O. The 80% aqueous MeOH fraction was evaporated and further partitioned between <i>n</i>-BuOH and H<sub>2</sub>O. The <i>n</i>-BuOH fraction (1.6 g) was concentrated in vacuo and later subjected to silica gel chromatography using a step gradient system starting the elution with CH<sub>2</sub>Cl<sub>2</sub> followed by increasing <i>i</i>-PrOH in CH<sub>2</sub>Cl<sub>2,</sub> and finally with MeOH. On the basis of NMR-guided fractionation, The material eluting with 50% <i>i</i>-PrOH was selected and further purified by reversed-phase HLPC [column, YMC-Pack ODS-AQ, 250 mm × 10 mm; flow rate, 2.0 mL/min; PDA detection 200–800 nm] using a linear MeOH–H<sub>2</sub>O gradient (60–100% MeOH over 20 min, 100% MeOH for 20 min) to afford <b>1</b> (2.8 mg), <b>2</b> (0.4 mg), <b>3</b> (3.0 mg), <b>4</b> (0.7 mg), and <b>5</b> (0.2 mg) at <i>t</i><sub>R</sub> 18.7, 17.5, 23.5, 23.4, and 23.0 min, respectively.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Brintonamide A (<b>1</b>)</h4><div class="NLM_p last">Colorless amorphous solid; [α]<sup>20</sup><sub>D</sub> −37 (<i>c</i> 0.05, MeOH). <sup>1</sup>H NMR, COSY, edited-HSQC, HMBC, ROESY, and TOCSY (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S1</a>). HRESI/APCIMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> 779.4321 (calcd for C<sub>39</sub>H<sub>60</sub>N<sub>6</sub>O<sub>9</sub>Na, 779.4319), [M + H]<sup>+</sup> 757.4491 (calcd for C<sub>39</sub>H<sub>61</sub>N<sub>6</sub>O<sub>9</sub>, 757.4500).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Brintonamide B (<b>2</b>)</h4><div class="NLM_p last">Colorless amorphous solid; [α]<sup>20</sup><sub>D</sub> −52 (<i>c</i> 0.08, MeOH). <sup>1</sup>H NMR, COSY, edited-HSQC, HMBC, ROESY, and TOCSY (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S2</a>). HRESI/APCIMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> 765.4172 (calcd for C<sub>38</sub>H<sub>58</sub>N<sub>6</sub>O<sub>9</sub>Na, 765.4163), [M + H]<sup>+</sup> 743.4343 (calcd for C<sub>38</sub>H<sub>59</sub>N<sub>6</sub>O<sub>9</sub>, 743.4344).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Brintonamide C (<b>3</b>)</h4><div class="NLM_p last">Colorless amorphous solid; [α]<sup>20</sup><sub>D</sub> −8.3 (<i>c</i> 0.04, MeOH). <sup>1</sup>H NMR, COSY, edited-HSQC, HMBC, ROESY, and TOCSY (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S3</a>). HRESI/APCIMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> 954.5311 (calcd for C<sub>50</sub>H<sub>73</sub>N<sub>7</sub>O<sub>10</sub>Na, 954.5317), [M + H]<sup>+</sup> 932.5504 (calcd for C<sub>50</sub>H<sub>74</sub>N<sub>7</sub>O<sub>10</sub>, 932.5497).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Brintonamide D (<b>4</b>)</h4><div class="NLM_p last">Colorless amorphous solid; [α]<sup>20</sup><sub>D</sub> −73 (<i>c</i> 0.05, MeOH). <sup>1</sup>H NMR, COSY, edited-HSQC, HMBC, ROESY, and TOCSY (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S4</a>). HRESI/APCIMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> 909.4765 (calcd for C<sub>48</sub>H<sub>66</sub>N<sub>6</sub>O<sub>10</sub>Na, 909.4765).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Brintonamide E (<b>5</b>)</h4><div class="NLM_p last">Colorless amorphous solid; [α]<sup>20</sup><sub>D</sub> −39 (<i>c</i> 0.05, MeOH). <sup>1</sup>H NMR, COSY, edited-HSQC, HMBC, and ROESY (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Table S5</a>). HRESI/APCIMS <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> 909.4773 (calcd for C<sub>48</sub>H<sub>66</sub>N<sub>6</sub>O<sub>10</sub>Na, 909.4773).</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Absolute Configuration</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Acid Hydrolysis and Chiral Amino Acid Analysis by LC-MS</h4><div class="NLM_p last">A sample of compounds <b>1</b>–<b>5</b> (100 μg each) was hydrolyzed with 6 N HCl (0.5 mL) at 110 °C for 24 h. The acid hydrolyzates were concentrated to dryness, reconstituted in 100 μL of H<sub>2</sub>O, and then analyzed by chiral HPLC [column: Chirobiotic TAG (250 mm × 4.6 mm), Supelco; solvent, MeOH/10 mM NH<sub>4</sub>OAc (40:60, pH 5.53); flow rate 0.5 mL/min; detection by ESIMS in positive ion mode (MRM scan)]. <span class="smallcaps smallerCapital">l</span>-Ala, <span class="smallcaps smallerCapital">l</span>-Pro, <i>N</i>-Me-<span class="smallcaps smallerCapital">l</span>-Leu, <i>N</i>-Me-<span class="smallcaps smallerCapital">d</span>-Phe, and <i>N</i>,<i>N</i>-Me<sub>2</sub>-<span class="smallcaps smallerCapital">l</span>-Phe eluted at <i>t</i><sub>R</sub> 7.5, 12.2, 13.5, 38, and 114 min, respectively. The retention times (<i>t</i><sub>R</sub>, min; MRM ion pair, parent → product) of the authentic amino acids were as follows: <span class="smallcaps smallerCapital">l</span>-Ala (7.5; 90 → 44), <span class="smallcaps smallerCapital">d</span>-Ala (11.9), <span class="smallcaps smallerCapital">l</span>-Pro (12.2; 116 → 70), <span class="smallcaps smallerCapital">d</span>-Pro (33.3), <i>N</i>-Me-<span class="smallcaps smallerCapital">l</span>-Leu (13.5; 146 → 100), <i>N</i>-Me-<span class="smallcaps smallerCapital">d</span>-Leu (112), <i>N</i>-Me-<span class="smallcaps smallerCapital">l</span>-Phe (22; 180.1 → 134.1), <i>N</i>-Me-<span class="smallcaps smallerCapital">d</span>-Phe (38), <i>N</i>,<i>N</i>-Me<sub>2</sub>-<span class="smallcaps smallerCapital">l</span>-Phe (114; 194 → 148), and <i>N</i>,<i>N</i>-Me<sub>2</sub>-<span class="smallcaps smallerCapital">d</span>-Phe (106). The compound-dependent MS parameters were as follows. Ala: DP 26, EP 3, CE 19, CXP 3. Pro: DP 32.4, EP 4, CE 21.8, CXP 2.8. <i>N</i>-Me-Leu: DP 28, EP 6, CE 17, CXP 3. <i>N</i>-Me-Phe: DP 29, EP 4, CE 20, CXP 3. <i>N</i>,<i>N</i>-Me<sub>2</sub>-Phe: DP 33, EP 4, CE 20, CXP 3. The source and gas-dependent MS parameters were as follows: CUR 50, CAD medium, IS 5500, TEM 750, GS1 65, and GS2 65. D-Hiva present in <b>2</b> was detected in the negative ion mode at <i>t</i><sub>R</sub> 4.4 min. The retention times (<i>t</i><sub>R</sub>, min; MRM ion pair, parent → product) of the authentic amino acids were as follows: L-Hiva (4.2; 117 → 70), D-Hiva (4.4). The compound-dependent MS parameters were as follows: DP −20, EP −4, CE −18, and CXP 1.7. The source and gas-dependent MS parameters were as follows: CUR 30, CAD medium, IS −4500, TEM 750, GS1 65, and GS2 65. The absolute configuration of the Hmpa unit in <b>1</b> was determined by chiral HPLC analysis under different conditions [column: CHIRALPAK MA (+) (50 mm × 4.6 mm); solvent, CH<sub>3</sub>CN/2 mM CuSO<sub>4</sub> (10:90); flow rate 1 mL/min; detection by UV (254 nm)]. The retention times (<i>t</i><sub>R</sub>, min) of the authentic standards were as follows: (2<i>R</i>,3<i>S</i>)-Hmpa (10.3), (2<i>R</i>,3<i>R</i>)-Hmpa (12.2), (2<i>S</i>,3<i>R</i>)-Hmpa (15), (2<i>S</i>,3<i>S</i>)-Hmpa (17.9). Under these conditions, all other units eluted at <i>t</i><sub>R</sub> < 8.0 min. The absolute configuration of the Hmpa unit in the hydrolyzate of brintonamide A (<b>1</b>) was found to be (2<i>R</i>,3<i>S</i>)-Hmpa.</div></div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Total Synthesis</h3><div class="NLM_p last">Detailed procedures for the total synthesis of brintonamides (<b>1</b>–<b>5</b>) and analogues (<b>6</b>, <b>7</b>) can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Cell Culture</h3><div class="NLM_p last">MDA-MB-231, MDA-MB-468, HCT116, and PANC-1 cells were propagated and maintained in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen), while LOX-IMVI, SNB-78, and SF-268 cells were propagated and maintained in Roswell Park Memorial Institute medium (RPMI 1640, Thermo Fisher Scientific). The media were supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT) and 1% antibiotic-antimycotic (Invitrogen) at 37 °C humidified air and 5% CO<sub>2</sub>.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cell Viability Assay</h3><div class="NLM_p">MDA-MB-231 cells were seeded in 96-well plates (10000 cells/well). After 24 h incubation, the cells were treated with different concentrations of compounds (<b>1</b>–<b>7</b>), CCL27 (376-CR/CF; R&D Systems), or solvent control (DMSO). Following 48 h of incubation, cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide according to the manufacturer’s instructions (Promega).</div><div class="NLM_p last">In the experiment evaluating the effect of CCR10 inhibition on the viability, MDA-MB-231 cells were seeded in 96-well plates (10000 cells/well; serum free DMEM). After 24 h incubation, the cells were pretreated with different concentrations of brintonamides A and D (<b>1</b> and <b>4</b>) for 2 h followed by treatment with CCL27 (1 μg/mL final concentration). After 48 h incubation, cell viability was measured.</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Protease Profiling and KLK7 Inhibition Assays</h3><div class="NLM_p last">The enzyme assays performed in the screen were carried out by Reaction Biology Corp. Brintonamides A and D (<b>1</b> and <b>4</b>) were screened in 10-dose IC<sub>50</sub> with 3-fold serial dilution starting at 100 μM against 63 proteases in singlet. The control compounds were tested in a 10-dose IC<sub>50</sub> with 3-fold serial dilution starting at 10 μM. To validate the hit identified from the primary screen, brintonamides A–E (<b>1</b>–<b>5</b>), synthetic analogues (<b>6</b> and <b>7</b>), and the positive control gabexate mesylate were tested against KLK7 in 10-dose IC<sub>50</sub> with 3-fold serial dilution starting at 100 μM in duplicate. The protease activities were monitored as a time-course measurement of the increase in fluorescence signal from fluorescently labeled peptide substrate, and the initial linear portion of the slope (signal/min) was analyzed.</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> GPCR Profiling</h3><div class="NLM_p">Brintonamides A (<b>1</b>, 10 μM) and D (<b>4</b>, 10 and 20 μM) were profiled against gpcrMAX panel biosensor assays (compounds were tested in the agonist and antagonist mode) and orphanMAX panel (compounds were tested in the agonist mode).The assays were performed by DiscoveRx Corporation (Fremont, CA) utilizing the PathHunter β-arrestin enzyme fragment complementation (EFC) technology. The assay utilizes cells that are genetically engineered to overexpress the GPCR of interest as a fusion to ProLink (PK) (a small 44–47 aa portion of β-galactosidase) and β-arrestin as a fusion with enzyme acceptor (EA) (<i>N</i>-terminal deletion mutant of β-galactosidase, which is the rest of the enzyme). The removal of the 44 aa ProLink (PK) portion of β-galactosidase renders the enzyme inactive. The basic principle of the assay is based on the enzyme fragment complementation (EFC) technology using β-galactosidase as the functional reporter. Briefly, GPCR activation stimulates the recruitment and binding of (EA)-tagged-β-Arrestin to the ProLink-tagged GPCR resulting in the complementation of the two enzyme fragments and restoring the activity of β-galactosidase that is capable of hydrolyzing a substrate and generating a chemiluminescent signal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><div class="NLM_p">For agonist determination, the sample was incubated with PathHunter cell lines (HEK293, CHO, U2OS) stably overexpressing the ProLink (PK)-tagged GPCR of interest and the enzyme acceptor (EA)-tagged β-arrestin fusion proteins. The cells were seeded in a total volume of 20 μL in white 384-well plates and incubated at 37 °C for the appropriate time prior to testing to induce a response. Briefly, an intermediate dilution of sample stocks was prepared to generate 5× sample in assay buffer. To the cells, 5 μL of the 5× sample was added and further incubated at 37 °C or room temperature for 90 or 180 min.</div><div class="NLM_p">For antagonist determination, the cells were preincubated with antagonist followed by agonist challenge at the EC<sub>80</sub> concentration. To the cells, 5 μL of 5× sample was added and incubated for 30 min at 37 °C or room temperature. Following the incubation period, 5 μL of 6× EC<sub>80</sub> agonist prepared in assay buffer was added to the cells and incubated for 90 or 180 min at 37 °C or room temperature. The final assay vehicle concentration in both assay formats (agonist and antagonist) was 1%.</div><div class="NLM_p">The assay signal detection was performed through the addition of 12.5 or 15 μL (50% v/v) of PathHunter detection reagent cocktail followed by 1 h incubation at room temperature. After the incubation period, the chemiluminescent signal was read using a PerKinElmer Envision instrument. The data analysis was performed using the CBIS data analysis suite (ChemInnovation, CA). For the agonist mode assays, the percentage activity was calculated using the following formula: % activity = 100% × (mean RLU of test sample – mean RLU of vehicle control)/(mean MAX control ligand – mean RLU of vehicle control). For antagonist mode assays, the percentage inhibition was calculated using the following formula: % inhibition = 100% × (1 – (mean RLU of test sample – mean RLU of vehicle control)/(mean RLU of EC<sub>80</sub> control – mean RLU of vehicle control)).</div><div class="NLM_p last">Hit validation was performed by subjecting brintonamides A–E (<b>1</b>–<b>5</b>) and the synthetic analogues (<b>6</b> and <b>7</b>) to agonist and antagonist secondary screen utilizing five GPCR biosensor assays (Arrestin) against the following targets: CXCR7, CCR10, OXTR, SSTR3, and TACR2. The assays were performed at 10-point concentrations using 3-fold serial dilutions in duplicate.</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Molecular Docking (CCR10)</h3><div class="NLM_p last">Docking of brintonamides into CCR10 requires the development of a homology model (details in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Supporting Information</a>). Molecular docking of brintonamide ligands into the refined models was achieved in AutoDock VINA.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> For each model, the center of grid box was defined as the center of bound ligand, or the average of the centers of bound ligands in case the model was developed based on multiple templates. Maximum number of binding modes to generate was set as 100, with exhaustiveness of global search being set as 50. The top binding pose for each ligand was visually inspected and compared to other ligands; this was complemented by quantitative comparison of the trends in predicted binding affinities.</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> RNA Isolation, Reverse Transcription, and Real-Time Quantitative Polymerase Chain Reaction (qPCR)</h3><div class="NLM_p last">MDA-MB-231 cells (500000 cells/well) were seeded in 6-well plates. After 24 h, RNA was isolated using RNeasy mini kit (Qiagen). cDNA synthesis was carried out using SuperScript II reverse transcriptase and oligo (dT) (Invitrogen). qPCR was carried out after reverse transcription on a reaction solution (25 μL) prepared using a 1 μL aliquot of cDNA, 12.5 μL of TaqMan gene expression assay mix, 1.25 μL of 20× TaqMan gene expression assay mix, and 10.25 μL of RNase-free water. The qPCR experiment was performed using ABI 7300 sequence detection system. The thermocycler program used was: 2 min at 50 °C, 10 min at 95 °C, 15 s at 95 °C (40 cycles), and 1 min at 60 °C. <i>KLK7</i> (Hs00192503_m1), <i>CCR10</i> (Hs00706455_s1), <i>OXTR</i> (Hs00168573_m1), <i>SSTR3</i> (Hs00265633_s1), and <i>TACR2</i> (Hs00169052_m1) were used as target genes and <i>GAPDH</i> (Hs02758991_g1) was used as endogenous control.</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> siRNA Transfection and Assessment of Knockdown Efficiency</h3><div class="NLM_p last">MDA-MB-231 cells (300000 cells/well) were seeded in a 6-well plate. After 24 h, the cells were transfected for 48 h with 20 nM siRNA (<i>KLK7</i>: S11267) or 50 nM siRNA (<i>CCR10</i>, S194449; <i>OXTR</i>, S9946; <i>SSTR3</i>, S13503; <i>TACR2</i>, S13711; <i>Neg Ctrl</i>, AM17110; Life Technologies) using silentFect reagent according to the manufacturer’s instructions (BIO-RAD). RT-qPCR was performed to determine the extent of gene knockdown.</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Transwell Migration Assay</h3><div class="NLM_p">The effect on migration was examined using BD falcon cell culture inserts (353097) containing PET membrane with 8 μm pore size. Briefly, 5000 cells of MDA-MB-468 or MDA-MB-231 were suspended in complete medium (DMEM containing 10% FBS) and treated with different concentrations of brintonamide D (<b>4</b>), brintonamide A (<b>1</b>), or solvent control. The cells (500 μL) were seeded into the insets and 750 μL of complete medium containing the same concentration of <b>4</b> or solvent control was added into the other side of the membrane. The plate was incubated for 48 h (37 °C, 5% CO<sub>2</sub>). Following the incubation period, the non-migrated cells were removed using kimwipes and cotton swabs. Migrated cells were stained by crystal violet, and the number was counted under the microscope. The assay was performed in triplicate.</div><div class="NLM_p last">In experiments evaluating the effects of siRNA knockdown of target genes on the migration of MDA-MB-231 cells, the cells were transfected with 20 nM siRNA (<i>KLK7</i>, S11267) or 50 nM siRNA (<i>CCR10</i>, S194449; <i>OXTR</i>, S9946; <i>SSTR3</i>, S13503; <i>TACR2</i>, S13711; <i>Neg Ctrl</i>, AM17110; Life Technologies) using silentFect reagent, seeded into the migration chambers, and incubated for 72 h.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00885" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00885" class="ext-link">10.1021/acs.jmedchem.8b00885</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Includes NMR tables for brintonamides A–E (<b>1</b>–<b>5</b>) in CDCl<sub>3</sub>; experimental procedures for the synthesis of brintonamides A–E (<b>1</b>–<b>5</b>) and analogues (<b>6</b>, <b>7</b>); results and discussions related to the KLK7 enzyme kinetic studies; effects of brintonamide D on downstream cellular substrates of KLK7 as well as the migration of breast cancer cells; results and discussions related to CCR10 molecular modeling and expressions of CCR10 and other GPCR hits in cancer cells; experimental procedures for KLK7 experiments; relevant references;NMR spectra of brintonamides; HRMS of brintonamides (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates for homology model CCR5 model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UIW">5UIW</a> 4MBS (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates for homology model CCR9 model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWE">5LWE</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates for homology model δ opioid model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a> 4N6H(<a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_005.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf">jm8b00885_si_001.pdf (7.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_002.pdb">jm8b00885_si_002.pdb (428.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_003.pdb">jm8b00885_si_003.pdb (427.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_004.pdb">jm8b00885_si_004.pdb (428.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_005.csv">jm8b00885_si_005.csv (1.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00885" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hendrik Luesch</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Center for Natural Products, Drug Discovery
and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4091-7492" title="Orcid link">http://orcid.org/0000-0002-4091-7492</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0468716177676c44676b742a7162682a616071"><span class="__cf_email__" data-cfemail="274b524254444f674448570952414b09424352">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fatma
H. Al-Awadhi</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Center for Natural Products, Drug Discovery
and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bowen Gao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Chemical Oncogenomics, School of Chemical Biology
and Biotechnology, Peking University Shenzhen
Graduate School, Xili,
Nanshan District, Shenzhen, 518055, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammad A. Rezaei</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Center for Natural Products, Drug Discovery
and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Florida, Gainesville, Florida 32611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason C. Kwan</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Center for Natural Products, Drug Discovery
and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenglong Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Center for Natural Products, Drug Discovery
and Development (CNPD3), University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Ye</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Chemical Oncogenomics, School of Chemical Biology
and Biotechnology, Peking University Shenzhen
Graduate School, Xili,
Nanshan District, Shenzhen, 518055, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2780-9761" title="Orcid link">http://orcid.org/0000-0002-2780-9761</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerie J. Paul</span> - <span class="hlFld-Affiliation affiliation">Smithsonian
Marine Station, Fort Pierce, 701 Seaway Drive, Fort Pierce, Florida 34949, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The research was supported by the National Institutes of Health grant R01CA172310 and Shenzhen Peacock Plan (KQTD2015071714043444). We acknowledge Margaret O. James for assistance with enzyme kinetic studies.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric pressure chemical ionization</p></td></tr><tr><td class="NLM_term">ATLL</td><td class="NLM_def"><p class="first last">adult T-cell leukemia/lymphoma</p></td></tr><tr><td class="NLM_term">BCA</td><td class="NLM_def"><p class="first last">bicinchoninic acid</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">CCR10</td><td class="NLM_def"><p class="first last">chemokine receptor type 10</p></td></tr><tr><td class="NLM_term">CCL 27</td><td class="NLM_def"><p class="first last">C–C motif chemokine ligand 27</p></td></tr><tr><td class="NLM_term">CCL28</td><td class="NLM_def"><p class="first last">C–C motif chemokine ligand 28</p></td></tr><tr><td class="NLM_term">CE</td><td class="NLM_def"><p class="first last">collision energy</p></td></tr><tr><td class="NLM_term">CUR</td><td class="NLM_def"><p class="first last">curtain gas</p></td></tr><tr><td class="NLM_term">CXCL12</td><td class="NLM_def"><p class="first last">C-X-C motif chemokine ligand 12</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">chemokine receptor type 4</p></td></tr><tr><td class="NLM_term">CXCR7</td><td class="NLM_def"><p class="first last">chemokine receptor type 7</p></td></tr><tr><td class="NLM_term">CXP</td><td class="NLM_def"><p class="first last">collision cell exit potential</p></td></tr><tr><td class="NLM_term">DP</td><td class="NLM_def"><p class="first last">declustering potential</p></td></tr><tr><td class="NLM_term">Dsg-2</td><td class="NLM_def"><p class="first last">desmoglein-2</p></td></tr><tr><td class="NLM_term">E-cad</td><td class="NLM_def"><p class="first last">E-cadherin</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">EP</td><td class="NLM_def"><p class="first last">entrance potential</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GS1</td><td class="NLM_def"><p class="first last">gas 1</p></td></tr><tr><td class="NLM_term">GS2</td><td class="NLM_def"><p class="first last">gas 2</p></td></tr><tr><td class="NLM_term">HAE</td><td class="NLM_def"><p class="first last">hereditary angioedema</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Hiva</td><td class="NLM_def"><p class="first last">2-hydroxy isovaleric acid</p></td></tr><tr><td class="NLM_term">Hmpa</td><td class="NLM_def"><p class="first last">hydroxy-3-methyl pentanoic acid</p></td></tr><tr><td class="NLM_term">IS</td><td class="NLM_def"><p class="first last">ionspray voltage</p></td></tr><tr><td class="NLM_term">KLK7</td><td class="NLM_def"><p class="first last">kallikrein 7</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">OXTR</td><td class="NLM_def"><p class="first last">oxytocin receptor</p></td></tr><tr><td class="NLM_term">p-AKT</td><td class="NLM_def"><p class="first last">phosphorylated protein kinase B</p></td></tr><tr><td class="NLM_term">RT-qPCR</td><td class="NLM_def"><p class="first last">real-time quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SSTR 3</td><td class="NLM_def"><p class="first last">somatostatin receptor 3</p></td></tr><tr><td class="NLM_term">TACR2</td><td class="NLM_def"><p class="first last">tachykinin receptor 2</p></td></tr><tr><td class="NLM_term">TEM</td><td class="NLM_def"><p class="first last">temperature.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. A.</span>; <span class="NLM_string-name">Ye, L.</span>; <span class="NLM_string-name">Sanders, A. J.</span>; <span class="NLM_string-name">Lane, J.</span>; <span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Cancer Invasion and Metastasis: Molecular and Cellular Perspective</span>. In  <i>Madame Curie Bioscience Database [Internet]</i>; <span class="NLM_publisher-name">Landes Bioscience</span>: <span class="NLM_publisher-loc">Austin, TX</span>, <span class="NLM_year">2000</span>–<span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+A.+Martin&author=L.+Ye&author=A.+J.+Sanders&author=J.+Lane&author=W.+G.+Jiang&title=Madame+Curie+Bioscience+Database+%5BInternet%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DT.%2BA.%26atitle%3DCancer%2520Invasion%2520and%2520Metastasis%253A%2520Molecular%2520and%2520Cellular%2520Perspective%26btitle%3DMadame%2520Curie%2520Bioscience%2520Database%2520%255BInternet%255D%26pub%3DLandes%2520Bioscience%26date%3D2000%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netzel-Arnett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quigley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antalis, T. M.</span></span> <span> </span><span class="NLM_article-title">Membrane Anchored Serine Proteases: A Rapidly Expanding Group of Cell Surface Proteolytic Enzymes with Potential Roles in Cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1023/A:1023003616848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1023%2FA%3A1023003616848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=12784999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=237-258&author=S.+Netzel-Arnettauthor=J.+D.+Hooperauthor=R.+Szaboauthor=E.+L.+Madisonauthor=J.+P.+Quigleyauthor=H.+Buggeauthor=T.+M.+Antalis&title=Membrane+Anchored+Serine+Proteases%3A+A+Rapidly+Expanding+Group+of+Cell+Surface+Proteolytic+Enzymes+with+Potential+Roles+in+Cancer&doi=10.1023%2FA%3A1023003616848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer</span></div><div class="casAuthors">Netzel-Arnett, Sarah; Hooper, John D.; Szabo, Roman; Madison, Edwin L.; Quigley, James P.; Bugge, Thomas H.; Antalis, Toni M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">237-258</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Dysregulated proteolysis is a hallmark of cancer.  Malignant cells require a range of proteolytic activities to enable growth, survival, and expansion.  Serine proteases of the S1 or trypsin-like family have well recognized roles in the maintenance of normal homeostasis as well as in the pathol. of diseases such as cancer.  Recently a rapidly expanding subgroup of S1 proteases has been recognized that are directly anchored to plasma membranes.  These membrane anchored serine proteases are anchored either via a carboxy-terminal transmembrane domain (Type I), a carboxy terminal hydrophobic region that functions as a signal for membrane attachment via a glycosyl-phosphatidylinositol linkage (GPI-anchored), or via an amino terminal proximal transmembrane domain (Type II or TTSP).  The TTSPs also encode multiple domains in their stem regions that may function in regulatory interactions.  The serine protease catalytic domains of these enzymes show high homol. but also possess features indicating unique substrate specificities.  It is likely that the membrane anchored serine proteases have evolved to perform complex functions in the regulation of cellular signaling events at the plasma membrane and within the extracellular matrix.  Disruption or mutation of several of the genes encoding these proteases are assocd. with disease.  Many of the membrane anchored serine proteases show restricted tissue distribution in normal cells, but their expression is widely dysregulated during tumor growth and progression.  Diagnostic or therapeutic targeting of the membrane anchored serine proteases has potential as promising new approaches for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmLKMa6BFArVg90H21EOLACvtfcHk0lgl1iciMlhNkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CjtL0%253D&md5=2f4c573e9f9b5c663cf5cc5af90da188</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023003616848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023003616848%26sid%3Dliteratum%253Aachs%26aulast%3DNetzel-Arnett%26aufirst%3DS.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DSzabo%26aufirst%3DR.%26aulast%3DMadison%26aufirst%3DE.%2BL.%26aulast%3DQuigley%26aufirst%3DJ.%2BP.%26aulast%3DBugge%26aufirst%3DH.%26aulast%3DAntalis%26aufirst%3DT.%2BM.%26atitle%3DMembrane%2520Anchored%2520Serine%2520Proteases%253A%2520A%2520Rapidly%2520Expanding%2520Group%2520of%2520Cell%2520Surface%2520Proteolytic%2520Enzymes%2520with%2520Potential%2520Roles%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D237%26epage%3D258%26doi%3D10.1023%2FA%3A1023003616848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1210/edrv.22.2.0424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1210%2Fedrv.22.2.0424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=11294823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=184-204&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=The+New+Human+Tissue+Kallikrein+Gene+Family%3A+Structure%2C+Function%2C+and+Association+to+Disease&doi=10.1210%2Fedrv.22.2.0424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The new human tissue kallikrein gene family: Structure, function, and association to disease</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-204</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The human tissue kallikrein gene family was, until recently, thought to consist of only three genes.  Two of these human kallikreins, prostate-specific antigen and human glandular kallikrein 2, are currently used as valuable biomarkers of prostatic carcinoma.  More recently, new kallikrein-like genes have been discovered.  It is now clear that the human tissue kallikrein gene family contains at least 15 genes.  All genes share important similarities, including mapping at the same chromosomal locus (19q13.4), significant homol. at both the nucleotide and protein level, and similar genomic organization.  All genes encode for putative serine proteases and most of them are regulated by steroid hormones.  Recent data suggest that at least a few of these kallikrein genes are connected to malignancy.  In this review, we summarize the recently accumulated knowledge on the human tissue kallikrein gene family, including gene and protein structure, predicted enzymic activities, tissue expression, hormonal regulation, and alternative splicing.  We further describe the reported assocns. of the human kallikreins with various human diseases and identify future avenues for research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QpkM-LBKh7Vg90H21EOLACvtfcHk0lgl1iciMlhNkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D&md5=ca1b47cc183643d953e8abecd25cc730</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1210%2Fedrv.22.2.0424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.22.2.0424%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520New%2520Human%2520Tissue%2520Kallikrein%2520Gene%2520Family%253A%2520Structure%252C%2520Function%252C%2520and%2520Association%2520to%2520Disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2001%26volume%3D22%26spage%3D184%26epage%3D204%26doi%3D10.1210%2Fedrv.22.2.0424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stromqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallbrandt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span> <span> </span><span class="NLM_article-title">Cloning, Expression, and Characterization of Stratum Corneum Chymotryptic Enzyme: A Skin-Specific Human Serine Proteinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">19420</span>– <span class="NLM_lpage">19426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=19420-19426&author=L.+Hanssonauthor=M.+Stromqvistauthor=A.+Backmanauthor=P.+Wallbrandtauthor=A.+Carlsteinauthor=T.+Egelrud&title=Cloning%2C+Expression%2C+and+Characterization+of+Stratum+Corneum+Chymotryptic+Enzyme%3A+A+Skin-Specific+Human+Serine+Proteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DL.%26aulast%3DStromqvist%26aufirst%3DM.%26aulast%3DBackman%26aufirst%3DA.%26aulast%3DWallbrandt%26aufirst%3DP.%26aulast%3DCarlstein%26aufirst%3DA.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DCloning%252C%2520Expression%252C%2520and%2520Characterization%2520of%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%253A%2520A%2520Skin-Specific%2520Human%2520Serine%2520Proteinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D19420%26epage%3D19426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span> <span> </span><span class="NLM_article-title">Purification and Preliminary Characterization of Stratum Corneum Chymotryptic Enzyme: A Proteinase That May Be Involved in Desquamation</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/1523-1747.ep12363804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1111%2F1523-1747.ep12363804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=8393902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFyhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1993&pages=200-204&author=T.+Egelrud&title=Purification+and+Preliminary+Characterization+of+Stratum+Corneum+Chymotryptic+Enzyme%3A+A+Proteinase+That+May+Be+Involved+in+Desquamation&doi=10.1111%2F1523-1747.ep12363804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation</span></div><div class="casAuthors">Egelrud, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-4</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    </div><div class="casAbstract">In recent work, the authors showed that a serine proteinase, stratum corneum chymotrypic enzyme, with properties compatible with a role in desquamation in vitro as well as in vivo, is generally present in human stratum corneum.  The enzymol. properties of the stratum corneum chymotryptic enzyme in a KCl ext. of dissocd. plantar corneocytes were compared with those of other known chymotryptic serine proteinases.  Stratum corneum chymotryptic enzyme was found to differ significantly from bovine chymotrypsin, human cathepsin G, and human mast cell chymases in regard to inhibitor profile and substrate specificity.  Stratum corneum chymotryptic enzyme was further purified from KCl exts. of dissocd. plantar corneocytes by affinity chromatog. on gels with covalently linked soybean trypsin inhibitor.  The purified prepn. contained 1 major component with an apparent mol. wt. of 25 kDa and 1 minor component with a slightly higher apparent mol. wt. as revealed by Coomassie staining after SDS-PAGE of samples that had not been reduced.  Both of these components were assocd. with chymotrypsin-like activity as revealed by zymog. in polyacrylamide gels with copolymd. casein.  On zymog. gels, the purified prepn. was also found to contain minor amts. of components with trypsinlike activity.  The major purified protein had an apparent mol. wt. of ∼28 kDa after redn. and full denaturation and was shown to contain carbohydrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ZUZeBIhiv7Vg90H21EOLACvtfcHk0lgl1iciMlhNkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFyhtLg%253D&md5=2a007026ec4436aeff418a573c8b5282</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2F1523-1747.ep12363804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1523-1747.ep12363804%26sid%3Dliteratum%253Aachs%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DPurification%2520and%2520Preliminary%2520Characterization%2520of%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%253A%2520A%2520Proteinase%2520That%2520May%2520Be%2520Involved%2520in%2520Desquamation%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1993%26volume%3D101%26spage%3D200%26epage%3D204%26doi%3D10.1111%2F1523-1747.ep12363804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundström, A.</span></span> <span> </span><span class="NLM_article-title">A Chymotrypsin-like Proteinase That May Be Involved in Desquamation in Plantar Stratum Corneum</span>. <i>Arch. Dermatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1007/BF00371618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2FBF00371618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1712574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1991&pages=108-112&issue=2&author=T.+Egelrudauthor=A.+Lundstr%C3%B6m&title=A+Chymotrypsin-like+Proteinase+That+May+Be+Involved+in+Desquamation+in+Plantar+Stratum+Corneum&doi=10.1007%2FBF00371618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum</span></div><div class="casAuthors">Egelrud, T.; Lundstroem, A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-12</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    </div><div class="casAbstract">It was recently reported that unipolar cell shedding from plantar stratum corneum incubated in vitro, and the assocd. degrdn. of the desmosomal protein desmoglein I, are dependent on the activity of a proteinase that can be inhibited by aprotinin, chymostatin and Zn2+.  The aim of this work was to find a proteinase in plantar stratum corneum that fulfills the criteria for being the responsible enzyme.  Dissocd. plantar corneocytes were incubated with the chymotrypsin substrate (S 2586) and (S 2288), a substrate for a wide range of serine proteinases with arginine specificity.  There was a significant rate of hydrolysis of S 2586, but S 2288 was hydrolyzed only very slowly.  Extn. of dissocd. corneocytes with buffers contg. KCl or SDS released 1 major proteinase that could be detected by electrophoresis in polyacrylamide gels with copolymd. casein and subsequent incubations of the gels.  Both the caseinolytic activity and the S 2586-hydrolyzing activities were inhibited by aprotinin, chymostatin and Zn2+ but not by leupeptin.  The S-2586-hydrolyzing activity was also inhibited by soybean trypsin inhibitor and phenylmethylsulfonyl fluoride.  Both activities were optimal at pH 7-8 but were also significant at pH 5.5.  On gel-exclusion chromatog., the S 2586-hydrolyzing and caseinolytic activities were eluted with an apparent mol. wt. of ∼18 kDa.  When analyzed by electrophoresis in the presence of SDS under nonreducing conditions the caseinolytic enzyme had an apparent mol. wt. of ∼25 kDa.  It is concluded that the enzyme studied may be responsible for the degrdn. of intercellular cohesive structures during in vitro cell shedding from plantar stratum corneum, and that it does have properties compatible with a role in stratum corneum turnover under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlz9NFpJ9yqbVg90H21EOLACvtfcHk0livgn1VZXLBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1KktL8%253D&md5=e64aac60345efd40b722d903f5f9a3f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2FBF00371618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00371618%26sid%3Dliteratum%253Aachs%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DA.%26atitle%3DA%2520Chymotrypsin-like%2520Proteinase%2520That%2520May%2520Be%2520Involved%2520in%2520Desquamation%2520in%2520Plantar%2520Stratum%2520Corneum%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D1991%26volume%3D283%26issue%3D2%26spage%3D108%26epage%3D112%26doi%3D10.1007%2FBF00371618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Descargues, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prost, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraitag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazereeuw-Hautier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D ’Alessio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida-Yamamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodemer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambruno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovnanian, A.</span></span> <span> </span><span class="NLM_article-title">Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton Syndrome</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1622</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1038/sj.jid.5700284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fsj.jid.5700284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16628198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1Khu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1622-1632&author=P.+Descarguesauthor=C.+Deraisonauthor=C.+Prostauthor=S.+Fraitagauthor=J.+Mazereeuw-Hautierauthor=M.+D+%E2%80%99Alessioauthor=A.+Ishida-Yamamotoauthor=C.+Bodemerauthor=G.+Zambrunoauthor=A.+Hovnanian&title=Corneodesmosomal+Cadherins+Are+Preferential+Targets+of+Stratum+Corneum+Trypsin-+and+Chymotrypsin-like+Hyperactivity+in+Netherton+Syndrome&doi=10.1038%2Fsj.jid.5700284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton Syndrome</span></div><div class="casAuthors">Descargues, Pascal; Deraison, Celine; Prost, Catherine; Fraitag, Sylvie; Mazereeuw-Hautier, Juliette; D'Alessio, Marina; Ishida-Yamamoto, Akemi; Bodemer, Christine; Zambruno, Giovanna; Hovnanian, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1622-1632</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SPINK5 (serine protease inhibitor Kazal-type 5), encoding the protease inhibitor LEKTI (lympho-epithelial Kazal-type related inhibitor), is the defective gene in Netherton syndrome (NS), a severe inherited keratinizing disorder.  We have recently demonstrated epidermal protease hyperactivity in Spink5-/- mice resulting in desmosomal protein degrdn.  Herein, we investigated the mol. mechanism underlying the epidermal defect in 15 patients with NS.  We demonstrated that, in a majority of patients, desmoglein 1 (Dsg1) and desmocollin 1 (Dsc1) were dramatically reduced in the upper most living layers of the epidermis.  These defects were assocd. with premature degrdn. of corneodesmosomes.  Stratum corneum tryptic enzyme (SCTE)-like and stratum corneum chymotryptic enzyme (SCCE)-like activities were increased, suggesting that these proteases participate in the premature degrdn. of corneodesmosomal cadherins.  SCTE and SCCE expression was extended to the cell layers where Dsg1 and Dsc1 immunostaining was reduced.  In contrast, a subset of six patients with normal epidermal protease activity or residual LEKTI expression displayed apparently normal cadherin expression and less severe disease manifestations.  This suggests a degree of correlation between cadherin degrdn. and clin. severity.  This work further supports the implication of premature corneodesmosomal cadherin degrdn. in the pathogenesis of NS and provides evidence for addnl. factors playing a role in disease expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3TMqH7LYd9LVg90H21EOLACvtfcHk0livgn1VZXLBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1Khu74%253D&md5=92877c188e4c8ace34aa55eecb215868</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.jid.5700284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jid.5700284%26sid%3Dliteratum%253Aachs%26aulast%3DDescargues%26aufirst%3DP.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DProst%26aufirst%3DC.%26aulast%3DFraitag%26aufirst%3DS.%26aulast%3DMazereeuw-Hautier%26aufirst%3DJ.%26aulast%3DD%2B%25E2%2580%2599Alessio%26aufirst%3DM.%26aulast%3DIshida-Yamamoto%26aufirst%3DA.%26aulast%3DBodemer%26aufirst%3DC.%26aulast%3DZambruno%26aufirst%3DG.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DCorneodesmosomal%2520Cadherins%2520Are%2520Preferential%2520Targets%2520of%2520Stratum%2520Corneum%2520Trypsin-%2520and%2520Chymotrypsin-like%2520Hyperactivity%2520in%2520Netherton%2520Syndrome%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2006%26volume%3D126%26spage%3D1622%26epage%3D1632%26doi%3D10.1038%2Fsj.jid.5700284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cane’, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignotti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Las Casas, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anfossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecorelli, S.</span></span> <span> </span><span class="NLM_article-title">The Serine Protease Stratum Corneum Chymotryptic Enzyme (Kallikrein 7) Is Highly Overexpressed in Squamous Cervical Cancer Cells</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2004.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ygyno.2004.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15297163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVeqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=283-288&issue=2&author=A.+D.+Santinauthor=S.+Cane%E2%80%99author=S.+Belloneauthor=E.+Bignottiauthor=M.+Palmieriauthor=L.+E.+De+Las+Casasauthor=J.+J.+Romanauthor=S.+Anfossiauthor=T.+O%E2%80%99Brienauthor=S.+Pecorelli&title=The+Serine+Protease+Stratum+Corneum+Chymotryptic+Enzyme+%28Kallikrein+7%29+Is+Highly+Overexpressed+in+Squamous+Cervical+Cancer+Cells&doi=10.1016%2Fj.ygyno.2004.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells</span></div><div class="casAuthors">Santin, Alessandro D.; Cane, Stefania; Bellone, Stefania; Bignotti, Eliana; Palmieri, Michela; De Las Casas, Luis E.; Roman, Juan J.; Anfossi, Simone; O'Brien, Timothy; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-288</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To det. whether the Stratum Corneum Chymotryptic Enzyme (SCCE), a novel serine protease known to contribute to the cell shedding process by catalyzing the degrdn. of intercellular cohesive structures at the skin surface, is overexpressed in human cervical tumors.  SCCE expression was evaluated in 18 cervical cancer cell lines (i.e., 10 primary and 8 established cell lines) as well as in 8 normal cervical keratinocyte cultures by RT-PCR.  In addn., SCCE expression was evaluated by immunohistochem. on paraffin-embedded tumor tissue.  Normal cervical keratinocytes did not express SCCE.  In contrast, 50% of the primary and 50% of the established cervical cancer cell lines expressed SCCE by RT-PCR.  Eighty % (i.e., 4 of five) of primary squamous cervical tumors and 20% (i.e., 1 of 5) of primary adenocarcinomas expressed SCCE.  Five out of 5 (100%) of the patients harboring SCCE-pos. tumors were found to have metastatic involvement of the pelvic tumor draining lymph nodes.  Immunohistochem. staining of paraffin-embedded cervical cancer specimens confirmed SCCE expression in tumor cells and its absence on normal cervical epithelial cells.  Squamous cervical cancer expressed high levels of SCCE, suggesting that this protease may play an important role in invasion and metastasis.  Because SCCE appears only in abundance in tumor tissue and contains a secretion signal sequence, suggesting that SCCE is secreted, it may prove to be a useful diagnostic/prognostic tool for the detection of metastatic or recurrent disease or as a novel mol. target for cervical cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrii0V4qolSQLVg90H21EOLACvtfcHk0livgn1VZXLBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVeqsbc%253D&md5=6b6944b6d6dabb780d3a2cfd273b910a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2004.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2004.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DCane%25E2%2580%2599%26aufirst%3DS.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DBignotti%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DDe%2BLas%2BCasas%26aufirst%3DL.%2BE.%26aulast%3DRoman%26aufirst%3DJ.%2BJ.%26aulast%3DAnfossi%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DThe%2520Serine%2520Protease%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%2520%2528Kallikrein%25207%2529%2520Is%2520Highly%2520Overexpressed%2520in%2520Squamous%2520Cervical%2520Cancer%2520Cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2004%26volume%3D94%26issue%3D2%26spage%3D283%26epage%3D288%26doi%3D10.1016%2Fj.ygyno.2004.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, S. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsaros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigault de la Longrais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massobrio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1879</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2006.071456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1373%2Fclinchem.2006.071456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16916986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCgtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=1879-1886&issue=10&author=S.+J.+C.+Shanauthor=A.+Scorilasauthor=D.+Katsarosauthor=I.+Rigault+de+la+Longraisauthor=M.+Massobrioauthor=E.+P.+Diamandis&title=Unfavorable+Prognostic+Value+of+Human+Kallikrein+7+Quantified+by+ELISA+in+Ovarian+Cancer+Cytosols&doi=10.1373%2Fclinchem.2006.071456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols</span></div><div class="casAuthors">Shan, Shannon J. C.; Scorilas, Andreas; Katsaros, Dionyssios; Rigault de la Longrais, Irene; Massobrio, Marco; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1879-1886</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">Background: Human tissue kallikrein 7 (gene, KLK7; protein, hK7) is a member of the kallikrein family of secreted serine proteases.  Reports indicate that in ovarian cancer, KLK7 is significantly up-regulated at the mRNA level.  The aim of this study was to det. whether hK7, measured quant. by ELISA in ovarian cancer cytosols, is a prognostic biomarker for ovarian cancer.  Methods: We used a newly developed ELISA with 2 monoclonal antibodies to quantify hK7 prodn. in 260 ovarian tumor cytosols and correlated these data with various clinicopathol. variables and patient outcomes [progression-free survival (PFS) and overall survival (OS)] over a median follow-up period of 52 mo.  Results: Median (range) hK7 concn. in ovarian tumor cytosols was 2.84 (0-32.8) ng/mg of total protein.  Compared with healthy and benign ovarian tissues and non-ovarian tumors that metastasized to the ovary, malignant ovarian tumor cytosols highly overproduced hK7 (P < 0.001).  We used the median value as the cutoff value to categorize tumors as hK7-pos. and hK7-neg.  Women with hK7-pos. tumors most frequently had advanced-stage disease, higher tumor grade (G3), suboptimal debulking, and serous or undifferentiated histotype (P < 0.001).  Univariate anal. showed that hK7 positivity was assocd. with significantly shorter PFS (P = 0.01) but not OS.  Kaplan-Meier survival curves confirmed an increased risk of relapse in women with hK7-pos. tumors (P = 0.009).  In multivariate anal., hK7 was not significantly assocd. with either PFS or OS.  Conclusions: hK7 is assocd. with other unfavorable characteristics of ovarian cancer, but it is not an independent prognosticator for ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyuKmBg3wr7Vg90H21EOLACvtfcHk0ljN2fUwvrGaJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCgtb7E&md5=98d1ca862b930cbb6454c61b42db3e6d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2006.071456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2006.071456%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DS.%2BJ.%2BC.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DRigault%2Bde%2Bla%2BLongrais%26aufirst%3DI.%26aulast%3DMassobrio%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DUnfavorable%2520Prognostic%2520Value%2520of%2520Human%2520Kallikrein%25207%2520Quantified%2520by%2520ELISA%2520in%2520Ovarian%2520Cancer%2520Cytosols%26jtitle%3DClin.%2520Chem.%26date%3D2006%26volume%3D52%26issue%3D10%26spage%3D1879%26epage%3D1886%26doi%3D10.1373%2Fclinchem.2006.071456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgiotis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathioudaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span> <span> </span><span class="NLM_article-title">Expression Analysis of the Human Kallikrein 7 (KLK7) in Breast Tumors: A New Potential Biomarker for Prognosis of Breast Carcinoma</span>. <i>Thromb. Haemost.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1160/TH03-05-0261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1160%2FTH03-05-0261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=14691584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=180-186&issue=1&author=M.+Talieriauthor=E.+P.+Diamandisauthor=D.+Gourgiotisauthor=K.+Mathioudakiauthor=A.+Scorilas&title=Expression+Analysis+of+the+Human+Kallikrein+7+%28KLK7%29+in+Breast+Tumors%3A+A+New+Potential+Biomarker+for+Prognosis+of+Breast+Carcinoma&doi=10.1160%2FTH03-05-0261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: A new potential biomarker for prognosis of breast carcinoma</span></div><div class="casAuthors">Talieri, Maroulio; Diamandis, Eleftherios P.; Gourgiotis, Dimitrios; Mathioudaki, Kostandina; Scorilas, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Kallikreins are a subgroup of serine proteases that are involved in the post-translational processing of polypeptide precursors.  Growing evidence suggests that many kallikreins are implicated in carcinogenesis.  Human kallikrein gene 7 (KLK7; HSCCE) is a new member of the human kallikrein gene family.  KLK7 is expressed in normal breast tissue and is up-regulated in breast cancer cells by estrogens and glucocorticoids.  In the present study, expression of the KLK7 gene in 92 breast cancer tissues was analyzed by reverse transcription-PCR (RT-PCR) and direct sequencing of several samples.  The results were correlated with other clinicopathol. variables and patient outcome.  KLK7 gene expression was significantly lower in breast cancer patients of low stage (I/II) (p = 0.011) and patients with pos. progesterone receptors (p = 0.022).  Survival anal. showed that breast cancer patients with KLK7 pos. tumors have relatively shorter disease-free survival (DFS) and overall survival (OS) than patients with KLK7 neg. tumors.  These data suggest that KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLtnwQi8jl7Vg90H21EOLACvtfcHk0ljN2fUwvrGaJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D&md5=23134f1e50c39714b7998f39b2942263</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1160%2FTH03-05-0261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH03-05-0261%26sid%3Dliteratum%253Aachs%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DGourgiotis%26aufirst%3DD.%26aulast%3DMathioudaki%26aufirst%3DK.%26aulast%3DScorilas%26aufirst%3DA.%26atitle%3DExpression%2520Analysis%2520of%2520the%2520Human%2520Kallikrein%25207%2520%2528KLK7%2529%2520in%2520Breast%2520Tumors%253A%2520A%2520New%2520Potential%2520Biomarker%2520for%2520Prognosis%2520of%2520Breast%2520Carcinoma%26jtitle%3DThromb.%2520Haemost.%26date%3D2004%26volume%3D91%26issue%3D1%26spage%3D180%26epage%3D186%26doi%3D10.1160%2FTH03-05-0261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigemasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T. J.</span></span> <span> </span><span class="NLM_article-title">The Stratum Corneum Chymotryptic Enzyme That Mediates Shedding and Desquamation of Skin Cells Is Highly Overexpressed in Ovarian Tumor Cells</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">2074</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1999&pages=2074-2082&author=H.+Tanimotoauthor=L.+J.+Underwoodauthor=K.+Shigemasaauthor=Y.+Yanauthor=J.+Clarkeauthor=T.+H.+Parmleyauthor=T.+J.+O%E2%80%99Brien&title=The+Stratum+Corneum+Chymotryptic+Enzyme+That+Mediates+Shedding+and+Desquamation+of+Skin+Cells+Is+Highly+Overexpressed+in+Ovarian+Tumor+Cells&doi=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819991115%252986%253A10%253C2074%253A%253AAID-CNCR27%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DTanimoto%26aufirst%3DH.%26aulast%3DUnderwood%26aufirst%3DL.%2BJ.%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DParmley%26aufirst%3DT.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%2520That%2520Mediates%2520Shedding%2520and%2520Desquamation%2520of%2520Skin%2520Cells%2520Is%2520Highly%2520Overexpressed%2520in%2520Ovarian%2520Tumor%2520Cells%26jtitle%3DCancer%26date%3D1999%26volume%3D86%26spage%3D2074%26epage%3D2082%26doi%3D10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iakovlev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haun, R. S.</span></span> <span> </span><span class="NLM_article-title">Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-11-1079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F1055-9965.EPI-11-1079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1135-1142&issue=7&author=V.+Iakovlevauthor=E.+R.+Siegelauthor=M.-S.+Tsaoauthor=R.+S.+Haun&title=Expression+of+Kallikrein-Related+Peptidase+7+Predicts+Poor+Prognosis+in+Patients+with+Unresectable+Pancreatic+Ductal+Adenocarcinoma&doi=10.1158%2F1055-9965.EPI-11-1079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-11-1079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-11-1079%26sid%3Dliteratum%253Aachs%26aulast%3DIakovlev%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DE.%2BR.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DHaun%26aufirst%3DR.%2BS.%26atitle%3DExpression%2520of%2520Kallikrein-Related%2520Peptidase%25207%2520Predicts%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Unresectable%2520Pancreatic%2520Ductal%2520Adenocarcinoma%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2012%26volume%3D21%26issue%3D7%26spage%3D1135%26epage%3D1142%26doi%3D10.1158%2F1055-9965.EPI-11-1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T. R.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors as Promising Cancer Targets</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2016.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27000991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2016&pages=226-239&issue=2&author=Y.+Liuauthor=S.+Anauthor=R.+Wardauthor=Y.+Yangauthor=X.+X.+Guoauthor=W.+Liauthor=T.+R.+Xu&title=G+Protein-Coupled+Receptors+as+Promising+Cancer+Targets&doi=10.1016%2Fj.canlet.2016.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as promising cancer targets</span></div><div class="casAuthors">Liu, Ying; An, Su; Ward, Richard; Yang, Yang; Guo, Xiao-Xi; Li, Wei; Xu, Tian-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) regulate an array of fundamental biol. processes, such as growth, metab. and homeostasis.  Specifically, GPCRs are involved in cancer initiation and progression.  However, compared with the involvement of the epidermal growth factor receptor in cancer, that of GPCRs have been largely ignored.  Recent findings have implicated many GPCRs in tumorigenesis, tumor progression, invasion and metastasis.  Moreover, GPCRs contribute to the establishment and maintenance of a microenvironment which is permissive for tumor formation and growth, including effects upon surrounding blood vessels, signaling mols. and the extracellular matrix.  Thus, GPCRs are considered to be among the most useful drug targets against many solid cancers.  Development of selective ligands targeting GPCRs may provide novel and effective treatment strategies against cancer and some anticancer compds. are now in clin. trials.  Here, we focus on tumor related GPCRs, such as G protein-coupled receptor 30, the lysophosphatidic acid receptor, angiotensin receptors 1 and 2, the sphingosine 1-phosphate receptors and gastrin releasing peptide receptor.  We also summarize their tissue distributions, activation and roles in tumorigenesis and discuss the potential use of GPCR agonists and antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG-8ucpYwkTbVg90H21EOLACvtfcHk0lhqJz-o_zMKvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D&md5=c43749e81e9001a32cd6fcdf5e6a9084</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%2BX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DT.%2BR.%26atitle%3DG%2520Protein-Coupled%2520Receptors%2520as%2520Promising%2520Cancer%2520Targets%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D376%26issue%3D2%26spage%3D226%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2016.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohar, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verástegui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnik, a.</span></span> <span> </span><span class="NLM_article-title">Involvement of Chemokine Receptors in Breast Cancer Metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>410</i></span> (<span class="NLM_issue">6824</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1038/35065016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2F35065016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=50-56&issue=6824&author=a.+M%C3%BCllerauthor=B.+Homeyauthor=H.+Sotoauthor=N.+Geauthor=D.+Catronauthor=M.+E.+Buchananauthor=T.+McClanahanauthor=E.+Murphyauthor=W.+Yuanauthor=S.+N.+Wagnerauthor=J.+L.+Barreraauthor=a.+Moharauthor=E.+Ver%C3%A1steguiauthor=a.+Zlotnik&title=Involvement+of+Chemokine+Receptors+in+Breast+Cancer+Metastasis&doi=10.1038%2F35065016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F35065016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35065016%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3Da.%26aulast%3DHomey%26aufirst%3DB.%26aulast%3DSoto%26aufirst%3DH.%26aulast%3DGe%26aufirst%3DN.%26aulast%3DCatron%26aufirst%3DD.%26aulast%3DBuchanan%26aufirst%3DM.%2BE.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DWagner%26aufirst%3DS.%2BN.%26aulast%3DBarrera%26aufirst%3DJ.%2BL.%26aulast%3DMohar%26aufirst%3Da.%26aulast%3DVer%25C3%25A1stegui%26aufirst%3DE.%26aulast%3DZlotnik%26aufirst%3Da.%26atitle%3DInvolvement%2520of%2520Chemokine%2520Receptors%2520in%2520Breast%2520Cancer%2520Metastasis%26jtitle%3DNature%26date%3D2001%26volume%3D410%26issue%3D6824%26spage%3D50%26epage%3D56%26doi%3D10.1038%2F35065016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarvaiya, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabikian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span> <span> </span><span class="NLM_article-title">Chemokines in Tumor Progression and Metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2171</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.18632%2Foncotarget.1426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2171-2185&author=P.+J.+Sarvaiyaauthor=D.+Guoauthor=I.+V.+Ulasovauthor=P.+Gabikianauthor=M.+S.+Lesniak&title=Chemokines+in+Tumor+Progression+and+Metastasis&doi=10.18632%2Foncotarget.1426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1426%26sid%3Dliteratum%253Aachs%26aulast%3DSarvaiya%26aufirst%3DP.%2BJ.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DUlasov%26aufirst%3DI.%2BV.%26aulast%3DGabikian%26aufirst%3DP.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26atitle%3DChemokines%2520in%2520Tumor%2520Progression%2520and%2520Metastasis%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D2171%26epage%3D2185%26doi%3D10.18632%2Foncotarget.1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardones, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span> <span> </span><span class="NLM_article-title">Chemokine Receptors and Melanoma Metastasis</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2004.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.jdermsci.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15519136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=71-78&issue=2&author=T.+Murakamiauthor=A.+R.+Cardonesauthor=S.+T.+Hwang&title=Chemokine+Receptors+and+Melanoma+Metastasis&doi=10.1016%2Fj.jdermsci.2004.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors and melanoma metastasis</span></div><div class="casAuthors">Murakami, Takashi; Cardones, Adela R.; Hwang, Sam T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-78</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis is the end result of a complex series of biol. events that leads to the formation of clin. significant secondary tumors at distant sites.  The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs.  Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin.  Herein, the authors review the evidence that suggests that a limited no. of chemokine receptors may play crit. roles in detg. organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival.  In particular, the authors describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma.  Preliminary evidence in this preclin. model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors.  Thus, manipulation of the chemokine network could have therapeutic potential in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbvCILfVH9bVg90H21EOLACvtfcHk0lhqJz-o_zMKvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOlsro%253D&md5=8d33fc481f4c679d39e6aba9bcad121b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DCardones%26aufirst%3DA.%2BR.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26atitle%3DChemokine%2520Receptors%2520and%2520Melanoma%2520Metastasis%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2004%26volume%3D36%26issue%3D2%26spage%3D71%26epage%3D78%26doi%3D10.1016%2Fj.jdermsci.2004.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajewicz, W.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors: Abnormalities in Signal Transmission, Disease States and Pharmacotherapy</span>. <i>Acta Polym. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.3390/ijms18122713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.3390%2Fijms18122713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=25272642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSjsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=229-243&author=M.+Zalewskaauthor=M.+Siaraauthor=W.+Sajewicz&title=G+Protein-Coupled+Receptors%3A+Abnormalities+in+Signal+Transmission%2C+Disease+States+and+Pharmacotherapy&doi=10.3390%2Fijms18122713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy</span></div><div class="casAuthors">Zalewska, Marta; Siara, Monika; Sajewicz, Waldemar</div><div class="citationInfo"><span class="NLM_cas:title">Acta Poloniae Pharmaceutica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-243, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">APPHAX</span>;
        ISSN:<span class="NLM_cas:issn">2353-5288</span>.
    
            (<span class="NLM_cas:orgname">Polish Pharmaceutical Society</span>)
        </div><div class="casAbstract">The aim of this review is to present the research results and draw new conclusions about the impact of alterations in the signal transmission through the G protein-coupled receptors (GPCRs) on the formation of diseases and drug therapy.  GPCR family is the largest and the most diverse group of membrane receptors.  They transmit signals into the cell by interaction with different ligands, which include, inter alia, hormones, neuro-transmitters, and photons.  GPCRs are responsible for the proper conduction of many physiol. processes such as vision, intercellular communication, the neuronal transmission, hormonal signaling and are involved in many pathol. processes.  They are also point on the binding pathway of multiple drugs.  They are targets of nearly one third of the drugs at the current pharmaceutical market.  The genes encoding GPCRs represent about 4% of the human genome.  Mutations that occur in them are assocd. with a broad spectrum of diseases of diverse etiol.  As a mutations result, there is a change in receptor activity (GPCR become inactive, overactive, or constitutively active), in the process of ligand binding and signal transduction.  Changes in the GPCRs functioning can cause diseases such as retinitis pigmentosa (rhodopsin mutations), nephrogenic diabetes insipidus (vasopressin receptor mutations), obesity (melanocortin receptor mutations).  Many mutational changes in genes encoding GPCR can change drug therapy of already existed diseases: heart failure (adrenergic receptors), asthma (cysteinyl leukotriene receptors).  Studies concerning the structure and function of genetically modified GPCRs allow to get know a variety of mechanisms of its action, which in turn can contribute to broaden the knowledge on the etiol. and pharmacotherapy of many currently incurable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-n_NbMzJINrVg90H21EOLACvtfcHk0lgGnEMJVgeC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSjsLfP&md5=267cdfb8b36271fe395e1af987bb0409</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fijms18122713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18122713%26sid%3Dliteratum%253Aachs%26aulast%3DZalewska%26aufirst%3DM.%26aulast%3DSiara%26aufirst%3DM.%26aulast%3DSajewicz%26aufirst%3DW.%26atitle%3DG%2520Protein-Coupled%2520Receptors%253A%2520Abnormalities%2520in%2520Signal%2520Transmission%252C%2520Disease%2520States%2520and%2520Pharmacotherapy%26jtitle%3DActa%2520Polym.%2520Pharm.%26date%3D2014%26volume%3D71%26spage%3D229%26epage%3D243%26doi%3D10.3390%2Fijms18122713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua
Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinness, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span> <span> </span><span class="NLM_article-title">A Novel Experimental Strategy to Assess the Metabolic Effects of Selective Activation of a G <sub>q</sub> -Coupled Receptor in Hepatocytes In Vivo</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3551</span>, <span class="refDoi"> DOI: 10.1210/en.2012-2127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1210%2Fen.2012-2127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=3539-3551&issue=10&author=J.+Hua%0ALiauthor=S.+Jainauthor=S.+M.+McMillinauthor=Y.+Cuiauthor=D.+Gautamauthor=W.+Sakamotoauthor=H.+Luauthor=W.+Jouauthor=O.+P.+McGuinnessauthor=O.+Gavrilovaauthor=J.+Wess&title=A+Novel+Experimental+Strategy+to+Assess+the+Metabolic+Effects+of+Selective+Activation+of+a+G+q+-Coupled+Receptor+in+Hepatocytes+In+Vivo&doi=10.1210%2Fen.2012-2127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-2127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-2127%26sid%3Dliteratum%253Aachs%26aulast%3DHua%2BLi%26aufirst%3DJ.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DMcMillin%26aufirst%3DS.%2BM.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DGautam%26aufirst%3DD.%26aulast%3DSakamoto%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DJou%26aufirst%3DW.%26aulast%3DMcGuinness%26aufirst%3DO.%2BP.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DA%2520Novel%2520Experimental%2520Strategy%2520to%2520Assess%2520the%2520Metabolic%2520Effects%2520of%2520Selective%2520Activation%2520of%2520a%2520G%2520q%2520-Coupled%2520Receptor%2520in%2520Hepatocytes%2520In%2520Vivo%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26issue%3D10%26spage%3D3539%26epage%3D3551%26doi%3D10.1210%2Fen.2012-2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. D.</span></span> <span> </span><span class="NLM_article-title">β-Adrenoceptors as Molecular Targets in the Treatment of Hypertension</span>. <i>Can. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">S8</span>, <span class="refDoi"> DOI: 10.1016/j.cjca.2014.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.cjca.2014.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24685403" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=S3-S8&author=S.+S.+G.+Fergusonauthor=R.+D.+Feldman&title=%CE%B2-Adrenoceptors+as+Molecular+Targets+in+the+Treatment+of+Hypertension&doi=10.1016%2Fj.cjca.2014.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cjca.2014.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cjca.2014.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DFeldman%26aufirst%3DR.%2BD.%26atitle%3D%25CE%25B2-Adrenoceptors%2520as%2520Molecular%2520Targets%2520in%2520the%2520Treatment%2520of%2520Hypertension%26jtitle%3DCan.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D30%26spage%3DS3%26epage%3DS8%26doi%3D10.1016%2Fj.cjca.2014.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajewicz, W.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors: Abnormalities in Signal Transmission, Disease States and Pharmacotherapy</span>. <i>Acta Pol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=229-243&author=M.+Zalewskaauthor=M.+Siaraauthor=W.+Sajewicz&title=G+Protein-Coupled+Receptors%3A+Abnormalities+in+Signal+Transmission%2C+Disease+States+and+Pharmacotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZalewska%26aufirst%3DM.%26aulast%3DSiara%26aufirst%3DM.%26aulast%3DSajewicz%26aufirst%3DW.%26atitle%3DG%2520Protein-Coupled%2520Receptors%253A%2520Abnormalities%2520in%2520Signal%2520Transmission%252C%2520Disease%2520States%2520and%2520Pharmacotherapy%26jtitle%3DActa%2520Pol.%2520Pharm.%26date%3D2014%26volume%3D71%26spage%3D229%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.-R.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors as Promising Cancer Targets</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2016.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27000991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2016&pages=226-239&issue=2&author=Y.+Liuauthor=S.+Anauthor=R.+Wardauthor=Y.+Yangauthor=X.-X.+Guoauthor=W.+Liauthor=T.-R.+Xu&title=G+Protein-Coupled+Receptors+as+Promising+Cancer+Targets&doi=10.1016%2Fj.canlet.2016.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as promising cancer targets</span></div><div class="casAuthors">Liu, Ying; An, Su; Ward, Richard; Yang, Yang; Guo, Xiao-Xi; Li, Wei; Xu, Tian-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) regulate an array of fundamental biol. processes, such as growth, metab. and homeostasis.  Specifically, GPCRs are involved in cancer initiation and progression.  However, compared with the involvement of the epidermal growth factor receptor in cancer, that of GPCRs have been largely ignored.  Recent findings have implicated many GPCRs in tumorigenesis, tumor progression, invasion and metastasis.  Moreover, GPCRs contribute to the establishment and maintenance of a microenvironment which is permissive for tumor formation and growth, including effects upon surrounding blood vessels, signaling mols. and the extracellular matrix.  Thus, GPCRs are considered to be among the most useful drug targets against many solid cancers.  Development of selective ligands targeting GPCRs may provide novel and effective treatment strategies against cancer and some anticancer compds. are now in clin. trials.  Here, we focus on tumor related GPCRs, such as G protein-coupled receptor 30, the lysophosphatidic acid receptor, angiotensin receptors 1 and 2, the sphingosine 1-phosphate receptors and gastrin releasing peptide receptor.  We also summarize their tissue distributions, activation and roles in tumorigenesis and discuss the potential use of GPCR agonists and antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG-8ucpYwkTbVg90H21EOLACvtfcHk0lgGnEMJVgeC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D&md5=c43749e81e9001a32cd6fcdf5e6a9084</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.-X.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DT.-R.%26atitle%3DG%2520Protein-Coupled%2520Receptors%2520as%2520Promising%2520Cancer%2520Targets%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D376%26issue%3D2%26spage%3D226%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2016.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">G-Protein-Coupled Receptors and Melanoma</span>. <i>Pigm. Cell Melanoma Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1111/j.1755-148X.2008.00478.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1111%2Fj.1755-148X.2008.00478.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=18582227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCks73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=415-428&issue=4&author=H.+J.+Leeauthor=B.+Wallauthor=S.+Chen&title=G-Protein-Coupled+Receptors+and+Melanoma&doi=10.1111%2Fj.1755-148X.2008.00478.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">G-protein-coupled receptors and melanoma</span></div><div class="casAuthors">Lee, Hwa Jin; Wall, Brian; Chen, Suzie</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-428</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCR) are the largest family of receptors with over 500 members.  Evaluation of GPCR gene expression in primary human tumors identified over-expression of GPCR in several tumor types.  Anal. of cancer samples in different disease stages also suggests that some GPCR may be involved in early tumor progression and others may play a crit. role in tumor invasion and metastasis.  Currently, >50% of drug targets to various human diseases are based on GPCR.  In this review, the relationships between several GPCR and melanoma development and/or progression will be discussed.  Finally, the possibility of using one or more of these GPCR as therapeutic targets in melanoma will be summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpivjWhlj9bVg90H21EOLACvtfcHk0lgRtN8koHTyDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCks73P&md5=bf14619fa21bd97920f9a92a56dfafd6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2008.00478.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2008.00478.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DWall%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DG-Protein-Coupled%2520Receptors%2520and%2520Melanoma%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2008%26volume%3D21%26issue%3D4%26spage%3D415%26epage%3D428%26doi%3D10.1111%2Fj.1755-148X.2008.00478.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rask-Andersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">Trends in GPCR Drug Discovery: New Agents, Targets and Indications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd.2017.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=29075003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=829-842&issue=12&author=A.+S.+Hauserauthor=M.+M.+Attwoodauthor=M.+Rask-Andersenauthor=H.+B.+Schi%C3%B6thauthor=D.+E.+Gloriam&title=Trends+in+GPCR+Drug+Discovery%3A+New+Agents%2C+Targets+and+Indications&doi=10.1038%2Fnrd.2017.178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in GPCR drug discovery: new agents, targets and indications</span></div><div class="casAuthors">Hauser, Alexander S.; Attwood, Misty M.; Rask-Andersen, Mathias; Schioth, Helgi B.; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">829-842</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are the most intensively studied drug targets, mostly due to their substantial involvement in human pathophysiol. and their pharmacol. tractability.  Here, we report an up-to-date anal. of all GPCR drugs and agents in clin. trials, which reveals current trends across mol. types, drug targets and therapeutic indications, including showing that 475 drugs (∼34% of all drugs approved by the US Food and Drug Administration (FDA)) act at 108 unique GPCRs.  Approx. 321 agents are currently in clin. trials, of which ∼20% target 66 potentially novel GPCR targets without an approved drug, and the no. of biol. drugs, allosteric modulators and biased agonists has increased.  The major disease indications for GPCR modulators show a shift towards diabetes, obesity and Alzheimer disease, although several central nervous system disorders are also highly represented.  The 224 (56%) non-olfactory GPCRs that have not yet been explored in clin. trials have broad untapped therapeutic potential, particularly in genetic and immune system disorders.  Finally, we provide an interactive online resource to analyze and infer trends in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9iw1QqR9GKrVg90H21EOLACvtfcHk0lgRtN8koHTyDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansbzF&md5=560893258493bd96c0af24d3bef08b6f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.178%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DAttwood%26aufirst%3DM.%2BM.%26aulast%3DRask-Andersen%26aufirst%3DM.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DTrends%2520in%2520GPCR%2520Drug%2520Discovery%253A%2520New%2520Agents%252C%2520Targets%2520and%2520Indications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D12%26spage%3D829%26epage%3D842%26doi%3D10.1038%2Fnrd.2017.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. K.</span></span> <span> </span><span class="NLM_article-title">Chemokines in Tumor Angiogenesis and Metastasis</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1007/s10555-007-9068-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10555-007-9068-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17828470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=453-467&issue=3%E2%80%934&author=S.+Singhauthor=A.+Sadanandamauthor=R.+K.+Singh&title=Chemokines+in+Tumor+Angiogenesis+and+Metastasis&doi=10.1007%2Fs10555-007-9068-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines in tumor angiogenesis and metastasis</span></div><div class="casAuthors">Singh, Seema; Sadanandam, Anguraj; Singh, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">453-467</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Chemokines are a large group of low mol. wt. cytokines that are known to selectively attract and activate different cell types.  Although the primary function of chemokines is well recognized as leukocyte attractants, recent evidences indicate that they also play a role in no. of tumor-related processes, such as growth, angiogenesis and metastasis.  Chemokines activate cells through cell surface seven trans-membranes, G-protein-coupled receptors (GPCR).  The role played by chemokines and their receptors in tumor pathophysiol. is complex as some chemokines favor tumor growth and metastasis, while others may enhance anti-tumor immunity.  These diverse functions of chemokines establish them as key mediators between the tumor cells and their microenvironment and play crit. role in tumor progression and metastasis.  In this review, we present some of the recent advances in chemokine research with special emphasis on its role in tumor angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIrEg2peMUvbVg90H21EOLACvtfcHk0lgRtN8koHTyDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbL&md5=9b8a51c31679ed1f9764ef8a77e40983</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9068-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9068-9%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DSadanandam%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DChemokines%2520in%2520Tumor%2520Angiogenesis%2520and%2520Metastasis%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26issue%3D3%25E2%2580%25934%26spage%3D453%26epage%3D467%26doi%3D10.1007%2Fs10555-007-9068-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span> <span> </span><span class="NLM_article-title">Cancer and the Chemokine Network</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrc1388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrc1388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15229479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=540-550&issue=7&author=F.+Balkwill&title=Cancer+and+the+Chemokine+Network&doi=10.1038%2Fnrc1388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer and the chemokine network</span></div><div class="casAuthors">Balkwill, Fran</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">540-550</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A complex network of chemokines and their receptors influences the development of primary tumors and metastases.  New information about the biol. role of chemokines in these processes is providing insights into host-tumor interactions, such as the role of the leukocyte infiltrate, and into the mechanisms that det. the metastatic potential and site-specific spread of cancer cells.  Chemokine-receptor antagonists are showing promise in animal models of inflammation and autoimmune disease.  Could manipulating the local chemokine network have therapeutic benefits in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYhFsIM97vbVg90H21EOLACvtfcHk0lgRtN8koHTyDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D&md5=a827ffe8e02074fed068557c4c8dec11</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrc1388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1388%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer%2520and%2520the%2520Chemokine%2520Network%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D7%26spage%3D540%26epage%3D550%26doi%3D10.1038%2Fnrc1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. C.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">8604</span>– <span class="NLM_lpage">8612</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F0008-5472.CAN-04-1844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8604-8612&issue=23&author=M.+C.%0AP.+Smithauthor=K.+E.+Lukerauthor=J.+R.+Garbowauthor=J.+L.+Priorauthor=E.+Jacksonauthor=D.+Piwnica-Wormsauthor=G.+D.+Luker&title=CXCR4+Regulates+Growth+of+Both+Primary+and+Metastatic+Breast+Cancer&doi=10.1158%2F0008-5472.CAN-04-1844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1844%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BC.%2BP.%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DGarbow%26aufirst%3DJ.%2BR.%26aulast%3DPrior%26aufirst%3DJ.%2BL.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DCXCR4%2520Regulates%2520Growth%2520of%2520Both%2520Primary%2520and%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D23%26spage%3D8604%26epage%3D8612%26doi%3D10.1158%2F0008-5472.CAN-04-1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabioglu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglio, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortobagyi, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, A.</span></span> <span> </span><span class="NLM_article-title">CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5686</span>– <span class="NLM_lpage">5693</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F1078-0432.CCR-05-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16115904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1CjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5686-5693&author=N.+Cabiogluauthor=M.+S.+Yaziciauthor=B.+Arunauthor=K.+R.+Broglioauthor=G.+N.+Hortobagyiauthor=J.+E.+Priceauthor=A.+Sahin&title=CCR7+and+CXCR4+as+Novel+Biomarkers+Predicting+Axillary+Lymph+Node+Metastasis+in+T1+Breast+Cancer&doi=10.1158%2F1078-0432.CCR-05-0014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer</span></div><div class="casAuthors">Cabioglu, Neslihan; Yazici, M. Sertac; Arun, Banu; Broglio, Kristine R.; Hortobagyi, Gabriel N.; Price, Janet E.; Sahin, Aysegul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5686-5693</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The chemokine receptors CCR7 and CXCR4 have been shown to play an important role in cancer metastasis.  We therefore studied the differential expression of CCR7 and CXCR4, along with that of the biomarker HER2-neu, to evaluate whether these biomarkers could predict axillary lymph node metastasis in breast cancer.  Biomarker expression levels were evaluated using paraffin-embedded tissue sections of lymph node-neg. (n = 99) and lymph node-pos. (n = 98) T1 breast cancer by immunohistochem. staining.  Lymph node-pos. tumors showed higher rates of high cytoplasmic CCR7 staining (21.5% vs. 8.5%, P = 0.013) and HER2-neu overexpression (21.5% vs. 9.3%, P = 0.019) than did lymph node-neg. tumors.  Similarly, high cytoplasmic CXCR4 expression occurred more commonly in lymph node-pos. tumors (11.2% vs. 5.1%, P = 0.113).  In contrast, predominantly nuclear CXCR4 staining was more likely to be found in lymph node-neg. tumors (54.5% vs. 37.8%, P = 0.018).  Furthermore, cytoplasmic CXCR4 coexpressed with HER2-neu was the only factor assocd. with involvement of four or more lymph nodes (16.7% vs. 1.2%, P = 0.04) among lymph node-pos. tumors.  When all three biomarkers (CCR7, CXCR4, HER2-neu) were utilized together, 50.0% of lymph node-pos. tumors highly expressed one of these biomarkers compared with 18.8% of the lymph node-neg. tumors (P < 0.0001) These results suggest that the chemokine receptor CCR7 is a novel biomarker that can predict lymph node metastases in breast cancer.  Utilization of addnl. markers, such as CXCR4 and HER2-neu, further improves the prediction of the presence and extent of lymph node involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXsChhVGu1rVg90H21EOLACvtfcHk0lgvCqGclzXZGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1CjsL4%253D&md5=de745effe766513b6ceb20fff6976a36</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0014%26sid%3Dliteratum%253Aachs%26aulast%3DCabioglu%26aufirst%3DN.%26aulast%3DYazici%26aufirst%3DM.%2BS.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DBroglio%26aufirst%3DK.%2BR.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DPrice%26aufirst%3DJ.%2BE.%26aulast%3DSahin%26aufirst%3DA.%26atitle%3DCCR7%2520and%2520CXCR4%2520as%2520Novel%2520Biomarkers%2520Predicting%2520Axillary%2520Lymph%2520Node%2520Metastasis%2520in%2520T1%2520Breast%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D5686%26epage%3D5693%26doi%3D10.1158%2F1078-0432.CCR-05-0014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaizumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atogami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomonaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamihira, S.</span></span> <span> </span><span class="NLM_article-title">Survey of Chemokine Receptor Expression Reveals Frequent Co-Expression of Skin-Homing CCR4 and CCR10 in Adult T-Cell Leukemia/lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1080/10428190600775599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1080%2F10428190600775599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17071491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCiu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=2163-2173&issue=10&author=H.+Harasawaauthor=Y.+Yamadaauthor=K.+Hieshimaauthor=Z.+Jinauthor=T.+Nakayamaauthor=O.+Yoshieauthor=K.+Shimizuauthor=H.+Hasegawaauthor=T.+Hayashiauthor=Y.+Imaizumiauthor=S.+Ikedaauthor=H.+Sodaauthor=H.+Sodaauthor=S.+Atogamiauthor=Y.+Takasakiauthor=K.+Tsukasakiauthor=M.+Tomonagaauthor=K.+Murataauthor=K.+Sugaharaauthor=K.+Tsurudaauthor=S.+Kamihira&title=Survey+of+Chemokine+Receptor+Expression+Reveals+Frequent+Co-Expression+of+Skin-Homing+CCR4+and+CCR10+in+Adult+T-Cell+Leukemia%2Flymphoma&doi=10.1080%2F10428190600775599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma</span></div><div class="casAuthors">Harasawa, Hitomi; Yamada, Yasuaki; Hieshima, Kunio; Jin, Zhe; Nakayama, Takashi; Yoshie, Osamu; Shimizu, Kazuhiro; Hasegawa, Hiroo; Hayashi, Tomayoshi; Imaizumi, Yoshitaka; Ikeda, Shuichi; Soda, Hiroshi; Soda, Hisashi; Atogami, Sunao; Takasaki, Yumi; Tsukasaki, Kunihiro; Tomonaga, Masao; Murata, Ken; Sugahara, Kazuyuki; Tsuruda, Kazuto; Kamihira, Shimeru</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2163-2173</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Adult T-cell leukemia/lymphoma (ATLL) is a malignancy of mature T-cell origin with multi-organ involvement.  Because the chemokine receptors play crucial roles in tissue-specific homing of mature lymphocytes, particular chemokine receptors expressed on ATLL cells may be involved in their tissue infiltration.  We thus performed a comprehensive survey on the chemokine receptor expression in ATLL.  ATLL cells expressed transcripts of CCR1, CCR4, CCR7, CCR8, CCR10 and CXCR4 but hardly expressed those of CCR2, CCR3, CCR5, CCR6, CCR9, CXCR1, CXCR2, CXCR3 and CXCR5.  These results were confirmed at the protein level by flow cytometric anal.  Notably, patients who have skin lesions showed significantly higher levels of CCR10 mRNA expression than patients without skin lesions.  ATLL cells migrated efficiently to the CCR4 ligand, CCL22, and moderately to the CCR10 ligands, CCL27 and CCL28.  Moreover, ATLL skin lesions consistently contained transcripts of CCR10 and its ligands CCL27 and CCL28 besides those of CCR4 and its ligands CCL17 and CCL22 that have been reported previously.  Collectively, the frequent co-expression of CCR4 and CCR10, the known pair of skin-homing chemokine receptors, may play an important role in ATLL invasion into the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi6_rcnXSHsrVg90H21EOLACvtfcHk0lgvCqGclzXZGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCiu7%252FO&md5=3ef92d2575c6dbb0c28dbb2f94737841</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F10428190600775599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190600775599%26sid%3Dliteratum%253Aachs%26aulast%3DHarasawa%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHieshima%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DImaizumi%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DH.%26aulast%3DSoda%26aufirst%3DH.%26aulast%3DAtogami%26aufirst%3DS.%26aulast%3DTakasaki%26aufirst%3DY.%26aulast%3DTsukasaki%26aufirst%3DK.%26aulast%3DTomonaga%26aufirst%3DM.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DK.%26aulast%3DKamihira%26aufirst%3DS.%26atitle%3DSurvey%2520of%2520Chemokine%2520Receptor%2520Expression%2520Reveals%2520Frequent%2520Co-Expression%2520of%2520Skin-Homing%2520CCR4%2520and%2520CCR10%2520in%2520Adult%2520T-Cell%2520Leukemia%252Flymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2006%26volume%3D47%26issue%3D10%26spage%3D2163%26epage%3D2173%26doi%3D10.1080%2F10428190600775599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieramici, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offidani, A.</span></span> <span> </span><span class="NLM_article-title">Potential Role of CCL27 and CCR10 Expression in Melanoma Progression and Immune Escape</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ejca.2006.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=1181-1187&issue=8&author=O.+Simonettiauthor=G.+Goteriauthor=G.+Lucariniauthor=A.+Filosaauthor=T.+Pieramiciauthor=C.+Rubiniauthor=G.+Biaginiauthor=A.+Offidani&title=Potential+Role+of+CCL27+and+CCR10+Expression+in+Melanoma+Progression+and+Immune+Escape&doi=10.1016%2Fj.ejca.2006.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DSimonetti%26aufirst%3DO.%26aulast%3DGoteri%26aufirst%3DG.%26aulast%3DLucarini%26aufirst%3DG.%26aulast%3DFilosa%26aufirst%3DA.%26aulast%3DPieramici%26aufirst%3DT.%26aulast%3DRubini%26aufirst%3DC.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DOffidani%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520CCL27%2520and%2520CCR10%2520Expression%2520in%2520Melanoma%2520Progression%2520and%2520Immune%2520Escape%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26issue%3D8%26spage%3D1181%26epage%3D1187%26doi%3D10.1016%2Fj.ejca.2006.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">290</span>, <span class="refDoi"> DOI: 10.3390/md15090290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.3390%2Fmd15090290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=290&issue=9&author=F.+H.+Al-Awadhiauthor=L.+A.+Salvadorauthor=B.+K.+Lawauthor=V.+J.+Paulauthor=H.+Luesch&title=Kempopeptin+C%2C+a+Novel+Marine-Derived+Serine+Protease+Inhibitor+Targeting+Invasive+Breast+Cancer&doi=10.3390%2Fmd15090290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmd15090290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd15090290%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DSalvador%26aufirst%3DL.%2BA.%26aulast%3DLaw%26aufirst%3DB.%2BK.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DKempopeptin%2520C%252C%2520a%2520Novel%2520Marine-Derived%2520Serine%2520Protease%2520Inhibitor%2520Targeting%2520Invasive%2520Breast%2520Cancer%26jtitle%3DMar.%2520Drugs%26date%3D2017%26volume%3D15%26issue%3D9%26spage%3D290%26doi%3D10.3390%2Fmd15090290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Grassystatins D–F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2986</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=2969-2986&issue=11&author=F.+H.+Al-Awadhiauthor=B.+K.+Lawauthor=V.+J.+Paulauthor=H.+Luesch&title=Grassystatins+D%E2%80%93F%2C+Potent+Aspartic+Protease+Inhibitors+from+Marine+Cyanobacteria+as+Potential+Antimetastatic+Agents+Targeting+Invasive+Breast+Cancer&doi=10.1021%2Facs.jnatprod.7b00551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00551%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DLaw%26aufirst%3DB.%2BK.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DGrassystatins%2520D%25E2%2580%2593F%252C%2520Potent%2520Aspartic%2520Protease%2520Inhibitors%2520from%2520Marine%2520Cyanobacteria%2520as%2520Potential%2520Antimetastatic%2520Agents%2520Targeting%2520Invasive%2520Breast%2520Cancer%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26issue%3D11%26spage%3D2969%26epage%3D2986%26doi%3D10.1021%2Facs.jnatprod.7b00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratnayake, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Tasiamide F, a Potent Inhibitor of Cathepsins D and E from a Marine Cyanobacterium</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3276</span>– <span class="NLM_lpage">3282</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.bmc.2016.04.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3276-3282&issue=15&author=F.+H.+Al-Awadhiauthor=R.+Ratnayakeauthor=V.+J.+Paulauthor=H.+Luesch&title=Tasiamide+F%2C+a+Potent+Inhibitor+of+Cathepsins+D+and+E+from+a+Marine+Cyanobacterium&doi=10.1016%2Fj.bmc.2016.04.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.062%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DRatnayake%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DTasiamide%2520F%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Cathepsins%2520D%2520and%2520E%2520from%2520a%2520Marine%2520Cyanobacterium%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D15%26spage%3D3276%26epage%3D3282%26doi%3D10.1016%2Fj.bmc.2016.04.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. T.</span></span> <span> </span><span class="NLM_article-title">Bioactive Natural Products from Marine Cyanobacteria for Drug Discovery</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2007.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.phytochem.2007.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=954-979&issue=7&author=L.+T.+Tan&title=Bioactive+Natural+Products+from+Marine+Cyanobacteria+for+Drug+Discovery&doi=10.1016%2Fj.phytochem.2007.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%2BT.%26atitle%3DBioactive%2520Natural%2520Products%2520from%2520Marine%2520Cyanobacteria%2520for%2520Drug%2520Discovery%26jtitle%3DPhytochemistry%26date%3D2007%26volume%3D68%26issue%3D7%26spage%3D954%26epage%3D979%26doi%3D10.1016%2Fj.phytochem.2007.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sitachitta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Grenadadiene and Grenadamide, Cyclopropyl-Containing Fatty Acid Metabolites from the Marine Cyanobacterium <i>Lyngbya majuscula</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1021/np970576a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np970576a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=681-684&issue=5&author=N.+Sitachittaauthor=W.+H.+Gerwick&title=Grenadadiene+and+Grenadamide%2C+Cyclopropyl-Containing+Fatty+Acid+Metabolites+from+the+Marine+Cyanobacterium+Lyngbya+majuscula&doi=10.1021%2Fnp970576a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp970576a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp970576a%26sid%3Dliteratum%253Aachs%26aulast%3DSitachitta%26aufirst%3DN.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DGrenadadiene%2520and%2520Grenadamide%252C%2520Cyclopropyl-Containing%2520Fatty%2520Acid%2520Metabolites%2520from%2520the%2520Marine%2520Cyanobacterium%2520Lyngbya%2520majuscula%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26issue%3D5%26spage%3D681%26epage%3D684%26doi%3D10.1021%2Fnp970576a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Semiplenamides A-G, Fatty Acid Amides from a Papua New Guinea Collection of the Marine Cyanobacterium <i>Lyngbya semiplena</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1021/np030242n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030242n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1364-1368&issue=10&author=B.+Hanauthor=K.+L.+McPhailauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Semiplenamides+A-G%2C+Fatty+Acid+Amides+from+a+Papua+New+Guinea+Collection+of+the+Marine+Cyanobacterium+Lyngbya+semiplena&doi=10.1021%2Fnp030242n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fnp030242n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030242n%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DB.%26aulast%3DMcPhail%26aufirst%3DK.%2BL.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DSemiplenamides%2520A-G%252C%2520Fatty%2520Acid%2520Amides%2520from%2520a%2520Papua%2520New%2520Guinea%2520Collection%2520of%2520the%2520Marine%2520Cyanobacterium%2520Lyngbya%2520semiplena%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2003%26volume%3D66%26issue%3D10%26spage%3D1364%26epage%3D1368%26doi%3D10.1021%2Fnp030242n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montaser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2676</span>– <span class="NLM_lpage">2681</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fcbic.201200502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=2676-2681&issue=18&author=R.+Montaserauthor=V.+J.+Paulauthor=H.+Luesch&title=Marine+Cyanobacterial+Fatty+Acid+Amides+Acting+on+Cannabinoid+Receptors&doi=10.1002%2Fcbic.201200502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200502%26sid%3Dliteratum%253Aachs%26aulast%3DMontaser%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DMarine%2520Cyanobacterial%2520Fatty%2520Acid%2520Amides%2520Acting%2520on%2520Cannabinoid%2520Receptors%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D18%26spage%3D2676%26epage%3D2681%26doi%3D10.1002%2Fcbic.201200502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debonsi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Cannabinomimetic Lipid from a Marine Cyanobacterium</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2317</span>, <span class="refDoi"> DOI: 10.1021/np200610t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200610t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=2313-2317&issue=10&author=M.+Guti%C3%A9rrezauthor=A.+R.+Pereiraauthor=H.+M.+Debonsiauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Cannabinomimetic+Lipid+from+a+Marine+Cyanobacterium&doi=10.1021%2Fnp200610t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fnp200610t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200610t%26sid%3Dliteratum%253Aachs%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DDebonsi%26aufirst%3DH.%2BM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DCannabinomimetic%2520Lipid%2520from%2520a%2520Marine%2520Cyanobacterium%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26issue%3D10%26spage%3D2313%26epage%3D2317%26doi%3D10.1021%2Fnp200610t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mevers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matainaho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allara’, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium <i>Moorea bouillonii</i></span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1007/s11745-014-3949-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs11745-014-3949-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=25204580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFagtrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=1127-1132&issue=11&author=E.+Meversauthor=T.+Matainahoauthor=M.+Allara%E2%80%99author=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Mooreamide+A%3A+A+Cannabinomimetic+Lipid+from+the+Marine+Cyanobacterium+Moorea+bouillonii&doi=10.1007%2Fs11745-014-3949-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Mooreamide A: a cannabinomimetic lipid from the marine cyanobacterium Moorea bouillonii</span></div><div class="casAuthors">Mevers, Emily; Matainaho, Teatulohi; Allara, Marco; Di Marzo, Vincenzo; Gerwick, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1127-1132</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of a collection of Moorea bouillonii from Papua New Guinea led to the isolation of a new alkyl amide, mooreamide A (I), along with the cytotoxic apratoxins A-C and E.  The planar structure of 1 was elucidated by NMR spectroscopy and mass spectrometry anal.  Structural homol. between mooreamide A and the endogenous cannabinoid ligands anandamide and 2-arachidonoyl glycerol inspired its evaluation against the neuroreceptors CB1 and CB2.  Mooreamide A was found to possess relatively potent and selective ligand binding activity to CB1 (K1 = 0.47 μM) vs. CB2 (K1 > 25 μM).  This represents the most potent marine-derived CB1 ligand described to date and adds to the growing family of marine metabolites that exhibit cannabinomimetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzlYqflvknrVg90H21EOLACvtfcHk0liGIx0tlaXpbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFagtrjP&md5=69e1d123708fdda592f585d0ff667a5a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs11745-014-3949-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11745-014-3949-9%26sid%3Dliteratum%253Aachs%26aulast%3DMevers%26aufirst%3DE.%26aulast%3DMatainaho%26aufirst%3DT.%26aulast%3DAllara%25E2%2580%2599%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DMooreamide%2520A%253A%2520A%2520Cannabinomimetic%2520Lipid%2520from%2520the%2520Marine%2520Cyanobacterium%2520Moorea%2520bouillonii%26jtitle%3DLipids%26date%3D2014%26volume%3D49%26issue%3D11%26spage%3D1127%26epage%3D1132%26doi%3D10.1007%2Fs11745-014-3949-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lax, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatz, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadafora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidgewell, K. J.</span></span> <span> </span><span class="NLM_article-title">Marine Cyanobacteria-Derived Serotonin Receptor 2C Active Fraction Induces Psychoactive Behavioral Effects in Mice</span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2731</span>, <span class="refDoi"> DOI: 10.1080/13880209.2016.1181659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1080%2F13880209.2016.1181659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27181630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFKqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=2723-2731&issue=11&author=N.+C.+Laxauthor=K.+T.+Ahmedauthor=C.+M.+Ignatzauthor=C.+Spadaforaauthor=B.+J.+Kolberauthor=K.+J.+Tidgewell&title=Marine+Cyanobacteria-Derived+Serotonin+Receptor+2C+Active+Fraction+Induces+Psychoactive+Behavioral+Effects+in+Mice&doi=10.1080%2F13880209.2016.1181659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Marine cyanobacteria-derived serotonin receptor 2C active fraction induces psychoactive behavioral effects in mice</span></div><div class="casAuthors">Lax, Neil C.; Ahmed, Kh Tanvir; Ignatz, Christopher M.; Spadafora, Carmenza; Kolber, Benedict J.; Tidgewell, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biology (Abingdon, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2723-2731</span>CODEN:
                <span class="NLM_cas:coden">PHBIFC</span>;
        ISSN:<span class="NLM_cas:issn">1388-0209</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Marine cyanobacteria offer a robust resource for natural products drug discovery due to the secondary metabolites they produce.  To identify novel cyanobacterial compds. that exhibit CNS psychoactive effects.  Cyanobacteria were collected from Las Perlas Archipelago, Panama and subjected to dichloromethane/methanol extn. and fractionation by column chromatog. before being screened for affinity against a panel of CNS targets.  A 50:50 Et acetate:methanol fraction of one cyanobacterial ext. (2064H) was subjected to HPLC and the major peak was isolated (2064H3).  At a dose of 20 μg per animal, 2064H and 2064H3 were tested in mice using behavioral assays that included the forced swim, open field and formalin tests.  2064H was shown to bind to the serotonin 2C (5-HT2C) receptor, a known target for depression and pain treatment.  2064H showed 59.6% inhibition of binding of [3H]-mesulergine with an IC50 value of 179 ng/mL and did not show inhibition of binding greater than 45% with any other receptors tested.  Both 2064H and 2064H3 decreased immobility time in the first minute of the tail suspension test.  Overall, manipulating the 5-HT2C receptor with these receptor-specific ligands derived from cyanobacteria altered pain, depression and anxiety-like behaviors, illustrating the importance of this receptor in affective behaviors.  These results demonstrate the potential of cyanobacteria as a source for CNS active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2T0QsMFLQ4rVg90H21EOLACvtfcHk0lixOHHGBEBEhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFKqu7g%253D&md5=5bced9995204ac2d5f5feee471bc7478</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F13880209.2016.1181659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13880209.2016.1181659%26sid%3Dliteratum%253Aachs%26aulast%3DLax%26aufirst%3DN.%2BC.%26aulast%3DAhmed%26aufirst%3DK.%2BT.%26aulast%3DIgnatz%26aufirst%3DC.%2BM.%26aulast%3DSpadafora%26aufirst%3DC.%26aulast%3DKolber%26aufirst%3DB.%2BJ.%26aulast%3DTidgewell%26aufirst%3DK.%2BJ.%26atitle%3DMarine%2520Cyanobacteria-Derived%2520Serotonin%2520Receptor%25202C%2520Active%2520Fraction%2520Induces%2520Psychoactive%2520Behavioral%2520Effects%2520in%2520Mice%26jtitle%3DPharm.%2520Biol.%26date%3D2016%26volume%3D54%26issue%3D11%26spage%3D2723%26epage%3D2731%26doi%3D10.1080%2F13880209.2016.1181659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fcbic.201700627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=29405541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=815-825&author=F.+H.+Al-Awadhiauthor=V.+J.+Paulauthor=H.+Luesch&title=Structural+Diversity+and+Anticancer+Activity+of+Marine-Derived+Elastase+Inhibitors%3A+Key+Features+and+Mechanisms+Mediating+the+Antimetastatic+Effects+in+Invasive+Breast+Cancer&doi=10.1002%2Fcbic.201700627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer</span></div><div class="casAuthors">Al-Awadhi, Fatma H.; Paul, Valerie J.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-825</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three new 3-amino-6-hydroxy-2-piperidone (Ahp)-contg. cyclic depsipeptides, named loggerpeptins A-C (1-3), along with molassamide (4), were discovered from a marine cyanobacterium, extending the structural diversity of this prevalent scaffold of cyanobacterial serine protease inhibitors.  Molassamide, which contains a 2-amino-butenoic (Abu) unit in the cyclic core, was the most potent and selective analog against human neutrophil elastase (HNE).  Given the growing evidence supporting the role of HNE in breast cancer progression and metastasis, we assessed the cellular effects of compds. 3 and 4 in the context of targeting invasive breast cancer.  Both compds. inhibited cleavage of the elastase substrate CD40 in biochem. assays; however, only 4 exhibited significant cellular activity.  As CD40 and other receptor proteolytic processing culminates in NFκB activation, we assessed the effects of 4 on the expression of target genes, including ICAM-1.  ICAM-1 is also a direct target of elastase and, in our studies, compd. 4 attenuated both elastase-induced ICAM-1 gene expression and ICAM-1 proteolytic processing by elastase, revealing a potential dual effect on migration through modulation of gene expression and proteolytic processing.  Molassamide also specifically inhibited the elastase-mediated migration of highly invasive triple-neg. breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Bv5EyZFddbVg90H21EOLACvtfcHk0lixOHHGBEBEhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlSrurg%253D&md5=bb59c45f50f29812b680e4433f72c95c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700627%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DStructural%2520Diversity%2520and%2520Anticancer%2520Activity%2520of%2520Marine-Derived%2520Elastase%2520Inhibitors%253A%2520Key%2520Features%2520and%2520Mechanisms%2520Mediating%2520the%2520Antimetastatic%2520Effects%2520in%2520Invasive%2520Breast%2520Cancer%26jtitle%3DChemBioChem%26date%3D2018%26volume%3D19%26spage%3D815%26epage%3D825%26doi%3D10.1002%2Fcbic.201700627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Utility of Kallikrein-Related Peptidases (KLKs) as Cancer Biomarkers</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1600</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2008.105189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1373%2Fclinchem.2008.105189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=18687738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CiurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=1600-1607&issue=10&author=N.+Emamiauthor=E.+P.+Diamandis&title=Utility+of+Kallikrein-Related+Peptidases+%28KLKs%29+as+Cancer+Biomarkers&doi=10.1373%2Fclinchem.2008.105189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers</span></div><div class="casAuthors">Emami, Nashmil; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1600-1607</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">A review.  The human kallikrein-related peptidase (KLK) family consists of 15 highly conserved serine proteases, which are encoded by the largest uninterrupted cluster of protease genes in the human genome.  To date, several members of the family have been reported as potential cancer biomarkers.  Although primarily known for their biomarker value in prostate, ovarian, and breast cancers, more recent data suggest analogous roles of KLKs in several other cancers, including gastrointestinal, head and neck, lung, and brain malignancies.  Among the proposed KLK cancer biomarkers, prostate-specific antigen (also known as KLK3) is the most widely recognized member in urol. oncol.  Despite substantial progress in the understanding of the biomarker utility of individual KLKs, the current challenge lies in devising biomarker panels to increase the accuracy of prognosis, prediction of therapy, and diagnosis.  To date, multiparametric KLK panels have been proposed for prostate, ovarian, and lung cancers.  In addn. to their biomarker utility, emerging evidence has revealed a no. of crit. functional roles for KLKs in the pathogenesis of cancer and their potential use as therapeutic targets.  KLKs have biomarker utility in many cancer types but individually lack sufficient specificity or sensitivity to be used in clin. practice; however, groups of KLKs and other candidate biomarkers may offer improved performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTfLyJ0y_4IrVg90H21EOLACvtfcHk0lixOHHGBEBEhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CiurnF&md5=500cc078593c60ebbdef0660a70f6054</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2008.105189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2008.105189%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DUtility%2520of%2520Kallikrein-Related%2520Peptidases%2520%2528KLKs%2529%2520as%2520Cancer%2520Biomarkers%26jtitle%3DClin.%2520Chem.%26date%3D2008%26volume%3D54%26issue%3D10%26spage%3D1600%26epage%3D1607%26doi%3D10.1373%2Fclinchem.2008.105189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obiezu, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Human Tissue Kallikrein Gene Family: Applications in Cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>224</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2004.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2004.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15911097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2005&pages=1-22&issue=1&author=C.+V.+Obiezuauthor=E.+P.+Diamandis&title=Human+Tissue+Kallikrein+Gene+Family%3A+Applications+in+Cancer&doi=10.1016%2Fj.canlet.2004.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Human tissue kallikrein gene family: applications in cancer</span></div><div class="casAuthors">Obiezu, Christina V.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes.  Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes.  These genes, and their protein products, share a high degree of homol. and are expressed in a wide array of tissues, mainly those that are under steroid hormone control.  PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker.  In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been assocd. with several types of cancer.  For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer.  New evidence raises the possibility that some kallikreins are directly involved with cancer progression.  We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVQ3Ly8oHCbVg90H21EOLACvtfcHk0ljFNmOhTFzR-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D&md5=837a7e70ff67c0e7d17986f0b833ddc7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520Tissue%2520Kallikrein%2520Gene%2520Family%253A%2520Applications%2520in%2520Cancer%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D224%26issue%3D1%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2004.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borgoño, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">The Emerging Roles of Human Tissue Kallikreins in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrc1474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrc1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15516960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=876-890&issue=11&author=C.+A.+Borgo%C3%B1oauthor=E.+P.+Diamandis&title=The+Emerging+Roles+of+Human+Tissue+Kallikreins+in+Cancer&doi=10.1038%2Fnrc1474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging roles of human tissue kallikreins in cancer</span></div><div class="casAuthors">Borgono, Carla A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-890</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiol. roles.  Although primarily known for their clin. applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis.  They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQTk6Djzi7LVg90H21EOLACvtfcHk0ljFNmOhTFzR-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D&md5=a5bd96fc35210ea97a97703942827d0d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrc1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1474%26sid%3Dliteratum%253Aachs%26aulast%3DBorgo%25C3%25B1o%26aufirst%3DC.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520Emerging%2520Roles%2520of%2520Human%2520Tissue%2520Kallikreins%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D11%26spage%3D876%26epage%3D890%26doi%3D10.1038%2Fnrc1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdolen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiechle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, J.</span></span> <span> </span><span class="NLM_article-title">Emerging Clinical Importance of the Cancer Biomarkers Kallikrein-Related Peptidases (KLK) in Female and Male Reproductive Organ Malignancies</span>. <i>Radiol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.2478/raon-2013-0053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.2478%2Fraon-2013-0053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24294176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2013&pages=319-329&author=M.+Schmittauthor=V.+Magdolenauthor=F.+Yangauthor=M.+Kiechleauthor=J.+Bayaniauthor=G.+M.+Yousefauthor=A.+Scorilasauthor=E.+P.+Diamandisauthor=J.+Dorn&title=Emerging+Clinical+Importance+of+the+Cancer+Biomarkers+Kallikrein-Related+Peptidases+%28KLK%29+in+Female+and+Male+Reproductive+Organ+Malignancies&doi=10.2478%2Fraon-2013-0053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies</span></div><div class="casAuthors">Schmitt, Manfred; Magdolen, Viktor; Yang, Feng; Kiechle, Marion; Bayani, Jane; Yousef, George M.; Scorilas, Andreas; Diamandis, Eleftherios; Dorn, Julia</div><div class="citationInfo"><span class="NLM_cas:title">Radiology and Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">RONCEM</span>;
        ISSN:<span class="NLM_cas:issn">1318-2099</span>.
    
            (<span class="NLM_cas:orgname">Association of Radiology and Oncology</span>)
        </div><div class="casAbstract">A review.  Background. Tumor tissue-assocd. KLKs (kallikrein-related peptidases) are clin. important biomarkers that may allow prognosis of the cancer disease and/or prediction of response/failure of cancer patients to cancer-directed drugs.  Regarding the female/male reproductive tract, remarkably, all of the fifteen KLKs are expressed in the normal prostate, breast, cervix uteri, and the testis, whereas the uterus/endometrium and the ovary are expressing a limited no. of KLKs only.  Conclusions. Most of the information regarding elevated expression of KLKs in tumor-affected organs is available for ovarian cancer; depicting them as valuable biomarkers in the cancerous phenotype.  In contrast, for breast cancer, a series of KLKs was found to be downregulated.  However, in breast cancer, KLK4 is elevated which is also true for ovarian and prostate cancer.  In such cases, selective synthetic KLK inhibitors that aim at blocking the proteolytic activities of certain KLKs may serve as future candidate therapeutic drugs to interfere with tumor progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeEBrnUoneLVg90H21EOLACvtfcHk0ljFNmOhTFzR-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtrjE&md5=58da368a0a1cbe6c5a223d3379c8ffb1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2478%2Fraon-2013-0053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fraon-2013-0053%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DKiechle%26aufirst%3DM.%26aulast%3DBayani%26aufirst%3DJ.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DDorn%26aufirst%3DJ.%26atitle%3DEmerging%2520Clinical%2520Importance%2520of%2520the%2520Cancer%2520Biomarkers%2520Kallikrein-Related%2520Peptidases%2520%2528KLK%2529%2520in%2520Female%2520and%2520Male%2520Reproductive%2520Organ%2520Malignancies%26jtitle%3DRadiol.%2520Oncol.%26date%3D2013%26volume%3D47%26spage%3D319%26epage%3D329%26doi%3D10.2478%2Fraon-2013-0053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, T. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, O. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahão, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muri, E. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzer, L.</span></span> <span> </span><span class="NLM_article-title">Isomannide Derivatives as New Class of Inhibitors for Human Kallikrein 7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6072</span>– <span class="NLM_lpage">6075</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.bmcl.2012.08.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6072-6075&issue=19&author=R.+F.+Freitasauthor=T.+S.+P.+Teixeiraauthor=T.+G.+Barrosauthor=J.+A.+N.+Santosauthor=M.+Y.+Kondoauthor=M.+A.+Julianoauthor=L.+Julianoauthor=M.+Blaberauthor=O.+A.+C.+Antunesauthor=O.+Abrah%C3%A3oauthor=S.+Pinheiroauthor=E.+M.+F.+Muriauthor=L.+Puzer&title=Isomannide+Derivatives+as+New+Class+of+Inhibitors+for+Human+Kallikrein+7&doi=10.1016%2Fj.bmcl.2012.08.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.047%26sid%3Dliteratum%253Aachs%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DTeixeira%26aufirst%3DT.%2BS.%2BP.%26aulast%3DBarros%26aufirst%3DT.%2BG.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DKondo%26aufirst%3DM.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DAntunes%26aufirst%3DO.%2BA.%2BC.%26aulast%3DAbrah%25C3%25A3o%26aufirst%3DO.%26aulast%3DPinheiro%26aufirst%3DS.%26aulast%3DMuri%26aufirst%3DE.%2BM.%2BF.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DIsomannide%2520Derivatives%2520as%2520New%2520Class%2520of%2520Inhibitors%2520for%2520Human%2520Kallikrein%25207%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D19%26spage%3D6072%26epage%3D6075%26doi%3D10.1016%2Fj.bmcl.2012.08.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, L. S. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muri, E. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzer, L.</span></span> <span> </span><span class="NLM_article-title">Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1021/ml4003698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=128-132&issue=2&author=J.+P.+C.+Oliveiraauthor=R.+F.+Freitasauthor=L.+S.+de+Meloauthor=T.+G.+Barrosauthor=J.+A.+N.+Santosauthor=M.+A.+Julianoauthor=S.+Pinheiroauthor=M.+Blaberauthor=L.+Julianoauthor=E.+M.+F.+Muriauthor=L.+Puzer&title=Isomannide-Based+Peptidomimetics+as+Inhibitors+for+Human+Tissue+Kallikreins+5+and+7&doi=10.1021%2Fml4003698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml4003698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003698%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DJ.%2BP.%2BC.%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DMelo%26aufirst%3DL.%2BS.%2Bde%26aulast%3DBarros%26aufirst%3DT.%2BG.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DPinheiro%26aufirst%3DS.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DMuri%26aufirst%3DE.%2BM.%2BF.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DIsomannide-Based%2520Peptidomimetics%2520as%2520Inhibitors%2520for%2520Human%2520Tissue%2520Kallikreins%25205%2520and%25207%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D2%26spage%3D128%26epage%3D132%26doi%3D10.1021%2Fml4003698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sotiropoulou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pampalakis, G.</span></span> <span> </span><span class="NLM_article-title">Targeting the Kallikrein-Related Peptidases for Drug Development</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2012.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.tips.2012.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=623-634&issue=12&author=G.+Sotiropoulouauthor=G.+Pampalakis&title=Targeting+the+Kallikrein-Related+Peptidases+for+Drug+Development&doi=10.1016%2Fj.tips.2012.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DPampalakis%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520Kallikrein-Related%2520Peptidases%2520for%2520Drug%2520Development%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26issue%3D12%26spage%3D623%26epage%3D634%26doi%3D10.1016%2Fj.tips.2012.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krastel, P.</span></span> <span> </span><span class="NLM_article-title">Cyclic Depsipeptides</span> (<span class="NLM_publisher-name">Novartis Institutes for Biomedical Research Inc.</span>) U.S. Patent <span class="NLM_patent">US156472 A1</span>, <span class="NLM_year">2009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Krastel&title=Cyclic+Depsipeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKrastel%26aufirst%3DP.%26atitle%3DCyclic%2520Depsipeptides%26pub%3DNovartis%2520Institutes%2520for%2520Biomedical%2520Research%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, L.</span></span> <span> </span><span class="NLM_article-title">Ecallantide Is a Novel Treatment for Attacks of Hereditary Angioedema due to C1 Inhibitor Deficiency</span>. <i>Clin., Cosmet. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.2147/CCID.S10322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.2147%2FCCID.S10322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=21760740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=61-68&author=H.+Farkasauthor=L.+Varga&title=Ecallantide+Is+a+Novel+Treatment+for+Attacks+of+Hereditary+Angioedema+due+to+C1+Inhibitor+Deficiency&doi=10.2147%2FCCID.S10322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency</span></div><div class="casAuthors">Farkas, Henriette; Varga, Lilian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical, Cosmetic and Investigational Dermatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CCIDCL</span>;
        ISSN:<span class="NLM_cas:issn">1178-7015</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Hereditary angioedema (HAE) resulting from the deficiency of the C1 inhibitor protein is a rare disease, characterized by paroxysms of edema formation in the subcutis and in the submucosa.  Edema can cause obstruction of the upper airway, which may lead to suffocation.  Prompt elimination of edema is necessary to save patients from this life-threatening condition.  Essentially, these edematous attacks are related to the activation of the kinin-kallikrein system and the consequent release of bradykinin.  Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.  This is the only agent approved recently by the FDA for all localizations of edematous HAE attacks.  Its advantages include no risk of viral contamination, high selectivity, very rapid onset of action, good tolerability, and straightforward s.c. administration.  Owing to the risk of anaphylaxis, ecallantide should be administered by a health care professional.  A postmarketing survey to improve risk-assessment and risk-minimization has been launched.  The results of these studies may lead to the approval of ecallantide for self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolK7xVUyG867Vg90H21EOLACvtfcHk0lhERfwq2_8RRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlelsrw%253D&md5=7bed921d9f5c6daec0ebaeadb2647b71</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2147%2FCCID.S10322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCCID.S10322%26sid%3Dliteratum%253Aachs%26aulast%3DFarkas%26aufirst%3DH.%26aulast%3DVarga%26aufirst%3DL.%26atitle%3DEcallantide%2520Is%2520a%2520Novel%2520Treatment%2520for%2520Attacks%2520of%2520Hereditary%2520Angioedema%2520due%2520to%2520C1%2520Inhibitor%2520Deficiency%26jtitle%3DClin.%252C%2520Cosmet.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D4%26spage%3D61%26epage%3D68%26doi%3D10.2147%2FCCID.S10322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacer, a C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavnar, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomonnson, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Endothelial CXCR7 Regulates Breast Cancer Metastasis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1716</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fonc.2015.236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=1716-1724&author=a+C.+Stacerauthor=J.+Fennerauthor=S.+P.+Cavnarauthor=a.+Xiaoauthor=S.+Zhaoauthor=S.+L.+Changauthor=a.+Salomonnsonauthor=K.+E.+Lukerauthor=G.+D.+Luker&title=Endothelial+CXCR7+Regulates+Breast+Cancer+Metastasis&doi=10.1038%2Fonc.2015.236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.236%26sid%3Dliteratum%253Aachs%26aulast%3DStacer%26aufirst%3Da%2BC.%26aulast%3DFenner%26aufirst%3DJ.%26aulast%3DCavnar%26aufirst%3DS.%2BP.%26aulast%3DXiao%26aufirst%3Da.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DSalomonnson%26aufirst%3Da.%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DEndothelial%2520CXCR7%2520Regulates%2520Breast%2520Cancer%2520Metastasis%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D1716%26epage%3D1724%26doi%3D10.1038%2Fonc.2015.236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cully, M.</span></span> <span> </span><span class="NLM_article-title">Lung Disease: CXCR7 Activation Overrides Lung Fibrosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">160</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd.2016.25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=160&author=M.+Cully&title=Lung+Disease%3A+CXCR7+Activation+Overrides+Lung+Fibrosis&doi=10.1038%2Fnrd.2016.25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.25%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26atitle%3DLung%2520Disease%253A%2520CXCR7%2520Activation%2520Overrides%2520Lung%2520Fibrosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D160%26doi%3D10.1038%2Fnrd.2016.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shido, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbany, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafii, S.</span></span> <span> </span><span class="NLM_article-title">Divergent Angiocrine Signals from Vascular Niche Balance Liver Regeneration and Fibrosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span> (<span class="NLM_issue">7481</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/nature12681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnature12681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24256728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ovVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=97-102&issue=7481&author=B.-S.+Dingauthor=Z.+Caoauthor=R.+Lisauthor=D.+J.+Nolanauthor=P.+Guoauthor=M.+Simonsauthor=M.+E.+Penfoldauthor=K.+Shidoauthor=S.+Y.+Rabbanyauthor=S.+Rafii&title=Divergent+Angiocrine+Signals+from+Vascular+Niche+Balance+Liver+Regeneration+and+Fibrosis&doi=10.1038%2Fnature12681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis</span></div><div class="casAuthors">Ding Bi-Sen; Cao Zhongwei; Lis Raphael; Guo Peipei; Shido Koji; Rafii Shahin; Nolan Daniel J; Simons Michael; Penfold Mark E; Rabbany Sina Y</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">97-102</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration.  The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined.  Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration.  Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis.  Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult.  The pro-fibrotic transition of vascular niche results from differential expression of stromal-derived factor-1 receptors, CXCR7 and CXCR4 (refs 18, 19, 20, 21), in liver sinusoidal endothelial cells.  After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration.  Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7(iΔEC/iΔEC)) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors.  By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression.  This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin(+) hepatic stellate-like cells and enforcing a pro-fibrotic vascular niche.  Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1(iΔEC/iΔEC)) or Cxcr4 (Cxcr4(iΔEC/iΔEC)) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors.  Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis.  Thus, we demonstrate that in response to liver injury, differential recruitment of pro-regenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis.  These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKlyEjWbjBdxBrI9DTGjC0fW6udTcc2ea5dXi7LxKp7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ovVahtg%253D%253D&md5=56b232923926af29cf7b0ddee6017cf8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature12681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12681%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DB.-S.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DLis%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DD.%2BJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%26aulast%3DShido%26aufirst%3DK.%26aulast%3DRabbany%26aufirst%3DS.%2BY.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DDivergent%2520Angiocrine%2520Signals%2520from%2520Vascular%2520Niche%2520Balance%2520Liver%2520Regeneration%2520and%2520Fibrosis%26jtitle%3DNature%26date%3D2014%26volume%3D505%26issue%3D7481%26spage%3D97%26epage%3D102%26doi%3D10.1038%2Fnature12681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">CCR10 and Its Ligands in Regulation of Epithelial Immunity and Diseases</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1007/s13238-012-2927-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs13238-012-2927-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=22684736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKis7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=571-580&issue=8&author=N.+Xiongauthor=Y.+Fuauthor=S.+Huauthor=M.+Xiaauthor=J.+Yang&title=CCR10+and+Its+Ligands+in+Regulation+of+Epithelial+Immunity+and+Diseases&doi=10.1007%2Fs13238-012-2927-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">CCR10 and its ligands in regulation of epithelial immunity and diseases</span></div><div class="casAuthors">Xiong, Na; Fu, Yaoyao; Hu, Shaomin; Xia, Mingcan; Yang, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">571-580</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">A review.  Epithelial tissues covering the external and internal surface of a body are constantly under phys., chem. or biol. assaults.  To protect the epithelial tissues and maintain their homeostasis, multiple layers of immune defense mechanisms are required.  Besides the epithelial tissue-resident immune cells that provide the first line of defense, circulating immune cells are also recruited into the local tissues in response to challenges.  Chemokines and chemokine receptors regulate tissue-specific migration, maintenance and functions of immune cells.  Among them, chemokine receptor CCR10 and its ligands chemokines CCL27 and CCL28 are uniquely involved in the epithelial immunity.  CCL27 is expressed predominantly in the skin by keratinocytes while CCL28 is expressed by epithelial cells of various mucosal tissues.  CCR10 is expressed by various subsets of innate-like T cells that are programmed to localize to the skin during their developmental processes in the thymus.  Circulating T cells might be imprinted by skin-assocd. antigen- presenting cells to express CCR10 for their recruitment to the skin during the local immune response.  On the other hand, IgA antibody-producing B cells generated in mucosa-assocd. lymphoid tissues express CCR10 for their migration and maintenance at mucosal sites.  Increasing evidence also found that CCR10/ligands are involved in regulation of other immune cells in epithelial immunity and are frequently exploited by epithelium-localizing or -originated cancer cells for their survival, proliferation and evasion from immune surveillance.  Herein, we review current knowledge on roles of CCR10/ligands in regulation of epithelial immunity and diseases and speculate on related important questions worth further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8PyTe9S4ErVg90H21EOLACvtfcHk0lhYdJKE_2FiXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKis7nO&md5=53c961f4acaef17f995b64be91e5fdc6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs13238-012-2927-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-012-2927-3%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DN.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DCCR10%2520and%2520Its%2520Ligands%2520in%2520Regulation%2520of%2520Epithelial%2520Immunity%2520and%2520Diseases%26jtitle%3DProtein%2520Cell%26date%3D2012%26volume%3D3%26issue%3D8%26spage%3D571%26epage%3D580%26doi%3D10.1007%2Fs13238-012-2927-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daubeuf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frossard, N.</span></span> <span> </span><span class="NLM_article-title">Protective Effect of a Protein Epitope Mimetic CCR10 Antagonist, POL7085, in a Model of Allergic Eosinophilic Airway Inflammation</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">77</span>, <span class="refDoi"> DOI: 10.1186/s12931-015-0231-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1186%2Fs12931-015-0231-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=26112287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BC2MbntFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=77&author=F.+Daubeufauthor=F.+Jungauthor=G.+J.+Douglasauthor=E.+Chevalierauthor=N.+Frossard&title=Protective+Effect+of+a+Protein+Epitope+Mimetic+CCR10+Antagonist%2C+POL7085%2C+in+a+Model+of+Allergic+Eosinophilic+Airway+Inflammation&doi=10.1186%2Fs12931-015-0231-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation</span></div><div class="casAuthors">Daubeuf Francois; Frossard Nelly; Jung Francoise; Douglas Garry J; Chevalier Eric</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Potential involvement of the CCR10/CCL28 axis was recently reported in murine models of allergic asthma.  If confirmed, blockade of the CCR10 receptor would represent an alternative to current asthma therapies.  We evaluated the effect of a novel Protein Epitope Mimetic CCR10 antagonist, POL7085, in a murine model of allergic eosinophilic airway inflammation.  METHODS:  Mice were sensitized and challenged to ovalbumin.  POL7085, a CCR10 antagonist (7.5 and 15 mg/kg), dexamethasone (1 mg/kg) or vehicle were administered intranasally once daily 1h before each allergen challenge.  On day 21, airway hyperresponsiveness, bronchoalveolar lavage inflammatory cells and Th2 cytokines, and lung tissue mucus and collagen were measured.  RESULTS:  Allergen challenge induced airway hyperresponsiveness in vehicle-treated animals as measured by whole body barometric plethysmography, and eosinophilia in bronchoalveolar lavage.  POL7085 dose-dependently and significantly decreased airway hyperresponsiveness (34 ± 16 %) and eosinophil numbers in bronchoalveolar lavage (66 ± 6 %).  In addition, the highest dose of POL7085 used significantly inhibited lung IL-4 (85 ± 4 %), IL-5 (87 ± 2 %) and IL-13 (190 ± 19 %) levels, and lung collagen (43 ± 11 %).  CONCLUSIONS:  The Protein Epitope Mimetic CCR10 antagonist, POL7085, significantly and dose-dependently decreased allergen-induced airway hyperresponsiveness and airway inflammation after once daily local treatment.  Our data give strong support for further investigations with CCR10 antagonists in asthmatic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwe_bbiTT_Be4jJGKT5N0fW6udTcc2eaHXynwnPTJ_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbntFygsw%253D%253D&md5=5fab29fd1becc778f27d1d01d0a70e0a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs12931-015-0231-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-015-0231-5%26sid%3Dliteratum%253Aachs%26aulast%3DDaubeuf%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DF.%26aulast%3DDouglas%26aufirst%3DG.%2BJ.%26aulast%3DChevalier%26aufirst%3DE.%26aulast%3DFrossard%26aufirst%3DN.%26atitle%3DProtective%2520Effect%2520of%2520a%2520Protein%2520Epitope%2520Mimetic%2520CCR10%2520Antagonist%252C%2520POL7085%252C%2520in%2520a%2520Model%2520of%2520Allergic%2520Eosinophilic%2520Airway%2520Inflammation%26jtitle%3DRespir.%2520Res.%26date%3D2015%26volume%3D16%26spage%3D77%26doi%3D10.1186%2Fs12931-015-0231-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span> <span> </span><span class="NLM_article-title">Upregulation of Chemokine Receptor CCR10 Is Essential for Glioma Proliferation, Invasion and Patient Survival</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">6576</span>– <span class="NLM_lpage">6583</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.18632%2Foncotarget.2134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6576-6583&author=L.+Chenauthor=X.+Liuauthor=H.-Y.+Zhangauthor=W.+Duauthor=Z.+Qinauthor=Y.+Yaoauthor=Y.+Maoauthor=L.+Zhou&title=Upregulation+of+Chemokine+Receptor+CCR10+Is+Essential+for+Glioma+Proliferation%2C+Invasion+and+Patient+Survival&doi=10.18632%2Foncotarget.2134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2134%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DUpregulation%2520of%2520Chemokine%2520Receptor%2520CCR10%2520Is%2520Essential%2520for%2520Glioma%2520Proliferation%252C%2520Invasion%2520and%2520Patient%2520Survival%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D6576%26epage%3D6583%26doi%3D10.18632%2Foncotarget.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide Receptor Ligands as Drugs for Psychiatric Diseases: The End of the Beginning?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrd3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd3702" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=462-478&issue=6&author=G.+Griebelauthor=F.+Holsboer&title=Neuropeptide+Receptor+Ligands+as+Drugs+for+Psychiatric+Diseases%3A+The+End+of+the+Beginning%3F&doi=10.1038%2Fnrd3702"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrd3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3702%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DHolsboer%26aufirst%3DF.%26atitle%3DNeuropeptide%2520Receptor%2520Ligands%2520as%2520Drugs%2520for%2520Psychiatric%2520Diseases%253A%2520The%2520End%2520of%2520the%2520Beginning%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D6%26spage%3D462%26epage%3D478%26doi%3D10.1038%2Fnrd3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbelaar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madiera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicchi, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volksdorf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1021/ml500514w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500514w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=513-517&issue=5&author=S.+K.+Shahauthor=S.+Heauthor=L.+Guoauthor=Q.+Truongauthor=H.+Qiauthor=W.+Duauthor=Z.+Laiauthor=J.+Liuauthor=T.+Jianauthor=Q.+Hongauthor=P.+Dobbelaarauthor=Z.+Yeauthor=E.+Shererauthor=Z.+Fengauthor=Y.+Yuauthor=F.+Wongauthor=K.+Samuelauthor=M.+Madieraauthor=B.+V.+Karanamauthor=V.+B.+Reddyauthor=S.+Mitelmanauthor=S.+X.+Tongauthor=G.+G.+Chicchiauthor=K.+L.+Tsaoauthor=D.+Truscaauthor=Y.+Fengauthor=M.+Wuauthor=Q.+Shaoauthor=M.+E.+Trujilloauthor=G.+J.+Eiermannauthor=C.+Liauthor=M.+Pachanskiauthor=G.+Fernandezauthor=D.+Nelsonauthor=P.+Buntingauthor=P.+Morissetteauthor=S.+Volksdorfauthor=J.+Kerrauthor=B.+B.+Zhangauthor=A.+D.+Howardauthor=Y.+P.+Zhouauthor=A.+Pasternakauthor=R.+P.+Nargundauthor=W.+K.+Hagmann&title=Discovery+of+MK-1421%2C+a+Potent%2C+Selective+sstr3+Antagonist%2C+as+a+Development+Candidate+for+Type+2+Diabetes&doi=10.1021%2Fml500514w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml500514w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500514w%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDobbelaar%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DMadiera%26aufirst%3DM.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DReddy%26aufirst%3DV.%2BB.%26aulast%3DMitelman%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%2BX.%26aulast%3DChicchi%26aufirst%3DG.%2BG.%26aulast%3DTsao%26aufirst%3DK.%2BL.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DBunting%26aufirst%3DP.%26aulast%3DMorissette%26aufirst%3DP.%26aulast%3DVolksdorf%26aufirst%3DS.%26aulast%3DKerr%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DZhou%26aufirst%3DY.%2BP.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DDiscovery%2520of%2520MK-1421%252C%2520a%2520Potent%252C%2520Selective%2520sstr3%2520Antagonist%252C%2520as%2520a%2520Development%2520Candidate%2520for%2520Type%25202%2520Diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D513%26epage%3D517%26doi%3D10.1021%2Fml500514w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbelaar, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellureficio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicchi, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1021/ml300063m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300063m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=484-489&issue=6&author=S.+Heauthor=Z.+Yeauthor=Q.+Truongauthor=S.+Shahauthor=W.+Duauthor=L.+Guoauthor=P.+H.+Dobbelaarauthor=Z.+Laiauthor=J.+Liuauthor=T.+Jianauthor=H.+Qiauthor=R.+K.+Bakshiauthor=Q.+Hongauthor=J.+Dellureficioauthor=A.+Pasternakauthor=Z.+Fengauthor=R.+Dejesusauthor=L.+Yangauthor=M.+Reibarkhauthor=S.+A.+Bradleyauthor=M.+A.+Holmesauthor=R.+G.+Ballauthor=R.+T.+Ruckauthor=M.+A.+Huffmanauthor=F.+Wongauthor=K.+Samuelauthor=V.+B.+Reddyauthor=S.+Mitelmanauthor=S.+X.+Tongauthor=G.+G.+Chicchiauthor=K.+L.+Tsaoauthor=D.+Truscaauthor=M.+Wuauthor=Q.+Shaoauthor=M.+E.+Trujilloauthor=G.+J.+Eiermannauthor=C.+Liauthor=B.+B.+Zhangauthor=A.+D.+Howardauthor=Y.+P.+Zhouauthor=R.+P.+Nargundauthor=W.+K.+Hagmann&title=The+Discovery+of+MK-4256%2C+a+Potent+SSTR3+Antagonist+as+a+Potential+Treatment+of+Type+2+Diabetes&doi=10.1021%2Fml300063m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml300063m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300063m%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DDobbelaar%26aufirst%3DP.%2BH.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDellureficio%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DDejesus%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DS.%2BA.%26aulast%3DHolmes%26aufirst%3DM.%2BA.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DV.%2BB.%26aulast%3DMitelman%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%2BX.%26aulast%3DChicchi%26aufirst%3DG.%2BG.%26aulast%3DTsao%26aufirst%3DK.%2BL.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DZhou%26aufirst%3DY.%2BP.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520Discovery%2520of%2520MK-4256%252C%2520a%2520Potent%2520SSTR3%2520Antagonist%2520as%2520a%2520Potential%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Fml300063m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzidou, V.</span></span> <span> </span><span class="NLM_article-title">Advances in the Role of Oxytocin Receptors in Human Parturition</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2017.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.mce.2017.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=28119132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2017&pages=56-63&author=S.+H.+Kimauthor=P.+R.+Bennettauthor=V.+Terzidou&title=Advances+in+the+Role+of+Oxytocin+Receptors+in+Human+Parturition&doi=10.1016%2Fj.mce.2017.01.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the role of oxytocin receptors in human parturition</span></div><div class="casAuthors">Kim, Sung Hye; Bennett, Phillip R.; Terzidou, Vasso</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) is a neurohypophysial hormone which has been found to play a central role in the regulation of human parturition.  The most established role of oxytocin/oxytocin receptor (OT/OTR) system in human parturition is the initiation of uterine contractions, however, recent evidence have demonstrated that it may have a more complex role including initiation of inflammation, regulation of miRNA expression, as well as mediation of other non-classical oxytocin actions via receptor crosstalk with other G protein-coupled receptors (GPCRs).  In this review we highlight both established and newly emerging roles of OT/OTR system in human parturition and discuss the expanding potential for OTRs as pharmacol. targets in the management of preterm labour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8IylxwAW2LVg90H21EOLACvtfcHk0ljym_ZYFO4xUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGrsr4%253D&md5=7936e6fff818bb5044ed8adb7c935997</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2017.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2017.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBennett%26aufirst%3DP.%2BR.%26aulast%3DTerzidou%26aufirst%3DV.%26atitle%3DAdvances%2520in%2520the%2520Role%2520of%2520Oxytocin%2520Receptors%2520in%2520Human%2520Parturition%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2017%26volume%3D449%26spage%3D56%26epage%3D63%26doi%3D10.1016%2Fj.mce.2017.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bale, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsa, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, M. M.</span></span> <span> </span><span class="NLM_article-title">CNS Region-Specific Oxytocin Receptor Expression: Importance in Regulation of Anxiety and Sex Behavior</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2546</span>– <span class="NLM_lpage">2552</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.21-07-02546.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1523%2FJNEUROSCI.21-07-02546.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=11264328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslClsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=2546-2552&issue=7&author=T.+L.+Baleauthor=A.+M.+Davisauthor=A.+P.+Augerauthor=D.+M.+Dorsaauthor=M.+M.+McCarthy&title=CNS+Region-Specific+Oxytocin+Receptor+Expression%3A+Importance+in+Regulation+of+Anxiety+and+Sex+Behavior&doi=10.1523%2FJNEUROSCI.21-07-02546.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior</span></div><div class="casAuthors">Bale, Tracy L.; Davis, Aline M.; Auger, Anthony P.; Dorsa, Daniel M.; McCarthy, Margaret M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2546-2552</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The oxytocin receptor (OTR) is differentially expressed in the CNS.  Because there are multiple mechanisms by which the OTR can be transcriptionally induced, the authors hypothesized that differences in OTR expression may be explained by activation of distinct signal transduction pathways and may be crit. for the control of anxiety and sex behaviors.  To det. the regulation and functional significance of this expression, the authors infused female rats with modifiers of protein kinases before assaying for behavior and oxytocin receptor binding.  In the ventromedial nucleus of the hypothalamus (VMH), estrogen-dependent induction of oxytocin receptors required protein kinase C activation, and oxytocin infused here promoted female sex behavior but had no effect on anxiety.  In contrast, dopamine controlled tonic oxytocin receptor expression in the central nucleus of the amygdala (cAmyg) through activation of protein kinase A, and oxytocin infused here was anxiolytic but had no effect on female sex behavior.  Therefore, the authors have identified brain region-specific regulation of the OTR in the VMH and cAmyg.  Distinct signal transduction pathways regulating receptor expression and binding in each brain region may mediate in part the ability of oxytocin to exert these differential behavioral effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdG4tH42o_57Vg90H21EOLACvtfcHk0lgEQyUBNoiBPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslClsLo%253D&md5=56243806786cd5f38fcfce8652ecb843</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.21-07-02546.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.21-07-02546.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBale%26aufirst%3DT.%2BL.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DAuger%26aufirst%3DA.%2BP.%26aulast%3DDorsa%26aufirst%3DD.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%2BM.%26atitle%3DCNS%2520Region-Specific%2520Oxytocin%2520Receptor%2520Expression%253A%2520Importance%2520in%2520Regulation%2520of%2520Anxiety%2520and%2520Sex%2520Behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26issue%3D7%26spage%3D2546%26epage%3D2552%26doi%3D10.1523%2FJNEUROSCI.21-07-02546.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einspanier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobunaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokugawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span> <span> </span><span class="NLM_article-title">Expression and Immunolocalization of the Oxytocin Receptor in Human Lactating and Non-Lactating Mammary Glands</span>. <i>Hum. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2645</span>– <span class="NLM_lpage">2653</span>, <span class="refDoi"> DOI: 10.1093/humrep/13.9.2645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1093%2Fhumrep%2F13.9.2645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=9806301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVCitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=2645-2653&issue=9&author=T.+Kimuraauthor=Y.+Itoauthor=A.+Einspanierauthor=K.+Tohyaauthor=T.+Nobunagaauthor=Y.+Tokugawaauthor=M.+Takemuraauthor=Y.+Kubotaauthor=R.+Ivellauthor=N.+Matsuuraauthor=F.+Sajiauthor=Y.+Murata&title=Expression+and+Immunolocalization+of+the+Oxytocin+Receptor+in+Human+Lactating+and+Non-Lactating+Mammary+Glands&doi=10.1093%2Fhumrep%2F13.9.2645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and immunolocalization of the oxytocin receptor in human lactating and non-lactating mammary glands</span></div><div class="casAuthors">Kimura, Tadashi; Ito, Yasuhiro; Einspanier, Almuth; Tohya, Kazuo; Nobunaga, Toshikatsu; Tokugawa, Yoshihiro; Takemura, Masahiko; Kubota, Yasue; Ivell, Richard; Matsuura, Nariaki; Saji, Fumitaka; Murata, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2645-2653</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The milk ejection reflex is mediated by the release of pituitary oxytocin and its interaction with specific receptors within the mammary gland.  Although up-regulation of the oxytocin receptor during lactation has been shown for the rat mammary gland by ligand binding assay, investigation of the receptor expression in human breast at the mol. level has not yet been carried out in detail.  Here the authors report the expression and immunolocalization of the oxytocin receptor in the human breast.  It appears that the expression level of the receptor-specific mRNA is not significantly elevated during lactation and the protein remains at a relatively low level.  However, this lack of increase may be only a diln. effect because of the high level of milk protein expression.  Immunohistochem. and immunoelectron microscopy using three anti-oxytocin receptor antibodies raised against different epitopes of the receptor indicated the presence of receptor immunoreactivity only to a very limited extent in the myoepithelial cells; more specific expression appeared to occur in the ductal/glandular epithelium in both the non-lactating as well as lactating breast.  This finding was also confirmed in a New World monkey, the common marmoset (Callithrix jacchus).  These results suggest that, at least for human and marmoset, in addn. to-or even instead of-myoid cells, the ductal/glandular epithelium is also a target for oxytocin action, not only during lactation but also in the non-lactating breast.  Thus, there may be other physiol. effects of oxytocin besides direct myoid cell contraction in the breast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYc_n6XYbxLbVg90H21EOLACvtfcHk0lgEQyUBNoiBPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVCitrY%253D&md5=8804a23be4d42917576afe95b6699f4a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2F13.9.2645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252F13.9.2645%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DEinspanier%26aufirst%3DA.%26aulast%3DTohya%26aufirst%3DK.%26aulast%3DNobunaga%26aufirst%3DT.%26aulast%3DTokugawa%26aufirst%3DY.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DY.%26aulast%3DIvell%26aufirst%3DR.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DSaji%26aufirst%3DF.%26aulast%3DMurata%26aufirst%3DY.%26atitle%3DExpression%2520and%2520Immunolocalization%2520of%2520the%2520Oxytocin%2520Receptor%2520in%2520Human%2520Lactating%2520and%2520Non-Lactating%2520Mammary%2520Glands%26jtitle%3DHum.%2520Reprod.%26date%3D1998%26volume%3D13%26issue%3D9%26spage%3D2645%26epage%3D2653%26doi%3D10.1093%2Fhumrep%2F13.9.2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reversi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chini, B.</span></span> <span> </span><span class="NLM_article-title">Oxytocin Receptor Signaling in Myoepithelial and Cancer Cells</span>. <i>J. Mammary Gland Biol. Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/s10911-005-9583-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10911-005-9583-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16807802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BD28zovFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=221-229&issue=3&author=A.+Reversiauthor=P.+Cassoniauthor=B.+Chini&title=Oxytocin+Receptor+Signaling+in+Myoepithelial+and+Cancer+Cells&doi=10.1007%2Fs10911-005-9583-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptor signaling in myoepithelial and cancer cells</span></div><div class="casAuthors">Reversi Alessandra; Cassoni Paola; Chini Bice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of mammary gland biology and neoplasia</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-9</span>
        ISSN:<span class="NLM_cas:issn">1083-3021</span>.
    </div><div class="casAbstract">Oxytocin (OT) plays a crucial role as a mediator of breast myoepithelial cell contraction, the process responsible for the ejection of milk during lactation, and is also involved in myoepithelial cell proliferation and postpartum mammary gland proliferation.  Furthermore, although a number of breast cancer cells have oxytocin receptors (OTRs), it has been reported that OT stimulates, inhibits, or has no effect on cell proliferation.  As these different effects seem to be mediated by different signaling pathways elicited by OTR stimulation, we here review the regulation of OTR signaling in different cell systems and discuss how understanding the molecular basis of receptor coupling specificity has become extremely important for understanding the role played by OTRs in regulating cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7vdCwW9GeC0EgZCMqtRBifW6udTcc2eaNqksXrh5C37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zovFyjsQ%253D%253D&md5=ce0c5744dfb12bed8a708c60b29a13b4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10911-005-9583-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10911-005-9583-7%26sid%3Dliteratum%253Aachs%26aulast%3DReversi%26aufirst%3DA.%26aulast%3DCassoni%26aufirst%3DP.%26aulast%3DChini%26aufirst%3DB.%26atitle%3DOxytocin%2520Receptor%2520Signaling%2520in%2520Myoepithelial%2520and%2520Cancer%2520Cells%26jtitle%3DJ.%2520Mammary%2520Gland%2520Biol.%2520Neoplasia%26date%3D2005%26volume%3D10%26issue%3D3%26spage%3D221%26epage%3D229%26doi%3D10.1007%2Fs10911-005-9583-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksioglu, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Grassystatins A-C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors That Reduce Antigen Presentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5732</span>– <span class="NLM_lpage">5747</span>, <span class="refDoi"> DOI: 10.1021/jm9009394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9009394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5732-5747&issue=18&author=J.+C.+Kwanauthor=E.+A.+Eksiogluauthor=C.+Liuauthor=V.+J.+Paulauthor=H.+Luesch&title=Grassystatins+A-C+from+Marine+Cyanobacteria%2C+Potent+Cathepsin+E+Inhibitors+That+Reduce+Antigen+Presentation&doi=10.1021%2Fjm9009394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm9009394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9009394%26sid%3Dliteratum%253Aachs%26aulast%3DKwan%26aufirst%3DJ.%2BC.%26aulast%3DEksioglu%26aufirst%3DE.%2BA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DGrassystatins%2520A-C%2520from%2520Marine%2520Cyanobacteria%252C%2520Potent%2520Cathepsin%2520E%2520Inhibitors%2520That%2520Reduce%2520Antigen%2520Presentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D18%26spage%3D5732%26epage%3D5747%26doi%3D10.1021%2Fjm9009394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakinuma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span> <span> </span><span class="NLM_article-title">CCR10 and CCL27 Are Overexpressed in Cutaneous Squamous Cell Carcinoma</span>. <i>Pathol., Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>207</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.prp.2010.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.prp.2010.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=21144674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFygur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2011&pages=43-48&issue=1&author=H.+Kaiauthor=T.+Kadonoauthor=T.+Kakinumaauthor=M.+Tomitaauthor=H.+Ohmatsuauthor=Y.+Asanoauthor=Y.+Tadaauthor=M.+Sugayaauthor=S.+Sato&title=CCR10+and+CCL27+Are+Overexpressed+in+Cutaneous+Squamous+Cell+Carcinoma&doi=10.1016%2Fj.prp.2010.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma</span></div><div class="casAuthors">Kai, Hiromichi; Kadono, Takafumi; Kakinuma, Takashi; Tomita, Manabu; Ohmatsu, Hanako; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Pathology, Research and Practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">PARPDS</span>;
        ISSN:<span class="NLM_cas:issn">0344-0338</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">C-C chemokine receptor (CCR)10 is a specific receptor for chemokine ligand (CCL)27, a selective chemoattractant for skin-assocd. memory T cells to cutaneous sites.  In melanoma, CCR10 increases the ability of neoplastic cells to grow, invade tissues, disseminate to lymph nodes, and escape the host immune responses.  In this study, we investigated the expression of CCR10 and its ligand CCL27 in squamous cell carcinoma (SCC).  CCR10 and CCL27 were expressed in SCC, actinic keratosis (AK), Bowen's disease, and seborrheic keratosis (predominantly prickle cell type), but not in seborrheic keratosis (predominantly basal cell type) and basal cell carcinoma.  Furthermore, CCR10 and CCL27 were overexpressed in SCC relative to Bowen's disease, an early stage of SCC.  Consistently, a human SCC cell line, A253 cells, and HaCaT cells exhibited CCL27 prodn. that was strongly induced by tumor necrosis factor-α and interleukin-1β.  Finally, A253 cells expressed stronger intracellular CCR10 compared to HaCaT cells by flow cytometry.  These results suggest that CCR10 and CCL27 overexpression in SCC is related to the progression of SCC and is useful for the diagnosis of SCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1l3T0w5CrErVg90H21EOLACvtfcHk0lhArlD8Fkil0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFygur3L&md5=794962fa4e47831c615b685000cc8474</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.prp.2010.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prp.2010.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKai%26aufirst%3DH.%26aulast%3DKadono%26aufirst%3DT.%26aulast%3DKakinuma%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DOhmatsu%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DSugaya%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26atitle%3DCCR10%2520and%2520CCL27%2520Are%2520Overexpressed%2520in%2520Cutaneous%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DPathol.%252C%2520Res.%2520Pract.%26date%3D2011%26volume%3D207%26issue%3D1%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.prp.2010.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühnelt-Leddihn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisendle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the Chemokine Receptors CXCR4, CCR7, CCR9, and CCR10 in Human Primary Cutaneous Melanoma: A Potential Prognostic Value for CCR7 and CCR10?</span>. <i>Arch. Dermatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>304</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1007/s00403-012-1222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs00403-012-1222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=22350183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2012&pages=185-193&issue=3&author=L.+K%C3%BChnelt-Leddihnauthor=K.+Eisendleauthor=H.+M%C3%BCllerauthor=B.+Zelgerauthor=G.+Weinlich&title=Overexpression+of+the+Chemokine+Receptors+CXCR4%2C+CCR7%2C+CCR9%2C+and+CCR10+in+Human+Primary+Cutaneous+Melanoma%3A+A+Potential+Prognostic+Value+for+CCR7+and+CCR10%3F&doi=10.1007%2Fs00403-012-1222-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?</span></div><div class="casAuthors">Kuehnelt-Leddihn, Laura; Mueller, Hansgeorg; Eisendle, Klaus; Zelger, Bernhard; Weinlich, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-193</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Multiple functional implications have been suggested for a limited no. of chemokines and their cognate receptors in melanoma pathogenesis.  The purpose of this study was to investigate the potential role of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 as prognostic markers in human primary cutaneous melanoma.  Chemokine receptor expression was analyzed by immunohistochem. in a total of 38 patients with cutaneous melanoma.  Results were statistically correlated with melanoma features and clin. disease progression.  No significant correlation between overexpression of CXCR4 or CCR9 and survival or prognosis was found.  CCR7 overexpression was assocd. with significantly lower survival (0.005 log rank) and shorter time to progression (0.009 log rank)-similar to CCR10 overexpression (lower survival: 0.001 log rank, shorter time to progression: 0.002 log rank).  In addn., CCR7 overexpression correlated with expression of metallothionein, while CCR10 seems to be assocd. with cerebral metastases.  Two chemokine receptors permitting the identification of high-risk patients were identified: CCR7 and CCR10 overexpressions were found to be assocd. with a worse outcome of disease course independent of Breslow's tumor thickness and Clark level, thus representing possible addnl. prognostic markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Jnv8ryd2DrVg90H21EOLACvtfcHk0lhArlD8Fkil0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOksbw%253D&md5=51efab7e68b4e3ae4973074fef72453a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs00403-012-1222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-012-1222-8%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChnelt-Leddihn%26aufirst%3DL.%26aulast%3DEisendle%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DZelger%26aufirst%3DB.%26aulast%3DWeinlich%26aufirst%3DG.%26atitle%3DOverexpression%2520of%2520the%2520Chemokine%2520Receptors%2520CXCR4%252C%2520CCR7%252C%2520CCR9%252C%2520and%2520CCR10%2520in%2520Human%2520Primary%2520Cutaneous%2520Melanoma%253A%2520A%2520Potential%2520Prognostic%2520Value%2520for%2520CCR7%2520and%2520CCR10%253F%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D2012%26volume%3D304%26issue%3D3%26spage%3D185%26epage%3D193%26doi%3D10.1007%2Fs00403-012-1222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieramici, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offidani, A.</span></span> <span> </span><span class="NLM_article-title">Potential Role of CCL27 and CCR10 Expression in Melanoma Progression and Immune Escape</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ejca.2006.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=1181-1187&issue=8&author=O.+Simonettiauthor=G.+Goteriauthor=G.+Lucariniauthor=A.+Filosaauthor=T.+Pieramiciauthor=C.+Rubiniauthor=G.+Biaginiauthor=A.+Offidani&title=Potential+Role+of+CCL27+and+CCR10+Expression+in+Melanoma+Progression+and+Immune+Escape&doi=10.1016%2Fj.ejca.2006.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DSimonetti%26aufirst%3DO.%26aulast%3DGoteri%26aufirst%3DG.%26aulast%3DLucarini%26aufirst%3DG.%26aulast%3DFilosa%26aufirst%3DA.%26aulast%3DPieramici%26aufirst%3DT.%26aulast%3DRubini%26aufirst%3DC.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DOffidani%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520CCL27%2520and%2520CCR10%2520Expression%2520in%2520Melanoma%2520Progression%2520and%2520Immune%2520Escape%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26issue%3D8%26spage%3D1181%26epage%3D1187%26doi%3D10.1016%2Fj.ejca.2006.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Baruch, A.</span></span> <span> </span><span class="NLM_article-title">Organ Selectivity in Metastasis: Regulation by Chemokines and Their Receptors</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1007/s10585-007-9097-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10585-007-9097-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17891505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVSqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=345-356&issue=4&author=A.+Ben-Baruch&title=Organ+Selectivity+in+Metastasis%3A+Regulation+by+Chemokines+and+Their+Receptors&doi=10.1007%2Fs10585-007-9097-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Organ selectivity in metastasis: regulation by chemokines and their receptors</span></div><div class="casAuthors">Ben-Baruch, Adit</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis results from a non-random process, in which organ selectivity by the tumor cells is largely detd. by factors that are expressed at the remote organs that eventually turn into preferred sites of metastasis formation.  These factors support the consecutive steps required for metastasis formation, including tumor cell adhesion to microvessel walls, extravasation into target tissue and migration.  Of the different components that regulate organ selectivity, instrumental roles were recently attributed to chemokines and their receptors.  The present review presents the rationale standing behind the first studies looking at the potential involvement of chemokine-related components in organ selectivity.  Based on these studies and many others that followed, the current paradigm is that chemokines that are expressed at specific organs det. to large extent organ specificity by promoting tumor cell adhesion to microvessel walls, by facilitating processes of extravasation into the target tissue and by inducing tumor cell migration.  Moreover, chemokines can possibly support addnl. steps that are required for "successful" establishment of metastases, such as tumor cell proliferation and survival.  The review focuses on the CXCL12-CXCR4 pair as the role model in our current understanding of chemokine involvement in organ selectivity.  This review also describes the prominent roles played by CCR7 and its corresponding chemokine ligands (CCL21, CCL19) in lymph node metastasis, and of the CCR10-CCL27 axis in melanoma skin survival and metastasis.  Overall, the present discussion describes chemokines as important constituents of the tumor microenvironment at metastatic sites, dictating directionality of chemokine receptor-expressing tumor cells, facilitating their adhesion and extravasation, and eventually contributing to organ selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZX80EGl9CU7Vg90H21EOLACvtfcHk0lhsK4TBdUfaaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVSqu7c%253D&md5=c85b981d596cde945daea08cf94763ef</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs10585-007-9097-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-007-9097-3%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Baruch%26aufirst%3DA.%26atitle%3DOrgan%2520Selectivity%2520in%2520Metastasis%253A%2520Regulation%2520by%2520Chemokines%2520and%2520Their%2520Receptors%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2008%26volume%3D25%26issue%3D4%26spage%3D345%26epage%3D356%26doi%3D10.1007%2Fs10585-007-9097-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Baruch, A.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Metastasis Formation</span>. <i>Cell Adhes. Migration</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4161/cam.3.4.9211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.4161%2Fcam.3.4.9211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BD1MjovFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=328-333&author=A.+Ben-Baruch&title=Site-Specific+Metastasis+Formation&doi=10.4161%2Fcam.3.4.9211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion</span></div><div class="casAuthors">Ben-Baruch Adit</div><div class="citationInfo"><span class="NLM_cas:title">Cell adhesion & migration</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">328-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The metastatic spread of tumors is a well-coordinated process in which different types of cancers tend to form metastases in defined organs.  The formation of site-specific metastases requires full compatibility between the intrinsic properties of the tumor cells and the tumor microenvironment.  It was recently found that chemokines which are expressed in specific loci promote the adhesion, migration and invasion of tumor cells that express the corresponding receptor(s).  Of the different members of the family, the CXCL12 chemokine and its cognate CXCR4 receptor are the prototypes of this process, although other members of the family (e.g.  CCR7 and CCR10) also play a role in determination of the metastatic spread.  This commentary addresses the fundamental roles of chemokines and their receptors in site-specific metastasis, with emphasis on CXCL12-CXCR4.  The article also describes some of the efforts that were performed thus far in order to identify the intracellular components involved in this process.  The focus is put on the roles played by proteins that regulate adhesion and migration of tumor cells in response to CXCL12, including mainly focal adhesion kinase (FAK), Pyk2/RAFTK and members of the Rho family of GTPases (RhoA, Rac, Cdc42).  This is followed by discussion of open questions that need to be addressed in future research, and of the potential therapeutic implications of the findings that are available to date in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSKpjb2A3ZN2PgL4LrC-0VfW6udTcc2eYnNudUyfd-pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjovFOntQ%253D%253D&md5=7df64d00f52b08934e2f2b01534299a1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.4161%2Fcam.3.4.9211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcam.3.4.9211%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Baruch%26aufirst%3DA.%26atitle%3DSite-Specific%2520Metastasis%2520Formation%26jtitle%3DCell%2520Adhes.%2520Migration%26date%3D2009%26volume%3D3%26spage%3D328%26epage%3D333%26doi%3D10.4161%2Fcam.3.4.9211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+Speed+and+Accuracy+of+Docking+with+a+New+Scoring+Function%2C+Efficient+Optimization%2C+and+Multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lhsK4TBdUfaaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520Speed%2520and%2520Accuracy%2520of%2520Docking%2520with%2520a%2520New%2520Scoring%2520Function%252C%2520Efficient%2520Optimization%252C%2520and%2520Multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Verrill M. Norwood, IV, Ariana C. Brice-Tutt, Shainnel O. Eans, Heather M. Stacy, Guqin Shi, Ranjala Ratnayake, James R. Rocca, Khalil A. Abboud, Chenglong Li, Hendrik Luesch, Jay P. McLaughlin, <span class="NLM_string-name hlFld-ContribAuthor">Robert W. Huigens, III</span>. </span><span class="cited-content_cbyCitation_article-title">Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine’s Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5119-5138. <a href="https://doi.org/10.1021/acs.jmedchem.9b01924" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01924%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreventing%252BMorphine-Seeking%252BBehavior%252Bthrough%252Bthe%252BRe-Engineering%252Bof%252BVincamine%2525E2%252580%252599s%252BBiological%252BActivity%26aulast%3DNorwood%26aufirst%3DVerrill%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D23032020%26date%3D08012020%26volume%3D63%26issue%3D10%26spage%3D5119%26epage%3D5138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingze Yang, Wenquan Peng, Yian Guo, <span class="NLM_string-name hlFld-ContribAuthor">Tao Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Dysoxylactam A. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 1776-1779. <a href="https://doi.org/10.1021/acs.orglett.0c00074" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00074%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTotal%252BSynthesis%252Bof%252BDysoxylactam%252BA%26aulast%3DYang%26aufirst%3DMingze%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07012020%26date%3D12022020%26volume%3D22%26issue%3D5%26spage%3D1776%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie Yu, Mingze Yang, Yian Guo, <span class="NLM_string-name hlFld-ContribAuthor">Tao Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Psymberin (Irciniastatin A). </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (10)
                                     , 3670-3673. <a href="https://doi.org/10.1021/acs.orglett.9b01113" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01113%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTotal%252BSynthesis%252Bof%252BPsymberin%252B%252528Irciniastatin%252BA%252529%26aulast%3DYu%26aufirst%3DJie%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29032019%26date%3D07052019%26volume%3D21%26issue%3D10%26spage%3D3670%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao Liang, Danmeng Luo, Jia-Lei Yan, Mohammad A. Rezaei, Lilibeth A. Salvador-Reyes, Sarath P. Gunasekera, Chenglong Li, Tao Ye, Valerie J. Paul, <span class="NLM_string-name hlFld-ContribAuthor">Hendrik Luesch</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Amantamide, a Selective CXCR7 Agonist from Marine Cyanobacteria. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (6)
                                     , 1622-1626. <a href="https://doi.org/10.1021/acs.orglett.9b00163" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00163%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDiscovery%252Bof%252BAmantamide%25252C%252Ba%252BSelective%252BCXCR7%252BAgonist%252Bfrom%252BMarine%252BCyanobacteria%26aulast%3DLiang%26aufirst%3DXiao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14012019%26date%3D19022019%26volume%3D21%26issue%3D6%26spage%3D1622%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jia-Lei Yan, Yingying Cheng, Jing Chen, Ranjala Ratnayake, Long H. Dang, Hendrik Luesch, Yian Guo, <span class="NLM_string-name hlFld-ContribAuthor">Tao Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Asperphenins A and B. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (19)
                                     , 6170-6173. <a href="https://doi.org/10.1021/acs.orglett.8b02652" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02652%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTotal%252BSynthesis%252Bof%252BAsperphenins%252BA%252Band%252BB%26aulast%3DYan%26aufirst%3DJia-Lei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19082018%26date%3D20092018%26volume%3D20%26issue%3D19%26spage%3D6170%26epage%3D6173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Huang</span>, <span class="hlFld-ContribAuthor ">Yeye  Guo</span>, <span class="hlFld-ContribAuthor ">Shujing  Liu</span>, <span class="hlFld-ContribAuthor ">Huaishan  Wang</span>, <span class="hlFld-ContribAuthor ">Jinjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Lingling  Ou</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting regulatory T cells for immunotherapy in melanoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biomedicine</span><span> <strong>2021,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43556-021-00038-z" title="DOI URL">https://doi.org/10.1186/s43556-021-00038-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43556-021-00038-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43556-021-00038-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biomedicine%26atitle%3DTargeting%252Bregulatory%252BT%252Bcells%252Bfor%252Bimmunotherapy%252Bin%252Bmelanoma%26aulast%3DHuang%26aufirst%3DLili%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dipesh  Dhakal</span>, <span class="hlFld-ContribAuthor ">Manyun  Chen</span>, <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>, <span class="hlFld-ContribAuthor ">Yousong  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Heterologous production of cyanobacterial compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Industrial Microbiology and Biotechnology</span><span> <strong>2021,</strong> <em>48 </em>
                                    (3-4)
                                     <a href="https://doi.org/10.1093/jimb/kuab003" title="DOI URL">https://doi.org/10.1093/jimb/kuab003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jimb/kuab003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjimb%2Fkuab003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Industrial%2520Microbiology%2520and%2520Biotechnology%26atitle%3DHeterologous%252Bproduction%252Bof%252Bcyanobacterial%252Bcompounds%26aulast%3DDhakal%26aufirst%3DDipesh%26date%3D2021%26date%3D2021%26volume%3D48%26issue%3D3-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rama Rao  Malla</span>, <span class="hlFld-ContribAuthor ">Batoul  Farran</span>, <span class="hlFld-ContribAuthor ">Ganji Purnachandra  Nagaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 15-37. <a href="https://doi.org/10.4331/wjbc.v12.i2.15" title="DOI URL">https://doi.org/10.4331/wjbc.v12.i2.15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4331/wjbc.v12.i2.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4331%2Fwjbc.v12.i2.15%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Biological%2520Chemistry%26atitle%3DUnderstanding%252Bthe%252Bfunction%252Bof%252Bthe%252Btumor%252Bmicroenvironment%25252C%252Band%252Bcompounds%252Bfrom%252Bmarine%252Borganisms%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DMalla%26aufirst%3DRama%2BRao%26date%3D2021%26volume%3D12%26issue%3D2%26spage%3D15%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas G.  Paciaroni</span>, <span class="hlFld-ContribAuthor ">Verrill M.  Norwood</span>, <span class="hlFld-ContribAuthor ">Ranjala  Ratnayake</span>, <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>, <span class="hlFld-ContribAuthor ">Robert W.  Huigens</span>. </span><span class="cited-content_cbyCitation_article-title">Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (14)
                                     , 115546. <a href="https://doi.org/10.1016/j.bmc.2020.115546" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115546%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DYohimbine%252Bas%252Ba%252BStarting%252BPoint%252Bto%252BAccess%252BDiverse%252BNatural%252BProduct-Like%252BAgents%252Bwith%252BRe-programmed%252BActivities%252Bagainst%252BCancer-Relevant%252BGPCR%252BTargets%26aulast%3DPaciaroni%26aufirst%3DNicholas%2BG.%26date%3D2020%26volume%3D28%26issue%3D14%26spage%3D115546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feipeng  Han</span>, <span class="hlFld-ContribAuthor ">Yian  Guo</span>, <span class="hlFld-ContribAuthor ">Tao  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Total synthesis of antiallergic bicyclic peptide seongsanamide A. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (13)
                                     , 1658-1662. <a href="https://doi.org/10.1039/D0QO00531B" title="DOI URL">https://doi.org/10.1039/D0QO00531B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00531B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00531B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DTotal%252Bsynthesis%252Bof%252Bantiallergic%252Bbicyclic%252Bpeptide%252Bseongsanamide%252BA%26aulast%3DHan%26aufirst%3DFeipeng%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D13%26spage%3D1658%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony R.  Carroll</span>, <span class="hlFld-ContribAuthor ">Brent R.  Copp</span>, <span class="hlFld-ContribAuthor ">Rohan A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert A.  Keyzers</span>, <span class="hlFld-ContribAuthor ">Michèle R.  Prinsep</span>. </span><span class="cited-content_cbyCitation_article-title">Marine natural products. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2020,</strong> <em>37 </em>
                                    (2)
                                     , 175-223. <a href="https://doi.org/10.1039/C9NP00069K" title="DOI URL">https://doi.org/10.1039/C9NP00069K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NP00069K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NP00069K%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DMarine%252Bnatural%252Bproducts%26aulast%3DCarroll%26aufirst%3DAnthony%2BR.%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D2%26spage%3D175%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole  Lounsbury</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in CXCR7 Modulators. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (2)
                                     , 33. <a href="https://doi.org/10.3390/ph13020033" title="DOI URL">https://doi.org/10.3390/ph13020033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13020033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13020033%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAdvances%252Bin%252BCXCR7%252BModulators%26aulast%3DLounsbury%26aufirst%3DNicole%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D2%26spage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Liang</span>, <span class="hlFld-ContribAuthor ">Danmeng  Luo</span>, <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in exploring the therapeutic potential of marine natural products. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>147 </em>, 104373. <a href="https://doi.org/10.1016/j.phrs.2019.104373" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104373%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DAdvances%252Bin%252Bexploring%252Bthe%252Btherapeutic%252Bpotential%252Bof%252Bmarine%252Bnatural%252Bproducts%26aulast%3DLiang%26aufirst%3DXiao%26date%3D2019%26volume%3D147%26spage%3D104373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edin  Muratspahić</span>, <span class="hlFld-ContribAuthor ">Michael  Freissmuth</span>, <span class="hlFld-ContribAuthor ">Christian W.  Gruber</span>. </span><span class="cited-content_cbyCitation_article-title">Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2019,</strong> <em>40 </em>
                                    (5)
                                     , 309-326. <a href="https://doi.org/10.1016/j.tips.2019.03.004" title="DOI URL">https://doi.org/10.1016/j.tips.2019.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2019.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2019.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DNature-Derived%252BPeptides%25253A%252BA%252BGrowing%252BNiche%252Bfor%252BGPCR%252BLigand%252BDiscovery%26aulast%3DMuratspahi%25C4%2587%26aufirst%3DEdin%26date%3D2019%26volume%3D40%26issue%3D5%26spage%3D309%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cyanobacterial-derived brintonamides A–E (<b>1</b>–<b>5</b>) with the differences among structures <b>1</b>–<b>5</b> highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Total Synthesis of Brintonamides A and B (<b>1</b> and <b>2</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Total Synthesis of Brintonamides C–E (<b>3</b>–<b>5</b>) and Analogues <b>6</b> and <b>7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antiproliferative activity of brintonamides (<b>1</b>–<b>7</b>) against MDA-MB-231 breast cancer cells. MDA-MB-231 cells were seeded (10 000 cells/well) in 96-well plates. Following 24 h incubation, the cells were treated with different concentrations of <b>1</b>–<b>7</b> or solvent control for 48 h. The cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay). Data is presented as mean ± SD, <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protease inhibitory activity of brintonamides (<b>1</b>–<b>7</b>). (A) Profiling brintonamides A and D (<b>1</b> and <b>4</b>) against a panel of 63 proteases. Heat maps represent % enzyme activities at 10 μM final concentrations of <b>1</b> and <b>4</b>. (B) Dose–response curves of the antiproteolytic activity of brintonamides <b>1</b>–<b>7</b> against KLK7 as a follow up study. The dose–response is presented as % fold inhibition against solvent control (DMSO). Data is presented as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GPCR profiling of brintonamides A and D (<b>1</b> and <b>4</b>) using cell-based functional screen. (A) Heatmap showing the profiling data of brintonamides A and D (<b>1</b> and <b>4</b>) against the gpcr<i>Max</i> and orphan panels of GPCR targets. (B) The GPCR assay principle based on the enzyme fragment complementation technology. (C,D) Scatter plots showing the % Activation or inhibition of 10 μM brintonamides A and D (<b>1</b> and <b>4</b>) against gpcr<i>Max</i> panel (agonist and antagonist modes). The hits identified in the screen with >50% activity or inhibitions are labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding conformation of (A) brintonamide D (<b>4</b>), (B) brintonamide E (<b>5</b>), (C) brintonamide A (<b>1</b>), and (D) brintonamide B (<b>2</b>) within CCR10 model. The interactions with key amino acid residues in the binding site are shown. The compounds are displayed as stick representation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of targeting CCR10 on the proliferation of MDA-MB-231 cells. The effect of CCL27 (A) and brintonamides (B) on the proliferation of MDA-MB-231 cells. MDA-MB-231 cells were incubated for 48 h in the presence of different concentrations of CCL27, brintonamide A (<b>1</b>), or brintonamide D (<b>4</b>), and the effects were compared to the solvent controls. (C) Effect of brintonamides on the CCL27 induced proliferation of MDA-MB-231 cells. MDA-MB-231 cells (10000 cells/well) were pretreated with different concentrations of <b>1</b> and <b>4</b> for 2 h, followed by treatment with CCL27 (1 μg/mL) for 48 h. (D) The effect of CCR10 knockdown on the proliferation of MDA-MB-231 cells. MDA-MB-231 cells were incubated in the presence of 50 nM siCCR10 (60% knockdown efficiency; see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9A</a>), and the effect was compared to the negative control. Data is presented as mean ± SD, <i>n</i> = 3. The asterisks denote significance of <i>P</i> < 0.05 relative to solvent control using two-tailed unpaired <i>t</i> test (* denotes <i>P</i> ≤ 0.05, **** denotes <i>P</i> ≤ 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of CCR10 antagonists and siCCR10 on the migration of MDA-MB-231 cells. (A) MDA-MB-231 cells were incubated for 48 h in the presence of 10 μM brintonamide A (<b>1</b>) and D (<b>4</b>), and the effect was compared to the solvent control. (B) MDA-MB-231 cells were incubated for 72 h in the presence of 50 nM siRNA (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf" class="ext-link">Figure S9A</a>), and the effect was compared to the negative control. The graph represents the number of migrated cells in each treatment group. The asterisks denote significance of <i>P</i> < 0.05 relative to solvent control using two tailed unpaired <i>t</i> test (** denotes <i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/medium/jm-2018-00885x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Summary of the SAR data of brintonamides obtained from the hits identified in the screens. The graph represents the IC<sub>50</sub> or EC<sub>50</sub> values of brintonamides <b>1</b>–<b>7</b> against the hits identified in the target-based screens. The <i>x</i>-axis represents brintonamides <b>1</b>–<b>7</b>, while the <i>y</i>-axis represents IC<sub>50</sub> or EC<sub>50</sub> values. The GPCR targets modulated by an IC<sub>50</sub> or EC<sub>50</sub> values greater than 20 μM are displayed as transparent bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00885/20180719/images/large/jm-2018-00885x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00885&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. A.</span>; <span class="NLM_string-name">Ye, L.</span>; <span class="NLM_string-name">Sanders, A. J.</span>; <span class="NLM_string-name">Lane, J.</span>; <span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Cancer Invasion and Metastasis: Molecular and Cellular Perspective</span>. In  <i>Madame Curie Bioscience Database [Internet]</i>; <span class="NLM_publisher-name">Landes Bioscience</span>: <span class="NLM_publisher-loc">Austin, TX</span>, <span class="NLM_year">2000</span>–<span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+A.+Martin&author=L.+Ye&author=A.+J.+Sanders&author=J.+Lane&author=W.+G.+Jiang&title=Madame+Curie+Bioscience+Database+%5BInternet%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DT.%2BA.%26atitle%3DCancer%2520Invasion%2520and%2520Metastasis%253A%2520Molecular%2520and%2520Cellular%2520Perspective%26btitle%3DMadame%2520Curie%2520Bioscience%2520Database%2520%255BInternet%255D%26pub%3DLandes%2520Bioscience%26date%3D2000%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netzel-Arnett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quigley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antalis, T. M.</span></span> <span> </span><span class="NLM_article-title">Membrane Anchored Serine Proteases: A Rapidly Expanding Group of Cell Surface Proteolytic Enzymes with Potential Roles in Cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1023/A:1023003616848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1023%2FA%3A1023003616848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=12784999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=237-258&author=S.+Netzel-Arnettauthor=J.+D.+Hooperauthor=R.+Szaboauthor=E.+L.+Madisonauthor=J.+P.+Quigleyauthor=H.+Buggeauthor=T.+M.+Antalis&title=Membrane+Anchored+Serine+Proteases%3A+A+Rapidly+Expanding+Group+of+Cell+Surface+Proteolytic+Enzymes+with+Potential+Roles+in+Cancer&doi=10.1023%2FA%3A1023003616848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer</span></div><div class="casAuthors">Netzel-Arnett, Sarah; Hooper, John D.; Szabo, Roman; Madison, Edwin L.; Quigley, James P.; Bugge, Thomas H.; Antalis, Toni M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">237-258</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Dysregulated proteolysis is a hallmark of cancer.  Malignant cells require a range of proteolytic activities to enable growth, survival, and expansion.  Serine proteases of the S1 or trypsin-like family have well recognized roles in the maintenance of normal homeostasis as well as in the pathol. of diseases such as cancer.  Recently a rapidly expanding subgroup of S1 proteases has been recognized that are directly anchored to plasma membranes.  These membrane anchored serine proteases are anchored either via a carboxy-terminal transmembrane domain (Type I), a carboxy terminal hydrophobic region that functions as a signal for membrane attachment via a glycosyl-phosphatidylinositol linkage (GPI-anchored), or via an amino terminal proximal transmembrane domain (Type II or TTSP).  The TTSPs also encode multiple domains in their stem regions that may function in regulatory interactions.  The serine protease catalytic domains of these enzymes show high homol. but also possess features indicating unique substrate specificities.  It is likely that the membrane anchored serine proteases have evolved to perform complex functions in the regulation of cellular signaling events at the plasma membrane and within the extracellular matrix.  Disruption or mutation of several of the genes encoding these proteases are assocd. with disease.  Many of the membrane anchored serine proteases show restricted tissue distribution in normal cells, but their expression is widely dysregulated during tumor growth and progression.  Diagnostic or therapeutic targeting of the membrane anchored serine proteases has potential as promising new approaches for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmLKMa6BFArVg90H21EOLACvtfcHk0lgYcl2tWuC5Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CjtL0%253D&md5=2f4c573e9f9b5c663cf5cc5af90da188</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023003616848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023003616848%26sid%3Dliteratum%253Aachs%26aulast%3DNetzel-Arnett%26aufirst%3DS.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DSzabo%26aufirst%3DR.%26aulast%3DMadison%26aufirst%3DE.%2BL.%26aulast%3DQuigley%26aufirst%3DJ.%2BP.%26aulast%3DBugge%26aufirst%3DH.%26aulast%3DAntalis%26aufirst%3DT.%2BM.%26atitle%3DMembrane%2520Anchored%2520Serine%2520Proteases%253A%2520A%2520Rapidly%2520Expanding%2520Group%2520of%2520Cell%2520Surface%2520Proteolytic%2520Enzymes%2520with%2520Potential%2520Roles%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D237%26epage%3D258%26doi%3D10.1023%2FA%3A1023003616848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1210/edrv.22.2.0424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1210%2Fedrv.22.2.0424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=11294823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=184-204&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=The+New+Human+Tissue+Kallikrein+Gene+Family%3A+Structure%2C+Function%2C+and+Association+to+Disease&doi=10.1210%2Fedrv.22.2.0424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The new human tissue kallikrein gene family: Structure, function, and association to disease</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-204</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The human tissue kallikrein gene family was, until recently, thought to consist of only three genes.  Two of these human kallikreins, prostate-specific antigen and human glandular kallikrein 2, are currently used as valuable biomarkers of prostatic carcinoma.  More recently, new kallikrein-like genes have been discovered.  It is now clear that the human tissue kallikrein gene family contains at least 15 genes.  All genes share important similarities, including mapping at the same chromosomal locus (19q13.4), significant homol. at both the nucleotide and protein level, and similar genomic organization.  All genes encode for putative serine proteases and most of them are regulated by steroid hormones.  Recent data suggest that at least a few of these kallikrein genes are connected to malignancy.  In this review, we summarize the recently accumulated knowledge on the human tissue kallikrein gene family, including gene and protein structure, predicted enzymic activities, tissue expression, hormonal regulation, and alternative splicing.  We further describe the reported assocns. of the human kallikreins with various human diseases and identify future avenues for research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QpkM-LBKh7Vg90H21EOLACvtfcHk0lgYcl2tWuC5Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D&md5=ca1b47cc183643d953e8abecd25cc730</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1210%2Fedrv.22.2.0424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.22.2.0424%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520New%2520Human%2520Tissue%2520Kallikrein%2520Gene%2520Family%253A%2520Structure%252C%2520Function%252C%2520and%2520Association%2520to%2520Disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2001%26volume%3D22%26spage%3D184%26epage%3D204%26doi%3D10.1210%2Fedrv.22.2.0424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stromqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallbrandt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span> <span> </span><span class="NLM_article-title">Cloning, Expression, and Characterization of Stratum Corneum Chymotryptic Enzyme: A Skin-Specific Human Serine Proteinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">19420</span>– <span class="NLM_lpage">19426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=19420-19426&author=L.+Hanssonauthor=M.+Stromqvistauthor=A.+Backmanauthor=P.+Wallbrandtauthor=A.+Carlsteinauthor=T.+Egelrud&title=Cloning%2C+Expression%2C+and+Characterization+of+Stratum+Corneum+Chymotryptic+Enzyme%3A+A+Skin-Specific+Human+Serine+Proteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DL.%26aulast%3DStromqvist%26aufirst%3DM.%26aulast%3DBackman%26aufirst%3DA.%26aulast%3DWallbrandt%26aufirst%3DP.%26aulast%3DCarlstein%26aufirst%3DA.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DCloning%252C%2520Expression%252C%2520and%2520Characterization%2520of%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%253A%2520A%2520Skin-Specific%2520Human%2520Serine%2520Proteinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D19420%26epage%3D19426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span> <span> </span><span class="NLM_article-title">Purification and Preliminary Characterization of Stratum Corneum Chymotryptic Enzyme: A Proteinase That May Be Involved in Desquamation</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/1523-1747.ep12363804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1111%2F1523-1747.ep12363804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=8393902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFyhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1993&pages=200-204&author=T.+Egelrud&title=Purification+and+Preliminary+Characterization+of+Stratum+Corneum+Chymotryptic+Enzyme%3A+A+Proteinase+That+May+Be+Involved+in+Desquamation&doi=10.1111%2F1523-1747.ep12363804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation</span></div><div class="casAuthors">Egelrud, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-4</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    </div><div class="casAbstract">In recent work, the authors showed that a serine proteinase, stratum corneum chymotrypic enzyme, with properties compatible with a role in desquamation in vitro as well as in vivo, is generally present in human stratum corneum.  The enzymol. properties of the stratum corneum chymotryptic enzyme in a KCl ext. of dissocd. plantar corneocytes were compared with those of other known chymotryptic serine proteinases.  Stratum corneum chymotryptic enzyme was found to differ significantly from bovine chymotrypsin, human cathepsin G, and human mast cell chymases in regard to inhibitor profile and substrate specificity.  Stratum corneum chymotryptic enzyme was further purified from KCl exts. of dissocd. plantar corneocytes by affinity chromatog. on gels with covalently linked soybean trypsin inhibitor.  The purified prepn. contained 1 major component with an apparent mol. wt. of 25 kDa and 1 minor component with a slightly higher apparent mol. wt. as revealed by Coomassie staining after SDS-PAGE of samples that had not been reduced.  Both of these components were assocd. with chymotrypsin-like activity as revealed by zymog. in polyacrylamide gels with copolymd. casein.  On zymog. gels, the purified prepn. was also found to contain minor amts. of components with trypsinlike activity.  The major purified protein had an apparent mol. wt. of ∼28 kDa after redn. and full denaturation and was shown to contain carbohydrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ZUZeBIhiv7Vg90H21EOLACvtfcHk0ljG55RRtwAWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFyhtLg%253D&md5=2a007026ec4436aeff418a573c8b5282</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2F1523-1747.ep12363804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1523-1747.ep12363804%26sid%3Dliteratum%253Aachs%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DPurification%2520and%2520Preliminary%2520Characterization%2520of%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%253A%2520A%2520Proteinase%2520That%2520May%2520Be%2520Involved%2520in%2520Desquamation%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1993%26volume%3D101%26spage%3D200%26epage%3D204%26doi%3D10.1111%2F1523-1747.ep12363804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundström, A.</span></span> <span> </span><span class="NLM_article-title">A Chymotrypsin-like Proteinase That May Be Involved in Desquamation in Plantar Stratum Corneum</span>. <i>Arch. Dermatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1007/BF00371618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2FBF00371618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1712574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1991&pages=108-112&issue=2&author=T.+Egelrudauthor=A.+Lundstr%C3%B6m&title=A+Chymotrypsin-like+Proteinase+That+May+Be+Involved+in+Desquamation+in+Plantar+Stratum+Corneum&doi=10.1007%2FBF00371618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum</span></div><div class="casAuthors">Egelrud, T.; Lundstroem, A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-12</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    </div><div class="casAbstract">It was recently reported that unipolar cell shedding from plantar stratum corneum incubated in vitro, and the assocd. degrdn. of the desmosomal protein desmoglein I, are dependent on the activity of a proteinase that can be inhibited by aprotinin, chymostatin and Zn2+.  The aim of this work was to find a proteinase in plantar stratum corneum that fulfills the criteria for being the responsible enzyme.  Dissocd. plantar corneocytes were incubated with the chymotrypsin substrate (S 2586) and (S 2288), a substrate for a wide range of serine proteinases with arginine specificity.  There was a significant rate of hydrolysis of S 2586, but S 2288 was hydrolyzed only very slowly.  Extn. of dissocd. corneocytes with buffers contg. KCl or SDS released 1 major proteinase that could be detected by electrophoresis in polyacrylamide gels with copolymd. casein and subsequent incubations of the gels.  Both the caseinolytic activity and the S 2586-hydrolyzing activities were inhibited by aprotinin, chymostatin and Zn2+ but not by leupeptin.  The S-2586-hydrolyzing activity was also inhibited by soybean trypsin inhibitor and phenylmethylsulfonyl fluoride.  Both activities were optimal at pH 7-8 but were also significant at pH 5.5.  On gel-exclusion chromatog., the S 2586-hydrolyzing and caseinolytic activities were eluted with an apparent mol. wt. of ∼18 kDa.  When analyzed by electrophoresis in the presence of SDS under nonreducing conditions the caseinolytic enzyme had an apparent mol. wt. of ∼25 kDa.  It is concluded that the enzyme studied may be responsible for the degrdn. of intercellular cohesive structures during in vitro cell shedding from plantar stratum corneum, and that it does have properties compatible with a role in stratum corneum turnover under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlz9NFpJ9yqbVg90H21EOLACvtfcHk0ljG55RRtwAWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1KktL8%253D&md5=e64aac60345efd40b722d903f5f9a3f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2FBF00371618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00371618%26sid%3Dliteratum%253Aachs%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DA.%26atitle%3DA%2520Chymotrypsin-like%2520Proteinase%2520That%2520May%2520Be%2520Involved%2520in%2520Desquamation%2520in%2520Plantar%2520Stratum%2520Corneum%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D1991%26volume%3D283%26issue%3D2%26spage%3D108%26epage%3D112%26doi%3D10.1007%2FBF00371618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Descargues, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prost, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraitag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazereeuw-Hautier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D ’Alessio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida-Yamamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodemer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambruno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovnanian, A.</span></span> <span> </span><span class="NLM_article-title">Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton Syndrome</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1622</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1038/sj.jid.5700284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fsj.jid.5700284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16628198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1Khu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1622-1632&author=P.+Descarguesauthor=C.+Deraisonauthor=C.+Prostauthor=S.+Fraitagauthor=J.+Mazereeuw-Hautierauthor=M.+D+%E2%80%99Alessioauthor=A.+Ishida-Yamamotoauthor=C.+Bodemerauthor=G.+Zambrunoauthor=A.+Hovnanian&title=Corneodesmosomal+Cadherins+Are+Preferential+Targets+of+Stratum+Corneum+Trypsin-+and+Chymotrypsin-like+Hyperactivity+in+Netherton+Syndrome&doi=10.1038%2Fsj.jid.5700284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton Syndrome</span></div><div class="casAuthors">Descargues, Pascal; Deraison, Celine; Prost, Catherine; Fraitag, Sylvie; Mazereeuw-Hautier, Juliette; D'Alessio, Marina; Ishida-Yamamoto, Akemi; Bodemer, Christine; Zambruno, Giovanna; Hovnanian, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1622-1632</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SPINK5 (serine protease inhibitor Kazal-type 5), encoding the protease inhibitor LEKTI (lympho-epithelial Kazal-type related inhibitor), is the defective gene in Netherton syndrome (NS), a severe inherited keratinizing disorder.  We have recently demonstrated epidermal protease hyperactivity in Spink5-/- mice resulting in desmosomal protein degrdn.  Herein, we investigated the mol. mechanism underlying the epidermal defect in 15 patients with NS.  We demonstrated that, in a majority of patients, desmoglein 1 (Dsg1) and desmocollin 1 (Dsc1) were dramatically reduced in the upper most living layers of the epidermis.  These defects were assocd. with premature degrdn. of corneodesmosomes.  Stratum corneum tryptic enzyme (SCTE)-like and stratum corneum chymotryptic enzyme (SCCE)-like activities were increased, suggesting that these proteases participate in the premature degrdn. of corneodesmosomal cadherins.  SCTE and SCCE expression was extended to the cell layers where Dsg1 and Dsc1 immunostaining was reduced.  In contrast, a subset of six patients with normal epidermal protease activity or residual LEKTI expression displayed apparently normal cadherin expression and less severe disease manifestations.  This suggests a degree of correlation between cadherin degrdn. and clin. severity.  This work further supports the implication of premature corneodesmosomal cadherin degrdn. in the pathogenesis of NS and provides evidence for addnl. factors playing a role in disease expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3TMqH7LYd9LVg90H21EOLACvtfcHk0ljG55RRtwAWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1Khu74%253D&md5=92877c188e4c8ace34aa55eecb215868</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.jid.5700284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jid.5700284%26sid%3Dliteratum%253Aachs%26aulast%3DDescargues%26aufirst%3DP.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DProst%26aufirst%3DC.%26aulast%3DFraitag%26aufirst%3DS.%26aulast%3DMazereeuw-Hautier%26aufirst%3DJ.%26aulast%3DD%2B%25E2%2580%2599Alessio%26aufirst%3DM.%26aulast%3DIshida-Yamamoto%26aufirst%3DA.%26aulast%3DBodemer%26aufirst%3DC.%26aulast%3DZambruno%26aufirst%3DG.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DCorneodesmosomal%2520Cadherins%2520Are%2520Preferential%2520Targets%2520of%2520Stratum%2520Corneum%2520Trypsin-%2520and%2520Chymotrypsin-like%2520Hyperactivity%2520in%2520Netherton%2520Syndrome%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2006%26volume%3D126%26spage%3D1622%26epage%3D1632%26doi%3D10.1038%2Fsj.jid.5700284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cane’, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignotti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Las Casas, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anfossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecorelli, S.</span></span> <span> </span><span class="NLM_article-title">The Serine Protease Stratum Corneum Chymotryptic Enzyme (Kallikrein 7) Is Highly Overexpressed in Squamous Cervical Cancer Cells</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2004.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ygyno.2004.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15297163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVeqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=283-288&issue=2&author=A.+D.+Santinauthor=S.+Cane%E2%80%99author=S.+Belloneauthor=E.+Bignottiauthor=M.+Palmieriauthor=L.+E.+De+Las+Casasauthor=J.+J.+Romanauthor=S.+Anfossiauthor=T.+O%E2%80%99Brienauthor=S.+Pecorelli&title=The+Serine+Protease+Stratum+Corneum+Chymotryptic+Enzyme+%28Kallikrein+7%29+Is+Highly+Overexpressed+in+Squamous+Cervical+Cancer+Cells&doi=10.1016%2Fj.ygyno.2004.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells</span></div><div class="casAuthors">Santin, Alessandro D.; Cane, Stefania; Bellone, Stefania; Bignotti, Eliana; Palmieri, Michela; De Las Casas, Luis E.; Roman, Juan J.; Anfossi, Simone; O'Brien, Timothy; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-288</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To det. whether the Stratum Corneum Chymotryptic Enzyme (SCCE), a novel serine protease known to contribute to the cell shedding process by catalyzing the degrdn. of intercellular cohesive structures at the skin surface, is overexpressed in human cervical tumors.  SCCE expression was evaluated in 18 cervical cancer cell lines (i.e., 10 primary and 8 established cell lines) as well as in 8 normal cervical keratinocyte cultures by RT-PCR.  In addn., SCCE expression was evaluated by immunohistochem. on paraffin-embedded tumor tissue.  Normal cervical keratinocytes did not express SCCE.  In contrast, 50% of the primary and 50% of the established cervical cancer cell lines expressed SCCE by RT-PCR.  Eighty % (i.e., 4 of five) of primary squamous cervical tumors and 20% (i.e., 1 of 5) of primary adenocarcinomas expressed SCCE.  Five out of 5 (100%) of the patients harboring SCCE-pos. tumors were found to have metastatic involvement of the pelvic tumor draining lymph nodes.  Immunohistochem. staining of paraffin-embedded cervical cancer specimens confirmed SCCE expression in tumor cells and its absence on normal cervical epithelial cells.  Squamous cervical cancer expressed high levels of SCCE, suggesting that this protease may play an important role in invasion and metastasis.  Because SCCE appears only in abundance in tumor tissue and contains a secretion signal sequence, suggesting that SCCE is secreted, it may prove to be a useful diagnostic/prognostic tool for the detection of metastatic or recurrent disease or as a novel mol. target for cervical cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrii0V4qolSQLVg90H21EOLACvtfcHk0lhIeNRFXi9pEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVeqsbc%253D&md5=6b6944b6d6dabb780d3a2cfd273b910a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2004.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2004.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DCane%25E2%2580%2599%26aufirst%3DS.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DBignotti%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DDe%2BLas%2BCasas%26aufirst%3DL.%2BE.%26aulast%3DRoman%26aufirst%3DJ.%2BJ.%26aulast%3DAnfossi%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DThe%2520Serine%2520Protease%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%2520%2528Kallikrein%25207%2529%2520Is%2520Highly%2520Overexpressed%2520in%2520Squamous%2520Cervical%2520Cancer%2520Cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2004%26volume%3D94%26issue%3D2%26spage%3D283%26epage%3D288%26doi%3D10.1016%2Fj.ygyno.2004.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, S. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsaros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigault de la Longrais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massobrio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1879</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2006.071456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1373%2Fclinchem.2006.071456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16916986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCgtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=1879-1886&issue=10&author=S.+J.+C.+Shanauthor=A.+Scorilasauthor=D.+Katsarosauthor=I.+Rigault+de+la+Longraisauthor=M.+Massobrioauthor=E.+P.+Diamandis&title=Unfavorable+Prognostic+Value+of+Human+Kallikrein+7+Quantified+by+ELISA+in+Ovarian+Cancer+Cytosols&doi=10.1373%2Fclinchem.2006.071456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols</span></div><div class="casAuthors">Shan, Shannon J. C.; Scorilas, Andreas; Katsaros, Dionyssios; Rigault de la Longrais, Irene; Massobrio, Marco; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1879-1886</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">Background: Human tissue kallikrein 7 (gene, KLK7; protein, hK7) is a member of the kallikrein family of secreted serine proteases.  Reports indicate that in ovarian cancer, KLK7 is significantly up-regulated at the mRNA level.  The aim of this study was to det. whether hK7, measured quant. by ELISA in ovarian cancer cytosols, is a prognostic biomarker for ovarian cancer.  Methods: We used a newly developed ELISA with 2 monoclonal antibodies to quantify hK7 prodn. in 260 ovarian tumor cytosols and correlated these data with various clinicopathol. variables and patient outcomes [progression-free survival (PFS) and overall survival (OS)] over a median follow-up period of 52 mo.  Results: Median (range) hK7 concn. in ovarian tumor cytosols was 2.84 (0-32.8) ng/mg of total protein.  Compared with healthy and benign ovarian tissues and non-ovarian tumors that metastasized to the ovary, malignant ovarian tumor cytosols highly overproduced hK7 (P < 0.001).  We used the median value as the cutoff value to categorize tumors as hK7-pos. and hK7-neg.  Women with hK7-pos. tumors most frequently had advanced-stage disease, higher tumor grade (G3), suboptimal debulking, and serous or undifferentiated histotype (P < 0.001).  Univariate anal. showed that hK7 positivity was assocd. with significantly shorter PFS (P = 0.01) but not OS.  Kaplan-Meier survival curves confirmed an increased risk of relapse in women with hK7-pos. tumors (P = 0.009).  In multivariate anal., hK7 was not significantly assocd. with either PFS or OS.  Conclusions: hK7 is assocd. with other unfavorable characteristics of ovarian cancer, but it is not an independent prognosticator for ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyuKmBg3wr7Vg90H21EOLACvtfcHk0lhIeNRFXi9pEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCgtb7E&md5=98d1ca862b930cbb6454c61b42db3e6d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2006.071456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2006.071456%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DS.%2BJ.%2BC.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DRigault%2Bde%2Bla%2BLongrais%26aufirst%3DI.%26aulast%3DMassobrio%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DUnfavorable%2520Prognostic%2520Value%2520of%2520Human%2520Kallikrein%25207%2520Quantified%2520by%2520ELISA%2520in%2520Ovarian%2520Cancer%2520Cytosols%26jtitle%3DClin.%2520Chem.%26date%3D2006%26volume%3D52%26issue%3D10%26spage%3D1879%26epage%3D1886%26doi%3D10.1373%2Fclinchem.2006.071456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgiotis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathioudaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span> <span> </span><span class="NLM_article-title">Expression Analysis of the Human Kallikrein 7 (KLK7) in Breast Tumors: A New Potential Biomarker for Prognosis of Breast Carcinoma</span>. <i>Thromb. Haemost.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1160/TH03-05-0261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1160%2FTH03-05-0261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=14691584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=180-186&issue=1&author=M.+Talieriauthor=E.+P.+Diamandisauthor=D.+Gourgiotisauthor=K.+Mathioudakiauthor=A.+Scorilas&title=Expression+Analysis+of+the+Human+Kallikrein+7+%28KLK7%29+in+Breast+Tumors%3A+A+New+Potential+Biomarker+for+Prognosis+of+Breast+Carcinoma&doi=10.1160%2FTH03-05-0261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: A new potential biomarker for prognosis of breast carcinoma</span></div><div class="casAuthors">Talieri, Maroulio; Diamandis, Eleftherios P.; Gourgiotis, Dimitrios; Mathioudaki, Kostandina; Scorilas, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Kallikreins are a subgroup of serine proteases that are involved in the post-translational processing of polypeptide precursors.  Growing evidence suggests that many kallikreins are implicated in carcinogenesis.  Human kallikrein gene 7 (KLK7; HSCCE) is a new member of the human kallikrein gene family.  KLK7 is expressed in normal breast tissue and is up-regulated in breast cancer cells by estrogens and glucocorticoids.  In the present study, expression of the KLK7 gene in 92 breast cancer tissues was analyzed by reverse transcription-PCR (RT-PCR) and direct sequencing of several samples.  The results were correlated with other clinicopathol. variables and patient outcome.  KLK7 gene expression was significantly lower in breast cancer patients of low stage (I/II) (p = 0.011) and patients with pos. progesterone receptors (p = 0.022).  Survival anal. showed that breast cancer patients with KLK7 pos. tumors have relatively shorter disease-free survival (DFS) and overall survival (OS) than patients with KLK7 neg. tumors.  These data suggest that KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLtnwQi8jl7Vg90H21EOLACvtfcHk0lhIeNRFXi9pEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D&md5=23134f1e50c39714b7998f39b2942263</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1160%2FTH03-05-0261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH03-05-0261%26sid%3Dliteratum%253Aachs%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DGourgiotis%26aufirst%3DD.%26aulast%3DMathioudaki%26aufirst%3DK.%26aulast%3DScorilas%26aufirst%3DA.%26atitle%3DExpression%2520Analysis%2520of%2520the%2520Human%2520Kallikrein%25207%2520%2528KLK7%2529%2520in%2520Breast%2520Tumors%253A%2520A%2520New%2520Potential%2520Biomarker%2520for%2520Prognosis%2520of%2520Breast%2520Carcinoma%26jtitle%3DThromb.%2520Haemost.%26date%3D2004%26volume%3D91%26issue%3D1%26spage%3D180%26epage%3D186%26doi%3D10.1160%2FTH03-05-0261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigemasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T. J.</span></span> <span> </span><span class="NLM_article-title">The Stratum Corneum Chymotryptic Enzyme That Mediates Shedding and Desquamation of Skin Cells Is Highly Overexpressed in Ovarian Tumor Cells</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">2074</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1999&pages=2074-2082&author=H.+Tanimotoauthor=L.+J.+Underwoodauthor=K.+Shigemasaauthor=Y.+Yanauthor=J.+Clarkeauthor=T.+H.+Parmleyauthor=T.+J.+O%E2%80%99Brien&title=The+Stratum+Corneum+Chymotryptic+Enzyme+That+Mediates+Shedding+and+Desquamation+of+Skin+Cells+Is+Highly+Overexpressed+in+Ovarian+Tumor+Cells&doi=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819991115%252986%253A10%253C2074%253A%253AAID-CNCR27%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DTanimoto%26aufirst%3DH.%26aulast%3DUnderwood%26aufirst%3DL.%2BJ.%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DParmley%26aufirst%3DT.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Stratum%2520Corneum%2520Chymotryptic%2520Enzyme%2520That%2520Mediates%2520Shedding%2520and%2520Desquamation%2520of%2520Skin%2520Cells%2520Is%2520Highly%2520Overexpressed%2520in%2520Ovarian%2520Tumor%2520Cells%26jtitle%3DCancer%26date%3D1999%26volume%3D86%26spage%3D2074%26epage%3D2082%26doi%3D10.1002%2F%28SICI%291097-0142%2819991115%2986%3A10%3C2074%3A%3AAID-CNCR27%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iakovlev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haun, R. S.</span></span> <span> </span><span class="NLM_article-title">Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-11-1079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F1055-9965.EPI-11-1079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1135-1142&issue=7&author=V.+Iakovlevauthor=E.+R.+Siegelauthor=M.-S.+Tsaoauthor=R.+S.+Haun&title=Expression+of+Kallikrein-Related+Peptidase+7+Predicts+Poor+Prognosis+in+Patients+with+Unresectable+Pancreatic+Ductal+Adenocarcinoma&doi=10.1158%2F1055-9965.EPI-11-1079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-11-1079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-11-1079%26sid%3Dliteratum%253Aachs%26aulast%3DIakovlev%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DE.%2BR.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DHaun%26aufirst%3DR.%2BS.%26atitle%3DExpression%2520of%2520Kallikrein-Related%2520Peptidase%25207%2520Predicts%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Unresectable%2520Pancreatic%2520Ductal%2520Adenocarcinoma%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2012%26volume%3D21%26issue%3D7%26spage%3D1135%26epage%3D1142%26doi%3D10.1158%2F1055-9965.EPI-11-1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T. R.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors as Promising Cancer Targets</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2016.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27000991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2016&pages=226-239&issue=2&author=Y.+Liuauthor=S.+Anauthor=R.+Wardauthor=Y.+Yangauthor=X.+X.+Guoauthor=W.+Liauthor=T.+R.+Xu&title=G+Protein-Coupled+Receptors+as+Promising+Cancer+Targets&doi=10.1016%2Fj.canlet.2016.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as promising cancer targets</span></div><div class="casAuthors">Liu, Ying; An, Su; Ward, Richard; Yang, Yang; Guo, Xiao-Xi; Li, Wei; Xu, Tian-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) regulate an array of fundamental biol. processes, such as growth, metab. and homeostasis.  Specifically, GPCRs are involved in cancer initiation and progression.  However, compared with the involvement of the epidermal growth factor receptor in cancer, that of GPCRs have been largely ignored.  Recent findings have implicated many GPCRs in tumorigenesis, tumor progression, invasion and metastasis.  Moreover, GPCRs contribute to the establishment and maintenance of a microenvironment which is permissive for tumor formation and growth, including effects upon surrounding blood vessels, signaling mols. and the extracellular matrix.  Thus, GPCRs are considered to be among the most useful drug targets against many solid cancers.  Development of selective ligands targeting GPCRs may provide novel and effective treatment strategies against cancer and some anticancer compds. are now in clin. trials.  Here, we focus on tumor related GPCRs, such as G protein-coupled receptor 30, the lysophosphatidic acid receptor, angiotensin receptors 1 and 2, the sphingosine 1-phosphate receptors and gastrin releasing peptide receptor.  We also summarize their tissue distributions, activation and roles in tumorigenesis and discuss the potential use of GPCR agonists and antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG-8ucpYwkTbVg90H21EOLACvtfcHk0lgiwyy24nSRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D&md5=c43749e81e9001a32cd6fcdf5e6a9084</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%2BX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DT.%2BR.%26atitle%3DG%2520Protein-Coupled%2520Receptors%2520as%2520Promising%2520Cancer%2520Targets%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D376%26issue%3D2%26spage%3D226%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2016.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohar, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verástegui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnik, a.</span></span> <span> </span><span class="NLM_article-title">Involvement of Chemokine Receptors in Breast Cancer Metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>410</i></span> (<span class="NLM_issue">6824</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1038/35065016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2F35065016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=50-56&issue=6824&author=a.+M%C3%BCllerauthor=B.+Homeyauthor=H.+Sotoauthor=N.+Geauthor=D.+Catronauthor=M.+E.+Buchananauthor=T.+McClanahanauthor=E.+Murphyauthor=W.+Yuanauthor=S.+N.+Wagnerauthor=J.+L.+Barreraauthor=a.+Moharauthor=E.+Ver%C3%A1steguiauthor=a.+Zlotnik&title=Involvement+of+Chemokine+Receptors+in+Breast+Cancer+Metastasis&doi=10.1038%2F35065016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F35065016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35065016%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3Da.%26aulast%3DHomey%26aufirst%3DB.%26aulast%3DSoto%26aufirst%3DH.%26aulast%3DGe%26aufirst%3DN.%26aulast%3DCatron%26aufirst%3DD.%26aulast%3DBuchanan%26aufirst%3DM.%2BE.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DWagner%26aufirst%3DS.%2BN.%26aulast%3DBarrera%26aufirst%3DJ.%2BL.%26aulast%3DMohar%26aufirst%3Da.%26aulast%3DVer%25C3%25A1stegui%26aufirst%3DE.%26aulast%3DZlotnik%26aufirst%3Da.%26atitle%3DInvolvement%2520of%2520Chemokine%2520Receptors%2520in%2520Breast%2520Cancer%2520Metastasis%26jtitle%3DNature%26date%3D2001%26volume%3D410%26issue%3D6824%26spage%3D50%26epage%3D56%26doi%3D10.1038%2F35065016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarvaiya, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabikian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span> <span> </span><span class="NLM_article-title">Chemokines in Tumor Progression and Metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2171</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.18632%2Foncotarget.1426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2171-2185&author=P.+J.+Sarvaiyaauthor=D.+Guoauthor=I.+V.+Ulasovauthor=P.+Gabikianauthor=M.+S.+Lesniak&title=Chemokines+in+Tumor+Progression+and+Metastasis&doi=10.18632%2Foncotarget.1426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1426%26sid%3Dliteratum%253Aachs%26aulast%3DSarvaiya%26aufirst%3DP.%2BJ.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DUlasov%26aufirst%3DI.%2BV.%26aulast%3DGabikian%26aufirst%3DP.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26atitle%3DChemokines%2520in%2520Tumor%2520Progression%2520and%2520Metastasis%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D2171%26epage%3D2185%26doi%3D10.18632%2Foncotarget.1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardones, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span> <span> </span><span class="NLM_article-title">Chemokine Receptors and Melanoma Metastasis</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2004.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.jdermsci.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15519136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=71-78&issue=2&author=T.+Murakamiauthor=A.+R.+Cardonesauthor=S.+T.+Hwang&title=Chemokine+Receptors+and+Melanoma+Metastasis&doi=10.1016%2Fj.jdermsci.2004.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors and melanoma metastasis</span></div><div class="casAuthors">Murakami, Takashi; Cardones, Adela R.; Hwang, Sam T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-78</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis is the end result of a complex series of biol. events that leads to the formation of clin. significant secondary tumors at distant sites.  The sites of distant metastasis are not random since certain tumors show a tendency to develop metastases in specific organs.  Human melanoma, for example, demonstrates frequent metastasis to brain, lungs, lymph nodes, and skin.  Herein, the authors review the evidence that suggests that a limited no. of chemokine receptors may play crit. roles in detg. organ-selective metastasis in melanoma by regulating diverse processes such as chemoattraction, adhesion, and survival.  In particular, the authors describe roles for CC chemokine receptor 7 (CCR7) in lymph node metastasis, CXC chemokine receptor 4 (CXCR4) in pulmonary metastasis, and CCR10 in skin metastasis, using a mouse model of melanoma.  Preliminary evidence in this preclin. model suggests that inhibiting the function of these receptors may decrease the ability of cancer cells to disseminate to other sites and/or block their ability to survive and form tumors.  Thus, manipulation of the chemokine network could have therapeutic potential in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbvCILfVH9bVg90H21EOLACvtfcHk0lgiwyy24nSRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOlsro%253D&md5=8d33fc481f4c679d39e6aba9bcad121b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DCardones%26aufirst%3DA.%2BR.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26atitle%3DChemokine%2520Receptors%2520and%2520Melanoma%2520Metastasis%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2004%26volume%3D36%26issue%3D2%26spage%3D71%26epage%3D78%26doi%3D10.1016%2Fj.jdermsci.2004.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajewicz, W.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors: Abnormalities in Signal Transmission, Disease States and Pharmacotherapy</span>. <i>Acta Polym. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.3390/ijms18122713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.3390%2Fijms18122713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=25272642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSjsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=229-243&author=M.+Zalewskaauthor=M.+Siaraauthor=W.+Sajewicz&title=G+Protein-Coupled+Receptors%3A+Abnormalities+in+Signal+Transmission%2C+Disease+States+and+Pharmacotherapy&doi=10.3390%2Fijms18122713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy</span></div><div class="casAuthors">Zalewska, Marta; Siara, Monika; Sajewicz, Waldemar</div><div class="citationInfo"><span class="NLM_cas:title">Acta Poloniae Pharmaceutica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-243, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">APPHAX</span>;
        ISSN:<span class="NLM_cas:issn">2353-5288</span>.
    
            (<span class="NLM_cas:orgname">Polish Pharmaceutical Society</span>)
        </div><div class="casAbstract">The aim of this review is to present the research results and draw new conclusions about the impact of alterations in the signal transmission through the G protein-coupled receptors (GPCRs) on the formation of diseases and drug therapy.  GPCR family is the largest and the most diverse group of membrane receptors.  They transmit signals into the cell by interaction with different ligands, which include, inter alia, hormones, neuro-transmitters, and photons.  GPCRs are responsible for the proper conduction of many physiol. processes such as vision, intercellular communication, the neuronal transmission, hormonal signaling and are involved in many pathol. processes.  They are also point on the binding pathway of multiple drugs.  They are targets of nearly one third of the drugs at the current pharmaceutical market.  The genes encoding GPCRs represent about 4% of the human genome.  Mutations that occur in them are assocd. with a broad spectrum of diseases of diverse etiol.  As a mutations result, there is a change in receptor activity (GPCR become inactive, overactive, or constitutively active), in the process of ligand binding and signal transduction.  Changes in the GPCRs functioning can cause diseases such as retinitis pigmentosa (rhodopsin mutations), nephrogenic diabetes insipidus (vasopressin receptor mutations), obesity (melanocortin receptor mutations).  Many mutational changes in genes encoding GPCR can change drug therapy of already existed diseases: heart failure (adrenergic receptors), asthma (cysteinyl leukotriene receptors).  Studies concerning the structure and function of genetically modified GPCRs allow to get know a variety of mechanisms of its action, which in turn can contribute to broaden the knowledge on the etiol. and pharmacotherapy of many currently incurable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-n_NbMzJINrVg90H21EOLACvtfcHk0lhYD9oNXbPfsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSjsLfP&md5=267cdfb8b36271fe395e1af987bb0409</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fijms18122713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18122713%26sid%3Dliteratum%253Aachs%26aulast%3DZalewska%26aufirst%3DM.%26aulast%3DSiara%26aufirst%3DM.%26aulast%3DSajewicz%26aufirst%3DW.%26atitle%3DG%2520Protein-Coupled%2520Receptors%253A%2520Abnormalities%2520in%2520Signal%2520Transmission%252C%2520Disease%2520States%2520and%2520Pharmacotherapy%26jtitle%3DActa%2520Polym.%2520Pharm.%26date%3D2014%26volume%3D71%26spage%3D229%26epage%3D243%26doi%3D10.3390%2Fijms18122713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua
Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinness, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span> <span> </span><span class="NLM_article-title">A Novel Experimental Strategy to Assess the Metabolic Effects of Selective Activation of a G <sub>q</sub> -Coupled Receptor in Hepatocytes In Vivo</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3551</span>, <span class="refDoi"> DOI: 10.1210/en.2012-2127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1210%2Fen.2012-2127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=3539-3551&issue=10&author=J.+Hua%0ALiauthor=S.+Jainauthor=S.+M.+McMillinauthor=Y.+Cuiauthor=D.+Gautamauthor=W.+Sakamotoauthor=H.+Luauthor=W.+Jouauthor=O.+P.+McGuinnessauthor=O.+Gavrilovaauthor=J.+Wess&title=A+Novel+Experimental+Strategy+to+Assess+the+Metabolic+Effects+of+Selective+Activation+of+a+G+q+-Coupled+Receptor+in+Hepatocytes+In+Vivo&doi=10.1210%2Fen.2012-2127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-2127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-2127%26sid%3Dliteratum%253Aachs%26aulast%3DHua%2BLi%26aufirst%3DJ.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DMcMillin%26aufirst%3DS.%2BM.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DGautam%26aufirst%3DD.%26aulast%3DSakamoto%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DJou%26aufirst%3DW.%26aulast%3DMcGuinness%26aufirst%3DO.%2BP.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DA%2520Novel%2520Experimental%2520Strategy%2520to%2520Assess%2520the%2520Metabolic%2520Effects%2520of%2520Selective%2520Activation%2520of%2520a%2520G%2520q%2520-Coupled%2520Receptor%2520in%2520Hepatocytes%2520In%2520Vivo%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26issue%3D10%26spage%3D3539%26epage%3D3551%26doi%3D10.1210%2Fen.2012-2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. D.</span></span> <span> </span><span class="NLM_article-title">β-Adrenoceptors as Molecular Targets in the Treatment of Hypertension</span>. <i>Can. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">S8</span>, <span class="refDoi"> DOI: 10.1016/j.cjca.2014.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.cjca.2014.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24685403" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=S3-S8&author=S.+S.+G.+Fergusonauthor=R.+D.+Feldman&title=%CE%B2-Adrenoceptors+as+Molecular+Targets+in+the+Treatment+of+Hypertension&doi=10.1016%2Fj.cjca.2014.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cjca.2014.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cjca.2014.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DFeldman%26aufirst%3DR.%2BD.%26atitle%3D%25CE%25B2-Adrenoceptors%2520as%2520Molecular%2520Targets%2520in%2520the%2520Treatment%2520of%2520Hypertension%26jtitle%3DCan.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D30%26spage%3DS3%26epage%3DS8%26doi%3D10.1016%2Fj.cjca.2014.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajewicz, W.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors: Abnormalities in Signal Transmission, Disease States and Pharmacotherapy</span>. <i>Acta Pol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=229-243&author=M.+Zalewskaauthor=M.+Siaraauthor=W.+Sajewicz&title=G+Protein-Coupled+Receptors%3A+Abnormalities+in+Signal+Transmission%2C+Disease+States+and+Pharmacotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZalewska%26aufirst%3DM.%26aulast%3DSiara%26aufirst%3DM.%26aulast%3DSajewicz%26aufirst%3DW.%26atitle%3DG%2520Protein-Coupled%2520Receptors%253A%2520Abnormalities%2520in%2520Signal%2520Transmission%252C%2520Disease%2520States%2520and%2520Pharmacotherapy%26jtitle%3DActa%2520Pol.%2520Pharm.%26date%3D2014%26volume%3D71%26spage%3D229%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.-R.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptors as Promising Cancer Targets</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2016.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27000991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2016&pages=226-239&issue=2&author=Y.+Liuauthor=S.+Anauthor=R.+Wardauthor=Y.+Yangauthor=X.-X.+Guoauthor=W.+Liauthor=T.-R.+Xu&title=G+Protein-Coupled+Receptors+as+Promising+Cancer+Targets&doi=10.1016%2Fj.canlet.2016.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as promising cancer targets</span></div><div class="casAuthors">Liu, Ying; An, Su; Ward, Richard; Yang, Yang; Guo, Xiao-Xi; Li, Wei; Xu, Tian-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) regulate an array of fundamental biol. processes, such as growth, metab. and homeostasis.  Specifically, GPCRs are involved in cancer initiation and progression.  However, compared with the involvement of the epidermal growth factor receptor in cancer, that of GPCRs have been largely ignored.  Recent findings have implicated many GPCRs in tumorigenesis, tumor progression, invasion and metastasis.  Moreover, GPCRs contribute to the establishment and maintenance of a microenvironment which is permissive for tumor formation and growth, including effects upon surrounding blood vessels, signaling mols. and the extracellular matrix.  Thus, GPCRs are considered to be among the most useful drug targets against many solid cancers.  Development of selective ligands targeting GPCRs may provide novel and effective treatment strategies against cancer and some anticancer compds. are now in clin. trials.  Here, we focus on tumor related GPCRs, such as G protein-coupled receptor 30, the lysophosphatidic acid receptor, angiotensin receptors 1 and 2, the sphingosine 1-phosphate receptors and gastrin releasing peptide receptor.  We also summarize their tissue distributions, activation and roles in tumorigenesis and discuss the potential use of GPCR agonists and antagonists in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG-8ucpYwkTbVg90H21EOLACvtfcHk0lhYD9oNXbPfsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOjs7c%253D&md5=c43749e81e9001a32cd6fcdf5e6a9084</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.-X.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DT.-R.%26atitle%3DG%2520Protein-Coupled%2520Receptors%2520as%2520Promising%2520Cancer%2520Targets%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D376%26issue%3D2%26spage%3D226%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2016.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">G-Protein-Coupled Receptors and Melanoma</span>. <i>Pigm. Cell Melanoma Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1111/j.1755-148X.2008.00478.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1111%2Fj.1755-148X.2008.00478.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=18582227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCks73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=415-428&issue=4&author=H.+J.+Leeauthor=B.+Wallauthor=S.+Chen&title=G-Protein-Coupled+Receptors+and+Melanoma&doi=10.1111%2Fj.1755-148X.2008.00478.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">G-protein-coupled receptors and melanoma</span></div><div class="casAuthors">Lee, Hwa Jin; Wall, Brian; Chen, Suzie</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-428</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCR) are the largest family of receptors with over 500 members.  Evaluation of GPCR gene expression in primary human tumors identified over-expression of GPCR in several tumor types.  Anal. of cancer samples in different disease stages also suggests that some GPCR may be involved in early tumor progression and others may play a crit. role in tumor invasion and metastasis.  Currently, >50% of drug targets to various human diseases are based on GPCR.  In this review, the relationships between several GPCR and melanoma development and/or progression will be discussed.  Finally, the possibility of using one or more of these GPCR as therapeutic targets in melanoma will be summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpivjWhlj9bVg90H21EOLACvtfcHk0lgF_Dh314VQnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCks73P&md5=bf14619fa21bd97920f9a92a56dfafd6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2008.00478.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2008.00478.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DWall%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DG-Protein-Coupled%2520Receptors%2520and%2520Melanoma%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2008%26volume%3D21%26issue%3D4%26spage%3D415%26epage%3D428%26doi%3D10.1111%2Fj.1755-148X.2008.00478.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rask-Andersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">Trends in GPCR Drug Discovery: New Agents, Targets and Indications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd.2017.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=29075003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=829-842&issue=12&author=A.+S.+Hauserauthor=M.+M.+Attwoodauthor=M.+Rask-Andersenauthor=H.+B.+Schi%C3%B6thauthor=D.+E.+Gloriam&title=Trends+in+GPCR+Drug+Discovery%3A+New+Agents%2C+Targets+and+Indications&doi=10.1038%2Fnrd.2017.178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in GPCR drug discovery: new agents, targets and indications</span></div><div class="casAuthors">Hauser, Alexander S.; Attwood, Misty M.; Rask-Andersen, Mathias; Schioth, Helgi B.; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">829-842</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are the most intensively studied drug targets, mostly due to their substantial involvement in human pathophysiol. and their pharmacol. tractability.  Here, we report an up-to-date anal. of all GPCR drugs and agents in clin. trials, which reveals current trends across mol. types, drug targets and therapeutic indications, including showing that 475 drugs (∼34% of all drugs approved by the US Food and Drug Administration (FDA)) act at 108 unique GPCRs.  Approx. 321 agents are currently in clin. trials, of which ∼20% target 66 potentially novel GPCR targets without an approved drug, and the no. of biol. drugs, allosteric modulators and biased agonists has increased.  The major disease indications for GPCR modulators show a shift towards diabetes, obesity and Alzheimer disease, although several central nervous system disorders are also highly represented.  The 224 (56%) non-olfactory GPCRs that have not yet been explored in clin. trials have broad untapped therapeutic potential, particularly in genetic and immune system disorders.  Finally, we provide an interactive online resource to analyze and infer trends in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9iw1QqR9GKrVg90H21EOLACvtfcHk0lgF_Dh314VQnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansbzF&md5=560893258493bd96c0af24d3bef08b6f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.178%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DAttwood%26aufirst%3DM.%2BM.%26aulast%3DRask-Andersen%26aufirst%3DM.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DTrends%2520in%2520GPCR%2520Drug%2520Discovery%253A%2520New%2520Agents%252C%2520Targets%2520and%2520Indications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D12%26spage%3D829%26epage%3D842%26doi%3D10.1038%2Fnrd.2017.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. K.</span></span> <span> </span><span class="NLM_article-title">Chemokines in Tumor Angiogenesis and Metastasis</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1007/s10555-007-9068-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10555-007-9068-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17828470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=453-467&issue=3%E2%80%934&author=S.+Singhauthor=A.+Sadanandamauthor=R.+K.+Singh&title=Chemokines+in+Tumor+Angiogenesis+and+Metastasis&doi=10.1007%2Fs10555-007-9068-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines in tumor angiogenesis and metastasis</span></div><div class="casAuthors">Singh, Seema; Sadanandam, Anguraj; Singh, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">453-467</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Chemokines are a large group of low mol. wt. cytokines that are known to selectively attract and activate different cell types.  Although the primary function of chemokines is well recognized as leukocyte attractants, recent evidences indicate that they also play a role in no. of tumor-related processes, such as growth, angiogenesis and metastasis.  Chemokines activate cells through cell surface seven trans-membranes, G-protein-coupled receptors (GPCR).  The role played by chemokines and their receptors in tumor pathophysiol. is complex as some chemokines favor tumor growth and metastasis, while others may enhance anti-tumor immunity.  These diverse functions of chemokines establish them as key mediators between the tumor cells and their microenvironment and play crit. role in tumor progression and metastasis.  In this review, we present some of the recent advances in chemokine research with special emphasis on its role in tumor angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIrEg2peMUvbVg90H21EOLACvtfcHk0lgF_Dh314VQnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yktLbL&md5=9b8a51c31679ed1f9764ef8a77e40983</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9068-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9068-9%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DSadanandam%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DChemokines%2520in%2520Tumor%2520Angiogenesis%2520and%2520Metastasis%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26issue%3D3%25E2%2580%25934%26spage%3D453%26epage%3D467%26doi%3D10.1007%2Fs10555-007-9068-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span> <span> </span><span class="NLM_article-title">Cancer and the Chemokine Network</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrc1388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrc1388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15229479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=540-550&issue=7&author=F.+Balkwill&title=Cancer+and+the+Chemokine+Network&doi=10.1038%2Fnrc1388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer and the chemokine network</span></div><div class="casAuthors">Balkwill, Fran</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">540-550</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A complex network of chemokines and their receptors influences the development of primary tumors and metastases.  New information about the biol. role of chemokines in these processes is providing insights into host-tumor interactions, such as the role of the leukocyte infiltrate, and into the mechanisms that det. the metastatic potential and site-specific spread of cancer cells.  Chemokine-receptor antagonists are showing promise in animal models of inflammation and autoimmune disease.  Could manipulating the local chemokine network have therapeutic benefits in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYhFsIM97vbVg90H21EOLACvtfcHk0lgF_Dh314VQnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D&md5=a827ffe8e02074fed068557c4c8dec11</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrc1388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1388%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer%2520and%2520the%2520Chemokine%2520Network%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D7%26spage%3D540%26epage%3D550%26doi%3D10.1038%2Fnrc1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. C.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">8604</span>– <span class="NLM_lpage">8612</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F0008-5472.CAN-04-1844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8604-8612&issue=23&author=M.+C.%0AP.+Smithauthor=K.+E.+Lukerauthor=J.+R.+Garbowauthor=J.+L.+Priorauthor=E.+Jacksonauthor=D.+Piwnica-Wormsauthor=G.+D.+Luker&title=CXCR4+Regulates+Growth+of+Both+Primary+and+Metastatic+Breast+Cancer&doi=10.1158%2F0008-5472.CAN-04-1844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1844%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BC.%2BP.%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DGarbow%26aufirst%3DJ.%2BR.%26aulast%3DPrior%26aufirst%3DJ.%2BL.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DCXCR4%2520Regulates%2520Growth%2520of%2520Both%2520Primary%2520and%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D23%26spage%3D8604%26epage%3D8612%26doi%3D10.1158%2F0008-5472.CAN-04-1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabioglu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglio, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortobagyi, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, A.</span></span> <span> </span><span class="NLM_article-title">CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5686</span>– <span class="NLM_lpage">5693</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1158%2F1078-0432.CCR-05-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16115904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1CjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5686-5693&author=N.+Cabiogluauthor=M.+S.+Yaziciauthor=B.+Arunauthor=K.+R.+Broglioauthor=G.+N.+Hortobagyiauthor=J.+E.+Priceauthor=A.+Sahin&title=CCR7+and+CXCR4+as+Novel+Biomarkers+Predicting+Axillary+Lymph+Node+Metastasis+in+T1+Breast+Cancer&doi=10.1158%2F1078-0432.CCR-05-0014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer</span></div><div class="casAuthors">Cabioglu, Neslihan; Yazici, M. Sertac; Arun, Banu; Broglio, Kristine R.; Hortobagyi, Gabriel N.; Price, Janet E.; Sahin, Aysegul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5686-5693</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The chemokine receptors CCR7 and CXCR4 have been shown to play an important role in cancer metastasis.  We therefore studied the differential expression of CCR7 and CXCR4, along with that of the biomarker HER2-neu, to evaluate whether these biomarkers could predict axillary lymph node metastasis in breast cancer.  Biomarker expression levels were evaluated using paraffin-embedded tissue sections of lymph node-neg. (n = 99) and lymph node-pos. (n = 98) T1 breast cancer by immunohistochem. staining.  Lymph node-pos. tumors showed higher rates of high cytoplasmic CCR7 staining (21.5% vs. 8.5%, P = 0.013) and HER2-neu overexpression (21.5% vs. 9.3%, P = 0.019) than did lymph node-neg. tumors.  Similarly, high cytoplasmic CXCR4 expression occurred more commonly in lymph node-pos. tumors (11.2% vs. 5.1%, P = 0.113).  In contrast, predominantly nuclear CXCR4 staining was more likely to be found in lymph node-neg. tumors (54.5% vs. 37.8%, P = 0.018).  Furthermore, cytoplasmic CXCR4 coexpressed with HER2-neu was the only factor assocd. with involvement of four or more lymph nodes (16.7% vs. 1.2%, P = 0.04) among lymph node-pos. tumors.  When all three biomarkers (CCR7, CXCR4, HER2-neu) were utilized together, 50.0% of lymph node-pos. tumors highly expressed one of these biomarkers compared with 18.8% of the lymph node-neg. tumors (P < 0.0001) These results suggest that the chemokine receptor CCR7 is a novel biomarker that can predict lymph node metastases in breast cancer.  Utilization of addnl. markers, such as CXCR4 and HER2-neu, further improves the prediction of the presence and extent of lymph node involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXsChhVGu1rVg90H21EOLACvtfcHk0lgFn0wHAkkJGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1CjsL4%253D&md5=de745effe766513b6ceb20fff6976a36</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0014%26sid%3Dliteratum%253Aachs%26aulast%3DCabioglu%26aufirst%3DN.%26aulast%3DYazici%26aufirst%3DM.%2BS.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DBroglio%26aufirst%3DK.%2BR.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DPrice%26aufirst%3DJ.%2BE.%26aulast%3DSahin%26aufirst%3DA.%26atitle%3DCCR7%2520and%2520CXCR4%2520as%2520Novel%2520Biomarkers%2520Predicting%2520Axillary%2520Lymph%2520Node%2520Metastasis%2520in%2520T1%2520Breast%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D5686%26epage%3D5693%26doi%3D10.1158%2F1078-0432.CCR-05-0014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaizumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atogami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomonaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamihira, S.</span></span> <span> </span><span class="NLM_article-title">Survey of Chemokine Receptor Expression Reveals Frequent Co-Expression of Skin-Homing CCR4 and CCR10 in Adult T-Cell Leukemia/lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1080/10428190600775599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1080%2F10428190600775599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17071491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCiu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=2163-2173&issue=10&author=H.+Harasawaauthor=Y.+Yamadaauthor=K.+Hieshimaauthor=Z.+Jinauthor=T.+Nakayamaauthor=O.+Yoshieauthor=K.+Shimizuauthor=H.+Hasegawaauthor=T.+Hayashiauthor=Y.+Imaizumiauthor=S.+Ikedaauthor=H.+Sodaauthor=H.+Sodaauthor=S.+Atogamiauthor=Y.+Takasakiauthor=K.+Tsukasakiauthor=M.+Tomonagaauthor=K.+Murataauthor=K.+Sugaharaauthor=K.+Tsurudaauthor=S.+Kamihira&title=Survey+of+Chemokine+Receptor+Expression+Reveals+Frequent+Co-Expression+of+Skin-Homing+CCR4+and+CCR10+in+Adult+T-Cell+Leukemia%2Flymphoma&doi=10.1080%2F10428190600775599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma</span></div><div class="casAuthors">Harasawa, Hitomi; Yamada, Yasuaki; Hieshima, Kunio; Jin, Zhe; Nakayama, Takashi; Yoshie, Osamu; Shimizu, Kazuhiro; Hasegawa, Hiroo; Hayashi, Tomayoshi; Imaizumi, Yoshitaka; Ikeda, Shuichi; Soda, Hiroshi; Soda, Hisashi; Atogami, Sunao; Takasaki, Yumi; Tsukasaki, Kunihiro; Tomonaga, Masao; Murata, Ken; Sugahara, Kazuyuki; Tsuruda, Kazuto; Kamihira, Shimeru</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2163-2173</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Adult T-cell leukemia/lymphoma (ATLL) is a malignancy of mature T-cell origin with multi-organ involvement.  Because the chemokine receptors play crucial roles in tissue-specific homing of mature lymphocytes, particular chemokine receptors expressed on ATLL cells may be involved in their tissue infiltration.  We thus performed a comprehensive survey on the chemokine receptor expression in ATLL.  ATLL cells expressed transcripts of CCR1, CCR4, CCR7, CCR8, CCR10 and CXCR4 but hardly expressed those of CCR2, CCR3, CCR5, CCR6, CCR9, CXCR1, CXCR2, CXCR3 and CXCR5.  These results were confirmed at the protein level by flow cytometric anal.  Notably, patients who have skin lesions showed significantly higher levels of CCR10 mRNA expression than patients without skin lesions.  ATLL cells migrated efficiently to the CCR4 ligand, CCL22, and moderately to the CCR10 ligands, CCL27 and CCL28.  Moreover, ATLL skin lesions consistently contained transcripts of CCR10 and its ligands CCL27 and CCL28 besides those of CCR4 and its ligands CCL17 and CCL22 that have been reported previously.  Collectively, the frequent co-expression of CCR4 and CCR10, the known pair of skin-homing chemokine receptors, may play an important role in ATLL invasion into the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi6_rcnXSHsrVg90H21EOLACvtfcHk0lgFn0wHAkkJGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCiu7%252FO&md5=3ef92d2575c6dbb0c28dbb2f94737841</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F10428190600775599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190600775599%26sid%3Dliteratum%253Aachs%26aulast%3DHarasawa%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHieshima%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DImaizumi%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DH.%26aulast%3DSoda%26aufirst%3DH.%26aulast%3DAtogami%26aufirst%3DS.%26aulast%3DTakasaki%26aufirst%3DY.%26aulast%3DTsukasaki%26aufirst%3DK.%26aulast%3DTomonaga%26aufirst%3DM.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DK.%26aulast%3DKamihira%26aufirst%3DS.%26atitle%3DSurvey%2520of%2520Chemokine%2520Receptor%2520Expression%2520Reveals%2520Frequent%2520Co-Expression%2520of%2520Skin-Homing%2520CCR4%2520and%2520CCR10%2520in%2520Adult%2520T-Cell%2520Leukemia%252Flymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2006%26volume%3D47%26issue%3D10%26spage%3D2163%26epage%3D2173%26doi%3D10.1080%2F10428190600775599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieramici, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offidani, A.</span></span> <span> </span><span class="NLM_article-title">Potential Role of CCL27 and CCR10 Expression in Melanoma Progression and Immune Escape</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ejca.2006.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=1181-1187&issue=8&author=O.+Simonettiauthor=G.+Goteriauthor=G.+Lucariniauthor=A.+Filosaauthor=T.+Pieramiciauthor=C.+Rubiniauthor=G.+Biaginiauthor=A.+Offidani&title=Potential+Role+of+CCL27+and+CCR10+Expression+in+Melanoma+Progression+and+Immune+Escape&doi=10.1016%2Fj.ejca.2006.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DSimonetti%26aufirst%3DO.%26aulast%3DGoteri%26aufirst%3DG.%26aulast%3DLucarini%26aufirst%3DG.%26aulast%3DFilosa%26aufirst%3DA.%26aulast%3DPieramici%26aufirst%3DT.%26aulast%3DRubini%26aufirst%3DC.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DOffidani%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520CCL27%2520and%2520CCR10%2520Expression%2520in%2520Melanoma%2520Progression%2520and%2520Immune%2520Escape%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26issue%3D8%26spage%3D1181%26epage%3D1187%26doi%3D10.1016%2Fj.ejca.2006.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">290</span>, <span class="refDoi"> DOI: 10.3390/md15090290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.3390%2Fmd15090290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=290&issue=9&author=F.+H.+Al-Awadhiauthor=L.+A.+Salvadorauthor=B.+K.+Lawauthor=V.+J.+Paulauthor=H.+Luesch&title=Kempopeptin+C%2C+a+Novel+Marine-Derived+Serine+Protease+Inhibitor+Targeting+Invasive+Breast+Cancer&doi=10.3390%2Fmd15090290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmd15090290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd15090290%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DSalvador%26aufirst%3DL.%2BA.%26aulast%3DLaw%26aufirst%3DB.%2BK.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DKempopeptin%2520C%252C%2520a%2520Novel%2520Marine-Derived%2520Serine%2520Protease%2520Inhibitor%2520Targeting%2520Invasive%2520Breast%2520Cancer%26jtitle%3DMar.%2520Drugs%26date%3D2017%26volume%3D15%26issue%3D9%26spage%3D290%26doi%3D10.3390%2Fmd15090290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Grassystatins D–F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2986</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=2969-2986&issue=11&author=F.+H.+Al-Awadhiauthor=B.+K.+Lawauthor=V.+J.+Paulauthor=H.+Luesch&title=Grassystatins+D%E2%80%93F%2C+Potent+Aspartic+Protease+Inhibitors+from+Marine+Cyanobacteria+as+Potential+Antimetastatic+Agents+Targeting+Invasive+Breast+Cancer&doi=10.1021%2Facs.jnatprod.7b00551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00551%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DLaw%26aufirst%3DB.%2BK.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DGrassystatins%2520D%25E2%2580%2593F%252C%2520Potent%2520Aspartic%2520Protease%2520Inhibitors%2520from%2520Marine%2520Cyanobacteria%2520as%2520Potential%2520Antimetastatic%2520Agents%2520Targeting%2520Invasive%2520Breast%2520Cancer%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26issue%3D11%26spage%3D2969%26epage%3D2986%26doi%3D10.1021%2Facs.jnatprod.7b00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratnayake, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Tasiamide F, a Potent Inhibitor of Cathepsins D and E from a Marine Cyanobacterium</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3276</span>– <span class="NLM_lpage">3282</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.bmc.2016.04.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3276-3282&issue=15&author=F.+H.+Al-Awadhiauthor=R.+Ratnayakeauthor=V.+J.+Paulauthor=H.+Luesch&title=Tasiamide+F%2C+a+Potent+Inhibitor+of+Cathepsins+D+and+E+from+a+Marine+Cyanobacterium&doi=10.1016%2Fj.bmc.2016.04.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.062%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DRatnayake%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DTasiamide%2520F%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Cathepsins%2520D%2520and%2520E%2520from%2520a%2520Marine%2520Cyanobacterium%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D15%26spage%3D3276%26epage%3D3282%26doi%3D10.1016%2Fj.bmc.2016.04.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. T.</span></span> <span> </span><span class="NLM_article-title">Bioactive Natural Products from Marine Cyanobacteria for Drug Discovery</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2007.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.phytochem.2007.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=954-979&issue=7&author=L.+T.+Tan&title=Bioactive+Natural+Products+from+Marine+Cyanobacteria+for+Drug+Discovery&doi=10.1016%2Fj.phytochem.2007.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%2BT.%26atitle%3DBioactive%2520Natural%2520Products%2520from%2520Marine%2520Cyanobacteria%2520for%2520Drug%2520Discovery%26jtitle%3DPhytochemistry%26date%3D2007%26volume%3D68%26issue%3D7%26spage%3D954%26epage%3D979%26doi%3D10.1016%2Fj.phytochem.2007.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sitachitta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Grenadadiene and Grenadamide, Cyclopropyl-Containing Fatty Acid Metabolites from the Marine Cyanobacterium <i>Lyngbya majuscula</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1021/np970576a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np970576a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=681-684&issue=5&author=N.+Sitachittaauthor=W.+H.+Gerwick&title=Grenadadiene+and+Grenadamide%2C+Cyclopropyl-Containing+Fatty+Acid+Metabolites+from+the+Marine+Cyanobacterium+Lyngbya+majuscula&doi=10.1021%2Fnp970576a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp970576a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp970576a%26sid%3Dliteratum%253Aachs%26aulast%3DSitachitta%26aufirst%3DN.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DGrenadadiene%2520and%2520Grenadamide%252C%2520Cyclopropyl-Containing%2520Fatty%2520Acid%2520Metabolites%2520from%2520the%2520Marine%2520Cyanobacterium%2520Lyngbya%2520majuscula%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26issue%3D5%26spage%3D681%26epage%3D684%26doi%3D10.1021%2Fnp970576a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Semiplenamides A-G, Fatty Acid Amides from a Papua New Guinea Collection of the Marine Cyanobacterium <i>Lyngbya semiplena</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1021/np030242n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030242n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1364-1368&issue=10&author=B.+Hanauthor=K.+L.+McPhailauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Semiplenamides+A-G%2C+Fatty+Acid+Amides+from+a+Papua+New+Guinea+Collection+of+the+Marine+Cyanobacterium+Lyngbya+semiplena&doi=10.1021%2Fnp030242n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fnp030242n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030242n%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DB.%26aulast%3DMcPhail%26aufirst%3DK.%2BL.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DSemiplenamides%2520A-G%252C%2520Fatty%2520Acid%2520Amides%2520from%2520a%2520Papua%2520New%2520Guinea%2520Collection%2520of%2520the%2520Marine%2520Cyanobacterium%2520Lyngbya%2520semiplena%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2003%26volume%3D66%26issue%3D10%26spage%3D1364%26epage%3D1368%26doi%3D10.1021%2Fnp030242n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montaser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2676</span>– <span class="NLM_lpage">2681</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fcbic.201200502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=2676-2681&issue=18&author=R.+Montaserauthor=V.+J.+Paulauthor=H.+Luesch&title=Marine+Cyanobacterial+Fatty+Acid+Amides+Acting+on+Cannabinoid+Receptors&doi=10.1002%2Fcbic.201200502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200502%26sid%3Dliteratum%253Aachs%26aulast%3DMontaser%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DMarine%2520Cyanobacterial%2520Fatty%2520Acid%2520Amides%2520Acting%2520on%2520Cannabinoid%2520Receptors%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D18%26spage%3D2676%26epage%3D2681%26doi%3D10.1002%2Fcbic.201200502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debonsi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Cannabinomimetic Lipid from a Marine Cyanobacterium</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2317</span>, <span class="refDoi"> DOI: 10.1021/np200610t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200610t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=2313-2317&issue=10&author=M.+Guti%C3%A9rrezauthor=A.+R.+Pereiraauthor=H.+M.+Debonsiauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Cannabinomimetic+Lipid+from+a+Marine+Cyanobacterium&doi=10.1021%2Fnp200610t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fnp200610t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200610t%26sid%3Dliteratum%253Aachs%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DDebonsi%26aufirst%3DH.%2BM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DCannabinomimetic%2520Lipid%2520from%2520a%2520Marine%2520Cyanobacterium%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26issue%3D10%26spage%3D2313%26epage%3D2317%26doi%3D10.1021%2Fnp200610t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mevers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matainaho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allara’, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium <i>Moorea bouillonii</i></span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1007/s11745-014-3949-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs11745-014-3949-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=25204580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFagtrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=1127-1132&issue=11&author=E.+Meversauthor=T.+Matainahoauthor=M.+Allara%E2%80%99author=V.+Di+Marzoauthor=W.+H.+Gerwick&title=Mooreamide+A%3A+A+Cannabinomimetic+Lipid+from+the+Marine+Cyanobacterium+Moorea+bouillonii&doi=10.1007%2Fs11745-014-3949-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Mooreamide A: a cannabinomimetic lipid from the marine cyanobacterium Moorea bouillonii</span></div><div class="casAuthors">Mevers, Emily; Matainaho, Teatulohi; Allara, Marco; Di Marzo, Vincenzo; Gerwick, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1127-1132</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of a collection of Moorea bouillonii from Papua New Guinea led to the isolation of a new alkyl amide, mooreamide A (I), along with the cytotoxic apratoxins A-C and E.  The planar structure of 1 was elucidated by NMR spectroscopy and mass spectrometry anal.  Structural homol. between mooreamide A and the endogenous cannabinoid ligands anandamide and 2-arachidonoyl glycerol inspired its evaluation against the neuroreceptors CB1 and CB2.  Mooreamide A was found to possess relatively potent and selective ligand binding activity to CB1 (K1 = 0.47 μM) vs. CB2 (K1 > 25 μM).  This represents the most potent marine-derived CB1 ligand described to date and adds to the growing family of marine metabolites that exhibit cannabinomimetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzlYqflvknrVg90H21EOLACvtfcHk0lhvCXJwf2Sk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFagtrjP&md5=69e1d123708fdda592f585d0ff667a5a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs11745-014-3949-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11745-014-3949-9%26sid%3Dliteratum%253Aachs%26aulast%3DMevers%26aufirst%3DE.%26aulast%3DMatainaho%26aufirst%3DT.%26aulast%3DAllara%25E2%2580%2599%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DMooreamide%2520A%253A%2520A%2520Cannabinomimetic%2520Lipid%2520from%2520the%2520Marine%2520Cyanobacterium%2520Moorea%2520bouillonii%26jtitle%3DLipids%26date%3D2014%26volume%3D49%26issue%3D11%26spage%3D1127%26epage%3D1132%26doi%3D10.1007%2Fs11745-014-3949-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lax, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatz, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadafora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidgewell, K. J.</span></span> <span> </span><span class="NLM_article-title">Marine Cyanobacteria-Derived Serotonin Receptor 2C Active Fraction Induces Psychoactive Behavioral Effects in Mice</span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2731</span>, <span class="refDoi"> DOI: 10.1080/13880209.2016.1181659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1080%2F13880209.2016.1181659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=27181630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFKqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=2723-2731&issue=11&author=N.+C.+Laxauthor=K.+T.+Ahmedauthor=C.+M.+Ignatzauthor=C.+Spadaforaauthor=B.+J.+Kolberauthor=K.+J.+Tidgewell&title=Marine+Cyanobacteria-Derived+Serotonin+Receptor+2C+Active+Fraction+Induces+Psychoactive+Behavioral+Effects+in+Mice&doi=10.1080%2F13880209.2016.1181659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Marine cyanobacteria-derived serotonin receptor 2C active fraction induces psychoactive behavioral effects in mice</span></div><div class="casAuthors">Lax, Neil C.; Ahmed, Kh Tanvir; Ignatz, Christopher M.; Spadafora, Carmenza; Kolber, Benedict J.; Tidgewell, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biology (Abingdon, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2723-2731</span>CODEN:
                <span class="NLM_cas:coden">PHBIFC</span>;
        ISSN:<span class="NLM_cas:issn">1388-0209</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Marine cyanobacteria offer a robust resource for natural products drug discovery due to the secondary metabolites they produce.  To identify novel cyanobacterial compds. that exhibit CNS psychoactive effects.  Cyanobacteria were collected from Las Perlas Archipelago, Panama and subjected to dichloromethane/methanol extn. and fractionation by column chromatog. before being screened for affinity against a panel of CNS targets.  A 50:50 Et acetate:methanol fraction of one cyanobacterial ext. (2064H) was subjected to HPLC and the major peak was isolated (2064H3).  At a dose of 20 μg per animal, 2064H and 2064H3 were tested in mice using behavioral assays that included the forced swim, open field and formalin tests.  2064H was shown to bind to the serotonin 2C (5-HT2C) receptor, a known target for depression and pain treatment.  2064H showed 59.6% inhibition of binding of [3H]-mesulergine with an IC50 value of 179 ng/mL and did not show inhibition of binding greater than 45% with any other receptors tested.  Both 2064H and 2064H3 decreased immobility time in the first minute of the tail suspension test.  Overall, manipulating the 5-HT2C receptor with these receptor-specific ligands derived from cyanobacteria altered pain, depression and anxiety-like behaviors, illustrating the importance of this receptor in affective behaviors.  These results demonstrate the potential of cyanobacteria as a source for CNS active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2T0QsMFLQ4rVg90H21EOLACvtfcHk0lhvCXJwf2Sk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFKqu7g%253D&md5=5bced9995204ac2d5f5feee471bc7478</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F13880209.2016.1181659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13880209.2016.1181659%26sid%3Dliteratum%253Aachs%26aulast%3DLax%26aufirst%3DN.%2BC.%26aulast%3DAhmed%26aufirst%3DK.%2BT.%26aulast%3DIgnatz%26aufirst%3DC.%2BM.%26aulast%3DSpadafora%26aufirst%3DC.%26aulast%3DKolber%26aufirst%3DB.%2BJ.%26aulast%3DTidgewell%26aufirst%3DK.%2BJ.%26atitle%3DMarine%2520Cyanobacteria-Derived%2520Serotonin%2520Receptor%25202C%2520Active%2520Fraction%2520Induces%2520Psychoactive%2520Behavioral%2520Effects%2520in%2520Mice%26jtitle%3DPharm.%2520Biol.%26date%3D2016%26volume%3D54%26issue%3D11%26spage%3D2723%26epage%3D2731%26doi%3D10.1080%2F13880209.2016.1181659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Awadhi, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fcbic.201700627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=29405541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=815-825&author=F.+H.+Al-Awadhiauthor=V.+J.+Paulauthor=H.+Luesch&title=Structural+Diversity+and+Anticancer+Activity+of+Marine-Derived+Elastase+Inhibitors%3A+Key+Features+and+Mechanisms+Mediating+the+Antimetastatic+Effects+in+Invasive+Breast+Cancer&doi=10.1002%2Fcbic.201700627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer</span></div><div class="casAuthors">Al-Awadhi, Fatma H.; Paul, Valerie J.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-825</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three new 3-amino-6-hydroxy-2-piperidone (Ahp)-contg. cyclic depsipeptides, named loggerpeptins A-C (1-3), along with molassamide (4), were discovered from a marine cyanobacterium, extending the structural diversity of this prevalent scaffold of cyanobacterial serine protease inhibitors.  Molassamide, which contains a 2-amino-butenoic (Abu) unit in the cyclic core, was the most potent and selective analog against human neutrophil elastase (HNE).  Given the growing evidence supporting the role of HNE in breast cancer progression and metastasis, we assessed the cellular effects of compds. 3 and 4 in the context of targeting invasive breast cancer.  Both compds. inhibited cleavage of the elastase substrate CD40 in biochem. assays; however, only 4 exhibited significant cellular activity.  As CD40 and other receptor proteolytic processing culminates in NFκB activation, we assessed the effects of 4 on the expression of target genes, including ICAM-1.  ICAM-1 is also a direct target of elastase and, in our studies, compd. 4 attenuated both elastase-induced ICAM-1 gene expression and ICAM-1 proteolytic processing by elastase, revealing a potential dual effect on migration through modulation of gene expression and proteolytic processing.  Molassamide also specifically inhibited the elastase-mediated migration of highly invasive triple-neg. breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Bv5EyZFddbVg90H21EOLACvtfcHk0lhvCXJwf2Sk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlSrurg%253D&md5=bb59c45f50f29812b680e4433f72c95c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700627%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Awadhi%26aufirst%3DF.%2BH.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DStructural%2520Diversity%2520and%2520Anticancer%2520Activity%2520of%2520Marine-Derived%2520Elastase%2520Inhibitors%253A%2520Key%2520Features%2520and%2520Mechanisms%2520Mediating%2520the%2520Antimetastatic%2520Effects%2520in%2520Invasive%2520Breast%2520Cancer%26jtitle%3DChemBioChem%26date%3D2018%26volume%3D19%26spage%3D815%26epage%3D825%26doi%3D10.1002%2Fcbic.201700627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Utility of Kallikrein-Related Peptidases (KLKs) as Cancer Biomarkers</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1600</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2008.105189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1373%2Fclinchem.2008.105189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=18687738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CiurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=1600-1607&issue=10&author=N.+Emamiauthor=E.+P.+Diamandis&title=Utility+of+Kallikrein-Related+Peptidases+%28KLKs%29+as+Cancer+Biomarkers&doi=10.1373%2Fclinchem.2008.105189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers</span></div><div class="casAuthors">Emami, Nashmil; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1600-1607</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">A review.  The human kallikrein-related peptidase (KLK) family consists of 15 highly conserved serine proteases, which are encoded by the largest uninterrupted cluster of protease genes in the human genome.  To date, several members of the family have been reported as potential cancer biomarkers.  Although primarily known for their biomarker value in prostate, ovarian, and breast cancers, more recent data suggest analogous roles of KLKs in several other cancers, including gastrointestinal, head and neck, lung, and brain malignancies.  Among the proposed KLK cancer biomarkers, prostate-specific antigen (also known as KLK3) is the most widely recognized member in urol. oncol.  Despite substantial progress in the understanding of the biomarker utility of individual KLKs, the current challenge lies in devising biomarker panels to increase the accuracy of prognosis, prediction of therapy, and diagnosis.  To date, multiparametric KLK panels have been proposed for prostate, ovarian, and lung cancers.  In addn. to their biomarker utility, emerging evidence has revealed a no. of crit. functional roles for KLKs in the pathogenesis of cancer and their potential use as therapeutic targets.  KLKs have biomarker utility in many cancer types but individually lack sufficient specificity or sensitivity to be used in clin. practice; however, groups of KLKs and other candidate biomarkers may offer improved performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTfLyJ0y_4IrVg90H21EOLACvtfcHk0lggSjq6ju1u_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CiurnF&md5=500cc078593c60ebbdef0660a70f6054</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2008.105189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2008.105189%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DUtility%2520of%2520Kallikrein-Related%2520Peptidases%2520%2528KLKs%2529%2520as%2520Cancer%2520Biomarkers%26jtitle%3DClin.%2520Chem.%26date%3D2008%26volume%3D54%26issue%3D10%26spage%3D1600%26epage%3D1607%26doi%3D10.1373%2Fclinchem.2008.105189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obiezu, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">Human Tissue Kallikrein Gene Family: Applications in Cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>224</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2004.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.canlet.2004.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15911097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2005&pages=1-22&issue=1&author=C.+V.+Obiezuauthor=E.+P.+Diamandis&title=Human+Tissue+Kallikrein+Gene+Family%3A+Applications+in+Cancer&doi=10.1016%2Fj.canlet.2004.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Human tissue kallikrein gene family: applications in cancer</span></div><div class="casAuthors">Obiezu, Christina V.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes.  Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes.  These genes, and their protein products, share a high degree of homol. and are expressed in a wide array of tissues, mainly those that are under steroid hormone control.  PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker.  In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been assocd. with several types of cancer.  For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer.  New evidence raises the possibility that some kallikreins are directly involved with cancer progression.  We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVQ3Ly8oHCbVg90H21EOLACvtfcHk0lggSjq6ju1u_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D&md5=837a7e70ff67c0e7d17986f0b833ddc7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520Tissue%2520Kallikrein%2520Gene%2520Family%253A%2520Applications%2520in%2520Cancer%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D224%26issue%3D1%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2004.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borgoño, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span> <span> </span><span class="NLM_article-title">The Emerging Roles of Human Tissue Kallikreins in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrc1474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrc1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=15516960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=876-890&issue=11&author=C.+A.+Borgo%C3%B1oauthor=E.+P.+Diamandis&title=The+Emerging+Roles+of+Human+Tissue+Kallikreins+in+Cancer&doi=10.1038%2Fnrc1474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging roles of human tissue kallikreins in cancer</span></div><div class="casAuthors">Borgono, Carla A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-890</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiol. roles.  Although primarily known for their clin. applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis.  They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQTk6Djzi7LVg90H21EOLACvtfcHk0lggSjq6ju1u_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D&md5=a5bd96fc35210ea97a97703942827d0d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrc1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1474%26sid%3Dliteratum%253Aachs%26aulast%3DBorgo%25C3%25B1o%26aufirst%3DC.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520Emerging%2520Roles%2520of%2520Human%2520Tissue%2520Kallikreins%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D11%26spage%3D876%26epage%3D890%26doi%3D10.1038%2Fnrc1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdolen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiechle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorilas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, J.</span></span> <span> </span><span class="NLM_article-title">Emerging Clinical Importance of the Cancer Biomarkers Kallikrein-Related Peptidases (KLK) in Female and Male Reproductive Organ Malignancies</span>. <i>Radiol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.2478/raon-2013-0053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.2478%2Fraon-2013-0053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24294176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2013&pages=319-329&author=M.+Schmittauthor=V.+Magdolenauthor=F.+Yangauthor=M.+Kiechleauthor=J.+Bayaniauthor=G.+M.+Yousefauthor=A.+Scorilasauthor=E.+P.+Diamandisauthor=J.+Dorn&title=Emerging+Clinical+Importance+of+the+Cancer+Biomarkers+Kallikrein-Related+Peptidases+%28KLK%29+in+Female+and+Male+Reproductive+Organ+Malignancies&doi=10.2478%2Fraon-2013-0053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies</span></div><div class="casAuthors">Schmitt, Manfred; Magdolen, Viktor; Yang, Feng; Kiechle, Marion; Bayani, Jane; Yousef, George M.; Scorilas, Andreas; Diamandis, Eleftherios; Dorn, Julia</div><div class="citationInfo"><span class="NLM_cas:title">Radiology and Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">RONCEM</span>;
        ISSN:<span class="NLM_cas:issn">1318-2099</span>.
    
            (<span class="NLM_cas:orgname">Association of Radiology and Oncology</span>)
        </div><div class="casAbstract">A review.  Background. Tumor tissue-assocd. KLKs (kallikrein-related peptidases) are clin. important biomarkers that may allow prognosis of the cancer disease and/or prediction of response/failure of cancer patients to cancer-directed drugs.  Regarding the female/male reproductive tract, remarkably, all of the fifteen KLKs are expressed in the normal prostate, breast, cervix uteri, and the testis, whereas the uterus/endometrium and the ovary are expressing a limited no. of KLKs only.  Conclusions. Most of the information regarding elevated expression of KLKs in tumor-affected organs is available for ovarian cancer; depicting them as valuable biomarkers in the cancerous phenotype.  In contrast, for breast cancer, a series of KLKs was found to be downregulated.  However, in breast cancer, KLK4 is elevated which is also true for ovarian and prostate cancer.  In such cases, selective synthetic KLK inhibitors that aim at blocking the proteolytic activities of certain KLKs may serve as future candidate therapeutic drugs to interfere with tumor progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeEBrnUoneLVg90H21EOLACvtfcHk0lggSjq6ju1u_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtrjE&md5=58da368a0a1cbe6c5a223d3379c8ffb1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2478%2Fraon-2013-0053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fraon-2013-0053%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DKiechle%26aufirst%3DM.%26aulast%3DBayani%26aufirst%3DJ.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DDorn%26aufirst%3DJ.%26atitle%3DEmerging%2520Clinical%2520Importance%2520of%2520the%2520Cancer%2520Biomarkers%2520Kallikrein-Related%2520Peptidases%2520%2528KLK%2529%2520in%2520Female%2520and%2520Male%2520Reproductive%2520Organ%2520Malignancies%26jtitle%3DRadiol.%2520Oncol.%26date%3D2013%26volume%3D47%26spage%3D319%26epage%3D329%26doi%3D10.2478%2Fraon-2013-0053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, T. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, O. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahão, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muri, E. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzer, L.</span></span> <span> </span><span class="NLM_article-title">Isomannide Derivatives as New Class of Inhibitors for Human Kallikrein 7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6072</span>– <span class="NLM_lpage">6075</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.bmcl.2012.08.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6072-6075&issue=19&author=R.+F.+Freitasauthor=T.+S.+P.+Teixeiraauthor=T.+G.+Barrosauthor=J.+A.+N.+Santosauthor=M.+Y.+Kondoauthor=M.+A.+Julianoauthor=L.+Julianoauthor=M.+Blaberauthor=O.+A.+C.+Antunesauthor=O.+Abrah%C3%A3oauthor=S.+Pinheiroauthor=E.+M.+F.+Muriauthor=L.+Puzer&title=Isomannide+Derivatives+as+New+Class+of+Inhibitors+for+Human+Kallikrein+7&doi=10.1016%2Fj.bmcl.2012.08.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.047%26sid%3Dliteratum%253Aachs%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DTeixeira%26aufirst%3DT.%2BS.%2BP.%26aulast%3DBarros%26aufirst%3DT.%2BG.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DKondo%26aufirst%3DM.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DAntunes%26aufirst%3DO.%2BA.%2BC.%26aulast%3DAbrah%25C3%25A3o%26aufirst%3DO.%26aulast%3DPinheiro%26aufirst%3DS.%26aulast%3DMuri%26aufirst%3DE.%2BM.%2BF.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DIsomannide%2520Derivatives%2520as%2520New%2520Class%2520of%2520Inhibitors%2520for%2520Human%2520Kallikrein%25207%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D19%26spage%3D6072%26epage%3D6075%26doi%3D10.1016%2Fj.bmcl.2012.08.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, L. S. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muri, E. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzer, L.</span></span> <span> </span><span class="NLM_article-title">Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1021/ml4003698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=128-132&issue=2&author=J.+P.+C.+Oliveiraauthor=R.+F.+Freitasauthor=L.+S.+de+Meloauthor=T.+G.+Barrosauthor=J.+A.+N.+Santosauthor=M.+A.+Julianoauthor=S.+Pinheiroauthor=M.+Blaberauthor=L.+Julianoauthor=E.+M.+F.+Muriauthor=L.+Puzer&title=Isomannide-Based+Peptidomimetics+as+Inhibitors+for+Human+Tissue+Kallikreins+5+and+7&doi=10.1021%2Fml4003698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml4003698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003698%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DJ.%2BP.%2BC.%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DMelo%26aufirst%3DL.%2BS.%2Bde%26aulast%3DBarros%26aufirst%3DT.%2BG.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DPinheiro%26aufirst%3DS.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DMuri%26aufirst%3DE.%2BM.%2BF.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DIsomannide-Based%2520Peptidomimetics%2520as%2520Inhibitors%2520for%2520Human%2520Tissue%2520Kallikreins%25205%2520and%25207%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D2%26spage%3D128%26epage%3D132%26doi%3D10.1021%2Fml4003698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sotiropoulou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pampalakis, G.</span></span> <span> </span><span class="NLM_article-title">Targeting the Kallikrein-Related Peptidases for Drug Development</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2012.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.tips.2012.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=623-634&issue=12&author=G.+Sotiropoulouauthor=G.+Pampalakis&title=Targeting+the+Kallikrein-Related+Peptidases+for+Drug+Development&doi=10.1016%2Fj.tips.2012.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DPampalakis%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520Kallikrein-Related%2520Peptidases%2520for%2520Drug%2520Development%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26issue%3D12%26spage%3D623%26epage%3D634%26doi%3D10.1016%2Fj.tips.2012.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krastel, P.</span></span> <span> </span><span class="NLM_article-title">Cyclic Depsipeptides</span> (<span class="NLM_publisher-name">Novartis Institutes for Biomedical Research Inc.</span>) U.S. Patent <span class="NLM_patent">US156472 A1</span>, <span class="NLM_year">2009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Krastel&title=Cyclic+Depsipeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKrastel%26aufirst%3DP.%26atitle%3DCyclic%2520Depsipeptides%26pub%3DNovartis%2520Institutes%2520for%2520Biomedical%2520Research%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, L.</span></span> <span> </span><span class="NLM_article-title">Ecallantide Is a Novel Treatment for Attacks of Hereditary Angioedema due to C1 Inhibitor Deficiency</span>. <i>Clin., Cosmet. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.2147/CCID.S10322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.2147%2FCCID.S10322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=21760740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=61-68&author=H.+Farkasauthor=L.+Varga&title=Ecallantide+Is+a+Novel+Treatment+for+Attacks+of+Hereditary+Angioedema+due+to+C1+Inhibitor+Deficiency&doi=10.2147%2FCCID.S10322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency</span></div><div class="casAuthors">Farkas, Henriette; Varga, Lilian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical, Cosmetic and Investigational Dermatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CCIDCL</span>;
        ISSN:<span class="NLM_cas:issn">1178-7015</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Hereditary angioedema (HAE) resulting from the deficiency of the C1 inhibitor protein is a rare disease, characterized by paroxysms of edema formation in the subcutis and in the submucosa.  Edema can cause obstruction of the upper airway, which may lead to suffocation.  Prompt elimination of edema is necessary to save patients from this life-threatening condition.  Essentially, these edematous attacks are related to the activation of the kinin-kallikrein system and the consequent release of bradykinin.  Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.  This is the only agent approved recently by the FDA for all localizations of edematous HAE attacks.  Its advantages include no risk of viral contamination, high selectivity, very rapid onset of action, good tolerability, and straightforward s.c. administration.  Owing to the risk of anaphylaxis, ecallantide should be administered by a health care professional.  A postmarketing survey to improve risk-assessment and risk-minimization has been launched.  The results of these studies may lead to the approval of ecallantide for self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolK7xVUyG867Vg90H21EOLACvtfcHk0ljs6Ko31eN1Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlelsrw%253D&md5=7bed921d9f5c6daec0ebaeadb2647b71</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2147%2FCCID.S10322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCCID.S10322%26sid%3Dliteratum%253Aachs%26aulast%3DFarkas%26aufirst%3DH.%26aulast%3DVarga%26aufirst%3DL.%26atitle%3DEcallantide%2520Is%2520a%2520Novel%2520Treatment%2520for%2520Attacks%2520of%2520Hereditary%2520Angioedema%2520due%2520to%2520C1%2520Inhibitor%2520Deficiency%26jtitle%3DClin.%252C%2520Cosmet.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D4%26spage%3D61%26epage%3D68%26doi%3D10.2147%2FCCID.S10322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacer, a C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavnar, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomonnson, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Endothelial CXCR7 Regulates Breast Cancer Metastasis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1716</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fonc.2015.236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=1716-1724&author=a+C.+Stacerauthor=J.+Fennerauthor=S.+P.+Cavnarauthor=a.+Xiaoauthor=S.+Zhaoauthor=S.+L.+Changauthor=a.+Salomonnsonauthor=K.+E.+Lukerauthor=G.+D.+Luker&title=Endothelial+CXCR7+Regulates+Breast+Cancer+Metastasis&doi=10.1038%2Fonc.2015.236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.236%26sid%3Dliteratum%253Aachs%26aulast%3DStacer%26aufirst%3Da%2BC.%26aulast%3DFenner%26aufirst%3DJ.%26aulast%3DCavnar%26aufirst%3DS.%2BP.%26aulast%3DXiao%26aufirst%3Da.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DSalomonnson%26aufirst%3Da.%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DEndothelial%2520CXCR7%2520Regulates%2520Breast%2520Cancer%2520Metastasis%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D1716%26epage%3D1724%26doi%3D10.1038%2Fonc.2015.236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cully, M.</span></span> <span> </span><span class="NLM_article-title">Lung Disease: CXCR7 Activation Overrides Lung Fibrosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">160</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd.2016.25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=160&author=M.+Cully&title=Lung+Disease%3A+CXCR7+Activation+Overrides+Lung+Fibrosis&doi=10.1038%2Fnrd.2016.25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.25%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26atitle%3DLung%2520Disease%253A%2520CXCR7%2520Activation%2520Overrides%2520Lung%2520Fibrosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D160%26doi%3D10.1038%2Fnrd.2016.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shido, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbany, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafii, S.</span></span> <span> </span><span class="NLM_article-title">Divergent Angiocrine Signals from Vascular Niche Balance Liver Regeneration and Fibrosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span> (<span class="NLM_issue">7481</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/nature12681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnature12681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=24256728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ovVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=97-102&issue=7481&author=B.-S.+Dingauthor=Z.+Caoauthor=R.+Lisauthor=D.+J.+Nolanauthor=P.+Guoauthor=M.+Simonsauthor=M.+E.+Penfoldauthor=K.+Shidoauthor=S.+Y.+Rabbanyauthor=S.+Rafii&title=Divergent+Angiocrine+Signals+from+Vascular+Niche+Balance+Liver+Regeneration+and+Fibrosis&doi=10.1038%2Fnature12681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis</span></div><div class="casAuthors">Ding Bi-Sen; Cao Zhongwei; Lis Raphael; Guo Peipei; Shido Koji; Rafii Shahin; Nolan Daniel J; Simons Michael; Penfold Mark E; Rabbany Sina Y</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">97-102</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration.  The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined.  Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration.  Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis.  Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult.  The pro-fibrotic transition of vascular niche results from differential expression of stromal-derived factor-1 receptors, CXCR7 and CXCR4 (refs 18, 19, 20, 21), in liver sinusoidal endothelial cells.  After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration.  Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7(iΔEC/iΔEC)) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors.  By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression.  This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin(+) hepatic stellate-like cells and enforcing a pro-fibrotic vascular niche.  Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1(iΔEC/iΔEC)) or Cxcr4 (Cxcr4(iΔEC/iΔEC)) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors.  Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis.  Thus, we demonstrate that in response to liver injury, differential recruitment of pro-regenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis.  These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKlyEjWbjBdxBrI9DTGjC0fW6udTcc2eaXww-WcKWt5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ovVahtg%253D%253D&md5=56b232923926af29cf7b0ddee6017cf8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature12681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12681%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DB.-S.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DLis%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DD.%2BJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%26aulast%3DShido%26aufirst%3DK.%26aulast%3DRabbany%26aufirst%3DS.%2BY.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DDivergent%2520Angiocrine%2520Signals%2520from%2520Vascular%2520Niche%2520Balance%2520Liver%2520Regeneration%2520and%2520Fibrosis%26jtitle%3DNature%26date%3D2014%26volume%3D505%26issue%3D7481%26spage%3D97%26epage%3D102%26doi%3D10.1038%2Fnature12681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">CCR10 and Its Ligands in Regulation of Epithelial Immunity and Diseases</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1007/s13238-012-2927-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs13238-012-2927-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=22684736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKis7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=571-580&issue=8&author=N.+Xiongauthor=Y.+Fuauthor=S.+Huauthor=M.+Xiaauthor=J.+Yang&title=CCR10+and+Its+Ligands+in+Regulation+of+Epithelial+Immunity+and+Diseases&doi=10.1007%2Fs13238-012-2927-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">CCR10 and its ligands in regulation of epithelial immunity and diseases</span></div><div class="casAuthors">Xiong, Na; Fu, Yaoyao; Hu, Shaomin; Xia, Mingcan; Yang, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">571-580</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">A review.  Epithelial tissues covering the external and internal surface of a body are constantly under phys., chem. or biol. assaults.  To protect the epithelial tissues and maintain their homeostasis, multiple layers of immune defense mechanisms are required.  Besides the epithelial tissue-resident immune cells that provide the first line of defense, circulating immune cells are also recruited into the local tissues in response to challenges.  Chemokines and chemokine receptors regulate tissue-specific migration, maintenance and functions of immune cells.  Among them, chemokine receptor CCR10 and its ligands chemokines CCL27 and CCL28 are uniquely involved in the epithelial immunity.  CCL27 is expressed predominantly in the skin by keratinocytes while CCL28 is expressed by epithelial cells of various mucosal tissues.  CCR10 is expressed by various subsets of innate-like T cells that are programmed to localize to the skin during their developmental processes in the thymus.  Circulating T cells might be imprinted by skin-assocd. antigen- presenting cells to express CCR10 for their recruitment to the skin during the local immune response.  On the other hand, IgA antibody-producing B cells generated in mucosa-assocd. lymphoid tissues express CCR10 for their migration and maintenance at mucosal sites.  Increasing evidence also found that CCR10/ligands are involved in regulation of other immune cells in epithelial immunity and are frequently exploited by epithelium-localizing or -originated cancer cells for their survival, proliferation and evasion from immune surveillance.  Herein, we review current knowledge on roles of CCR10/ligands in regulation of epithelial immunity and diseases and speculate on related important questions worth further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8PyTe9S4ErVg90H21EOLACvtfcHk0lixirtnybT9mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKis7nO&md5=53c961f4acaef17f995b64be91e5fdc6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs13238-012-2927-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-012-2927-3%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DN.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DCCR10%2520and%2520Its%2520Ligands%2520in%2520Regulation%2520of%2520Epithelial%2520Immunity%2520and%2520Diseases%26jtitle%3DProtein%2520Cell%26date%3D2012%26volume%3D3%26issue%3D8%26spage%3D571%26epage%3D580%26doi%3D10.1007%2Fs13238-012-2927-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daubeuf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frossard, N.</span></span> <span> </span><span class="NLM_article-title">Protective Effect of a Protein Epitope Mimetic CCR10 Antagonist, POL7085, in a Model of Allergic Eosinophilic Airway Inflammation</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">77</span>, <span class="refDoi"> DOI: 10.1186/s12931-015-0231-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1186%2Fs12931-015-0231-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=26112287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BC2MbntFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=77&author=F.+Daubeufauthor=F.+Jungauthor=G.+J.+Douglasauthor=E.+Chevalierauthor=N.+Frossard&title=Protective+Effect+of+a+Protein+Epitope+Mimetic+CCR10+Antagonist%2C+POL7085%2C+in+a+Model+of+Allergic+Eosinophilic+Airway+Inflammation&doi=10.1186%2Fs12931-015-0231-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation</span></div><div class="casAuthors">Daubeuf Francois; Frossard Nelly; Jung Francoise; Douglas Garry J; Chevalier Eric</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Potential involvement of the CCR10/CCL28 axis was recently reported in murine models of allergic asthma.  If confirmed, blockade of the CCR10 receptor would represent an alternative to current asthma therapies.  We evaluated the effect of a novel Protein Epitope Mimetic CCR10 antagonist, POL7085, in a murine model of allergic eosinophilic airway inflammation.  METHODS:  Mice were sensitized and challenged to ovalbumin.  POL7085, a CCR10 antagonist (7.5 and 15 mg/kg), dexamethasone (1 mg/kg) or vehicle were administered intranasally once daily 1h before each allergen challenge.  On day 21, airway hyperresponsiveness, bronchoalveolar lavage inflammatory cells and Th2 cytokines, and lung tissue mucus and collagen were measured.  RESULTS:  Allergen challenge induced airway hyperresponsiveness in vehicle-treated animals as measured by whole body barometric plethysmography, and eosinophilia in bronchoalveolar lavage.  POL7085 dose-dependently and significantly decreased airway hyperresponsiveness (34 ± 16 %) and eosinophil numbers in bronchoalveolar lavage (66 ± 6 %).  In addition, the highest dose of POL7085 used significantly inhibited lung IL-4 (85 ± 4 %), IL-5 (87 ± 2 %) and IL-13 (190 ± 19 %) levels, and lung collagen (43 ± 11 %).  CONCLUSIONS:  The Protein Epitope Mimetic CCR10 antagonist, POL7085, significantly and dose-dependently decreased allergen-induced airway hyperresponsiveness and airway inflammation after once daily local treatment.  Our data give strong support for further investigations with CCR10 antagonists in asthmatic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwe_bbiTT_Be4jJGKT5N0fW6udTcc2eaUDXudwq3Cmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbntFygsw%253D%253D&md5=5fab29fd1becc778f27d1d01d0a70e0a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs12931-015-0231-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-015-0231-5%26sid%3Dliteratum%253Aachs%26aulast%3DDaubeuf%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DF.%26aulast%3DDouglas%26aufirst%3DG.%2BJ.%26aulast%3DChevalier%26aufirst%3DE.%26aulast%3DFrossard%26aufirst%3DN.%26atitle%3DProtective%2520Effect%2520of%2520a%2520Protein%2520Epitope%2520Mimetic%2520CCR10%2520Antagonist%252C%2520POL7085%252C%2520in%2520a%2520Model%2520of%2520Allergic%2520Eosinophilic%2520Airway%2520Inflammation%26jtitle%3DRespir.%2520Res.%26date%3D2015%26volume%3D16%26spage%3D77%26doi%3D10.1186%2Fs12931-015-0231-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span> <span> </span><span class="NLM_article-title">Upregulation of Chemokine Receptor CCR10 Is Essential for Glioma Proliferation, Invasion and Patient Survival</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">6576</span>– <span class="NLM_lpage">6583</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.18632%2Foncotarget.2134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6576-6583&author=L.+Chenauthor=X.+Liuauthor=H.-Y.+Zhangauthor=W.+Duauthor=Z.+Qinauthor=Y.+Yaoauthor=Y.+Maoauthor=L.+Zhou&title=Upregulation+of+Chemokine+Receptor+CCR10+Is+Essential+for+Glioma+Proliferation%2C+Invasion+and+Patient+Survival&doi=10.18632%2Foncotarget.2134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2134%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DUpregulation%2520of%2520Chemokine%2520Receptor%2520CCR10%2520Is%2520Essential%2520for%2520Glioma%2520Proliferation%252C%2520Invasion%2520and%2520Patient%2520Survival%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D6576%26epage%3D6583%26doi%3D10.18632%2Foncotarget.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide Receptor Ligands as Drugs for Psychiatric Diseases: The End of the Beginning?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrd3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1038%2Fnrd3702" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=462-478&issue=6&author=G.+Griebelauthor=F.+Holsboer&title=Neuropeptide+Receptor+Ligands+as+Drugs+for+Psychiatric+Diseases%3A+The+End+of+the+Beginning%3F&doi=10.1038%2Fnrd3702"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrd3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3702%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DHolsboer%26aufirst%3DF.%26atitle%3DNeuropeptide%2520Receptor%2520Ligands%2520as%2520Drugs%2520for%2520Psychiatric%2520Diseases%253A%2520The%2520End%2520of%2520the%2520Beginning%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D6%26spage%3D462%26epage%3D478%26doi%3D10.1038%2Fnrd3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbelaar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madiera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicchi, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volksdorf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1021/ml500514w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500514w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=513-517&issue=5&author=S.+K.+Shahauthor=S.+Heauthor=L.+Guoauthor=Q.+Truongauthor=H.+Qiauthor=W.+Duauthor=Z.+Laiauthor=J.+Liuauthor=T.+Jianauthor=Q.+Hongauthor=P.+Dobbelaarauthor=Z.+Yeauthor=E.+Shererauthor=Z.+Fengauthor=Y.+Yuauthor=F.+Wongauthor=K.+Samuelauthor=M.+Madieraauthor=B.+V.+Karanamauthor=V.+B.+Reddyauthor=S.+Mitelmanauthor=S.+X.+Tongauthor=G.+G.+Chicchiauthor=K.+L.+Tsaoauthor=D.+Truscaauthor=Y.+Fengauthor=M.+Wuauthor=Q.+Shaoauthor=M.+E.+Trujilloauthor=G.+J.+Eiermannauthor=C.+Liauthor=M.+Pachanskiauthor=G.+Fernandezauthor=D.+Nelsonauthor=P.+Buntingauthor=P.+Morissetteauthor=S.+Volksdorfauthor=J.+Kerrauthor=B.+B.+Zhangauthor=A.+D.+Howardauthor=Y.+P.+Zhouauthor=A.+Pasternakauthor=R.+P.+Nargundauthor=W.+K.+Hagmann&title=Discovery+of+MK-1421%2C+a+Potent%2C+Selective+sstr3+Antagonist%2C+as+a+Development+Candidate+for+Type+2+Diabetes&doi=10.1021%2Fml500514w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml500514w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500514w%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDobbelaar%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DMadiera%26aufirst%3DM.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DReddy%26aufirst%3DV.%2BB.%26aulast%3DMitelman%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%2BX.%26aulast%3DChicchi%26aufirst%3DG.%2BG.%26aulast%3DTsao%26aufirst%3DK.%2BL.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DBunting%26aufirst%3DP.%26aulast%3DMorissette%26aufirst%3DP.%26aulast%3DVolksdorf%26aufirst%3DS.%26aulast%3DKerr%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DZhou%26aufirst%3DY.%2BP.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DDiscovery%2520of%2520MK-1421%252C%2520a%2520Potent%252C%2520Selective%2520sstr3%2520Antagonist%252C%2520as%2520a%2520Development%2520Candidate%2520for%2520Type%25202%2520Diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D513%26epage%3D517%26doi%3D10.1021%2Fml500514w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbelaar, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellureficio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicchi, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1021/ml300063m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300063m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=484-489&issue=6&author=S.+Heauthor=Z.+Yeauthor=Q.+Truongauthor=S.+Shahauthor=W.+Duauthor=L.+Guoauthor=P.+H.+Dobbelaarauthor=Z.+Laiauthor=J.+Liuauthor=T.+Jianauthor=H.+Qiauthor=R.+K.+Bakshiauthor=Q.+Hongauthor=J.+Dellureficioauthor=A.+Pasternakauthor=Z.+Fengauthor=R.+Dejesusauthor=L.+Yangauthor=M.+Reibarkhauthor=S.+A.+Bradleyauthor=M.+A.+Holmesauthor=R.+G.+Ballauthor=R.+T.+Ruckauthor=M.+A.+Huffmanauthor=F.+Wongauthor=K.+Samuelauthor=V.+B.+Reddyauthor=S.+Mitelmanauthor=S.+X.+Tongauthor=G.+G.+Chicchiauthor=K.+L.+Tsaoauthor=D.+Truscaauthor=M.+Wuauthor=Q.+Shaoauthor=M.+E.+Trujilloauthor=G.+J.+Eiermannauthor=C.+Liauthor=B.+B.+Zhangauthor=A.+D.+Howardauthor=Y.+P.+Zhouauthor=R.+P.+Nargundauthor=W.+K.+Hagmann&title=The+Discovery+of+MK-4256%2C+a+Potent+SSTR3+Antagonist+as+a+Potential+Treatment+of+Type+2+Diabetes&doi=10.1021%2Fml300063m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml300063m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300063m%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DDobbelaar%26aufirst%3DP.%2BH.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDellureficio%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DDejesus%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DS.%2BA.%26aulast%3DHolmes%26aufirst%3DM.%2BA.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DV.%2BB.%26aulast%3DMitelman%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%2BX.%26aulast%3DChicchi%26aufirst%3DG.%2BG.%26aulast%3DTsao%26aufirst%3DK.%2BL.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DZhou%26aufirst%3DY.%2BP.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520Discovery%2520of%2520MK-4256%252C%2520a%2520Potent%2520SSTR3%2520Antagonist%2520as%2520a%2520Potential%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Fml300063m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzidou, V.</span></span> <span> </span><span class="NLM_article-title">Advances in the Role of Oxytocin Receptors in Human Parturition</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2017.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.mce.2017.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=28119132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2017&pages=56-63&author=S.+H.+Kimauthor=P.+R.+Bennettauthor=V.+Terzidou&title=Advances+in+the+Role+of+Oxytocin+Receptors+in+Human+Parturition&doi=10.1016%2Fj.mce.2017.01.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the role of oxytocin receptors in human parturition</span></div><div class="casAuthors">Kim, Sung Hye; Bennett, Phillip R.; Terzidou, Vasso</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) is a neurohypophysial hormone which has been found to play a central role in the regulation of human parturition.  The most established role of oxytocin/oxytocin receptor (OT/OTR) system in human parturition is the initiation of uterine contractions, however, recent evidence have demonstrated that it may have a more complex role including initiation of inflammation, regulation of miRNA expression, as well as mediation of other non-classical oxytocin actions via receptor crosstalk with other G protein-coupled receptors (GPCRs).  In this review we highlight both established and newly emerging roles of OT/OTR system in human parturition and discuss the expanding potential for OTRs as pharmacol. targets in the management of preterm labour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8IylxwAW2LVg90H21EOLACvtfcHk0lgzubKWG0FXvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGrsr4%253D&md5=7936e6fff818bb5044ed8adb7c935997</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2017.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2017.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBennett%26aufirst%3DP.%2BR.%26aulast%3DTerzidou%26aufirst%3DV.%26atitle%3DAdvances%2520in%2520the%2520Role%2520of%2520Oxytocin%2520Receptors%2520in%2520Human%2520Parturition%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2017%26volume%3D449%26spage%3D56%26epage%3D63%26doi%3D10.1016%2Fj.mce.2017.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bale, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsa, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, M. M.</span></span> <span> </span><span class="NLM_article-title">CNS Region-Specific Oxytocin Receptor Expression: Importance in Regulation of Anxiety and Sex Behavior</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2546</span>– <span class="NLM_lpage">2552</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.21-07-02546.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1523%2FJNEUROSCI.21-07-02546.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=11264328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslClsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=2546-2552&issue=7&author=T.+L.+Baleauthor=A.+M.+Davisauthor=A.+P.+Augerauthor=D.+M.+Dorsaauthor=M.+M.+McCarthy&title=CNS+Region-Specific+Oxytocin+Receptor+Expression%3A+Importance+in+Regulation+of+Anxiety+and+Sex+Behavior&doi=10.1523%2FJNEUROSCI.21-07-02546.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior</span></div><div class="casAuthors">Bale, Tracy L.; Davis, Aline M.; Auger, Anthony P.; Dorsa, Daniel M.; McCarthy, Margaret M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2546-2552</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The oxytocin receptor (OTR) is differentially expressed in the CNS.  Because there are multiple mechanisms by which the OTR can be transcriptionally induced, the authors hypothesized that differences in OTR expression may be explained by activation of distinct signal transduction pathways and may be crit. for the control of anxiety and sex behaviors.  To det. the regulation and functional significance of this expression, the authors infused female rats with modifiers of protein kinases before assaying for behavior and oxytocin receptor binding.  In the ventromedial nucleus of the hypothalamus (VMH), estrogen-dependent induction of oxytocin receptors required protein kinase C activation, and oxytocin infused here promoted female sex behavior but had no effect on anxiety.  In contrast, dopamine controlled tonic oxytocin receptor expression in the central nucleus of the amygdala (cAmyg) through activation of protein kinase A, and oxytocin infused here was anxiolytic but had no effect on female sex behavior.  Therefore, the authors have identified brain region-specific regulation of the OTR in the VMH and cAmyg.  Distinct signal transduction pathways regulating receptor expression and binding in each brain region may mediate in part the ability of oxytocin to exert these differential behavioral effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdG4tH42o_57Vg90H21EOLACvtfcHk0lgzubKWG0FXvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslClsLo%253D&md5=56243806786cd5f38fcfce8652ecb843</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.21-07-02546.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.21-07-02546.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBale%26aufirst%3DT.%2BL.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DAuger%26aufirst%3DA.%2BP.%26aulast%3DDorsa%26aufirst%3DD.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%2BM.%26atitle%3DCNS%2520Region-Specific%2520Oxytocin%2520Receptor%2520Expression%253A%2520Importance%2520in%2520Regulation%2520of%2520Anxiety%2520and%2520Sex%2520Behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26issue%3D7%26spage%3D2546%26epage%3D2552%26doi%3D10.1523%2FJNEUROSCI.21-07-02546.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einspanier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobunaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokugawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span> <span> </span><span class="NLM_article-title">Expression and Immunolocalization of the Oxytocin Receptor in Human Lactating and Non-Lactating Mammary Glands</span>. <i>Hum. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2645</span>– <span class="NLM_lpage">2653</span>, <span class="refDoi"> DOI: 10.1093/humrep/13.9.2645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1093%2Fhumrep%2F13.9.2645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=9806301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVCitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=2645-2653&issue=9&author=T.+Kimuraauthor=Y.+Itoauthor=A.+Einspanierauthor=K.+Tohyaauthor=T.+Nobunagaauthor=Y.+Tokugawaauthor=M.+Takemuraauthor=Y.+Kubotaauthor=R.+Ivellauthor=N.+Matsuuraauthor=F.+Sajiauthor=Y.+Murata&title=Expression+and+Immunolocalization+of+the+Oxytocin+Receptor+in+Human+Lactating+and+Non-Lactating+Mammary+Glands&doi=10.1093%2Fhumrep%2F13.9.2645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and immunolocalization of the oxytocin receptor in human lactating and non-lactating mammary glands</span></div><div class="casAuthors">Kimura, Tadashi; Ito, Yasuhiro; Einspanier, Almuth; Tohya, Kazuo; Nobunaga, Toshikatsu; Tokugawa, Yoshihiro; Takemura, Masahiko; Kubota, Yasue; Ivell, Richard; Matsuura, Nariaki; Saji, Fumitaka; Murata, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2645-2653</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The milk ejection reflex is mediated by the release of pituitary oxytocin and its interaction with specific receptors within the mammary gland.  Although up-regulation of the oxytocin receptor during lactation has been shown for the rat mammary gland by ligand binding assay, investigation of the receptor expression in human breast at the mol. level has not yet been carried out in detail.  Here the authors report the expression and immunolocalization of the oxytocin receptor in the human breast.  It appears that the expression level of the receptor-specific mRNA is not significantly elevated during lactation and the protein remains at a relatively low level.  However, this lack of increase may be only a diln. effect because of the high level of milk protein expression.  Immunohistochem. and immunoelectron microscopy using three anti-oxytocin receptor antibodies raised against different epitopes of the receptor indicated the presence of receptor immunoreactivity only to a very limited extent in the myoepithelial cells; more specific expression appeared to occur in the ductal/glandular epithelium in both the non-lactating as well as lactating breast.  This finding was also confirmed in a New World monkey, the common marmoset (Callithrix jacchus).  These results suggest that, at least for human and marmoset, in addn. to-or even instead of-myoid cells, the ductal/glandular epithelium is also a target for oxytocin action, not only during lactation but also in the non-lactating breast.  Thus, there may be other physiol. effects of oxytocin besides direct myoid cell contraction in the breast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYc_n6XYbxLbVg90H21EOLACvtfcHk0lgzubKWG0FXvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVCitrY%253D&md5=8804a23be4d42917576afe95b6699f4a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2F13.9.2645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252F13.9.2645%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DEinspanier%26aufirst%3DA.%26aulast%3DTohya%26aufirst%3DK.%26aulast%3DNobunaga%26aufirst%3DT.%26aulast%3DTokugawa%26aufirst%3DY.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DY.%26aulast%3DIvell%26aufirst%3DR.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DSaji%26aufirst%3DF.%26aulast%3DMurata%26aufirst%3DY.%26atitle%3DExpression%2520and%2520Immunolocalization%2520of%2520the%2520Oxytocin%2520Receptor%2520in%2520Human%2520Lactating%2520and%2520Non-Lactating%2520Mammary%2520Glands%26jtitle%3DHum.%2520Reprod.%26date%3D1998%26volume%3D13%26issue%3D9%26spage%3D2645%26epage%3D2653%26doi%3D10.1093%2Fhumrep%2F13.9.2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reversi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chini, B.</span></span> <span> </span><span class="NLM_article-title">Oxytocin Receptor Signaling in Myoepithelial and Cancer Cells</span>. <i>J. Mammary Gland Biol. Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/s10911-005-9583-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10911-005-9583-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=16807802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BD28zovFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=221-229&issue=3&author=A.+Reversiauthor=P.+Cassoniauthor=B.+Chini&title=Oxytocin+Receptor+Signaling+in+Myoepithelial+and+Cancer+Cells&doi=10.1007%2Fs10911-005-9583-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptor signaling in myoepithelial and cancer cells</span></div><div class="casAuthors">Reversi Alessandra; Cassoni Paola; Chini Bice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of mammary gland biology and neoplasia</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-9</span>
        ISSN:<span class="NLM_cas:issn">1083-3021</span>.
    </div><div class="casAbstract">Oxytocin (OT) plays a crucial role as a mediator of breast myoepithelial cell contraction, the process responsible for the ejection of milk during lactation, and is also involved in myoepithelial cell proliferation and postpartum mammary gland proliferation.  Furthermore, although a number of breast cancer cells have oxytocin receptors (OTRs), it has been reported that OT stimulates, inhibits, or has no effect on cell proliferation.  As these different effects seem to be mediated by different signaling pathways elicited by OTR stimulation, we here review the regulation of OTR signaling in different cell systems and discuss how understanding the molecular basis of receptor coupling specificity has become extremely important for understanding the role played by OTRs in regulating cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7vdCwW9GeC0EgZCMqtRBifW6udTcc2eapY9j2N4bPkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zovFyjsQ%253D%253D&md5=ce0c5744dfb12bed8a708c60b29a13b4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10911-005-9583-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10911-005-9583-7%26sid%3Dliteratum%253Aachs%26aulast%3DReversi%26aufirst%3DA.%26aulast%3DCassoni%26aufirst%3DP.%26aulast%3DChini%26aufirst%3DB.%26atitle%3DOxytocin%2520Receptor%2520Signaling%2520in%2520Myoepithelial%2520and%2520Cancer%2520Cells%26jtitle%3DJ.%2520Mammary%2520Gland%2520Biol.%2520Neoplasia%26date%3D2005%26volume%3D10%26issue%3D3%26spage%3D221%26epage%3D229%26doi%3D10.1007%2Fs10911-005-9583-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksioglu, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Grassystatins A-C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors That Reduce Antigen Presentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5732</span>– <span class="NLM_lpage">5747</span>, <span class="refDoi"> DOI: 10.1021/jm9009394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9009394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5732-5747&issue=18&author=J.+C.+Kwanauthor=E.+A.+Eksiogluauthor=C.+Liuauthor=V.+J.+Paulauthor=H.+Luesch&title=Grassystatins+A-C+from+Marine+Cyanobacteria%2C+Potent+Cathepsin+E+Inhibitors+That+Reduce+Antigen+Presentation&doi=10.1021%2Fjm9009394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm9009394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9009394%26sid%3Dliteratum%253Aachs%26aulast%3DKwan%26aufirst%3DJ.%2BC.%26aulast%3DEksioglu%26aufirst%3DE.%2BA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DGrassystatins%2520A-C%2520from%2520Marine%2520Cyanobacteria%252C%2520Potent%2520Cathepsin%2520E%2520Inhibitors%2520That%2520Reduce%2520Antigen%2520Presentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D18%26spage%3D5732%26epage%3D5747%26doi%3D10.1021%2Fjm9009394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakinuma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span> <span> </span><span class="NLM_article-title">CCR10 and CCL27 Are Overexpressed in Cutaneous Squamous Cell Carcinoma</span>. <i>Pathol., Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>207</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.prp.2010.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.prp.2010.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=21144674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFygur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2011&pages=43-48&issue=1&author=H.+Kaiauthor=T.+Kadonoauthor=T.+Kakinumaauthor=M.+Tomitaauthor=H.+Ohmatsuauthor=Y.+Asanoauthor=Y.+Tadaauthor=M.+Sugayaauthor=S.+Sato&title=CCR10+and+CCL27+Are+Overexpressed+in+Cutaneous+Squamous+Cell+Carcinoma&doi=10.1016%2Fj.prp.2010.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma</span></div><div class="casAuthors">Kai, Hiromichi; Kadono, Takafumi; Kakinuma, Takashi; Tomita, Manabu; Ohmatsu, Hanako; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Pathology, Research and Practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">PARPDS</span>;
        ISSN:<span class="NLM_cas:issn">0344-0338</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">C-C chemokine receptor (CCR)10 is a specific receptor for chemokine ligand (CCL)27, a selective chemoattractant for skin-assocd. memory T cells to cutaneous sites.  In melanoma, CCR10 increases the ability of neoplastic cells to grow, invade tissues, disseminate to lymph nodes, and escape the host immune responses.  In this study, we investigated the expression of CCR10 and its ligand CCL27 in squamous cell carcinoma (SCC).  CCR10 and CCL27 were expressed in SCC, actinic keratosis (AK), Bowen's disease, and seborrheic keratosis (predominantly prickle cell type), but not in seborrheic keratosis (predominantly basal cell type) and basal cell carcinoma.  Furthermore, CCR10 and CCL27 were overexpressed in SCC relative to Bowen's disease, an early stage of SCC.  Consistently, a human SCC cell line, A253 cells, and HaCaT cells exhibited CCL27 prodn. that was strongly induced by tumor necrosis factor-α and interleukin-1β.  Finally, A253 cells expressed stronger intracellular CCR10 compared to HaCaT cells by flow cytometry.  These results suggest that CCR10 and CCL27 overexpression in SCC is related to the progression of SCC and is useful for the diagnosis of SCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1l3T0w5CrErVg90H21EOLACvtfcHk0liC5TcFieBK6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFygur3L&md5=794962fa4e47831c615b685000cc8474</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.prp.2010.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prp.2010.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKai%26aufirst%3DH.%26aulast%3DKadono%26aufirst%3DT.%26aulast%3DKakinuma%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DOhmatsu%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DSugaya%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26atitle%3DCCR10%2520and%2520CCL27%2520Are%2520Overexpressed%2520in%2520Cutaneous%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DPathol.%252C%2520Res.%2520Pract.%26date%3D2011%26volume%3D207%26issue%3D1%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.prp.2010.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühnelt-Leddihn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisendle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the Chemokine Receptors CXCR4, CCR7, CCR9, and CCR10 in Human Primary Cutaneous Melanoma: A Potential Prognostic Value for CCR7 and CCR10?</span>. <i>Arch. Dermatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>304</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1007/s00403-012-1222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs00403-012-1222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=22350183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2012&pages=185-193&issue=3&author=L.+K%C3%BChnelt-Leddihnauthor=K.+Eisendleauthor=H.+M%C3%BCllerauthor=B.+Zelgerauthor=G.+Weinlich&title=Overexpression+of+the+Chemokine+Receptors+CXCR4%2C+CCR7%2C+CCR9%2C+and+CCR10+in+Human+Primary+Cutaneous+Melanoma%3A+A+Potential+Prognostic+Value+for+CCR7+and+CCR10%3F&doi=10.1007%2Fs00403-012-1222-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?</span></div><div class="casAuthors">Kuehnelt-Leddihn, Laura; Mueller, Hansgeorg; Eisendle, Klaus; Zelger, Bernhard; Weinlich, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-193</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Multiple functional implications have been suggested for a limited no. of chemokines and their cognate receptors in melanoma pathogenesis.  The purpose of this study was to investigate the potential role of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 as prognostic markers in human primary cutaneous melanoma.  Chemokine receptor expression was analyzed by immunohistochem. in a total of 38 patients with cutaneous melanoma.  Results were statistically correlated with melanoma features and clin. disease progression.  No significant correlation between overexpression of CXCR4 or CCR9 and survival or prognosis was found.  CCR7 overexpression was assocd. with significantly lower survival (0.005 log rank) and shorter time to progression (0.009 log rank)-similar to CCR10 overexpression (lower survival: 0.001 log rank, shorter time to progression: 0.002 log rank).  In addn., CCR7 overexpression correlated with expression of metallothionein, while CCR10 seems to be assocd. with cerebral metastases.  Two chemokine receptors permitting the identification of high-risk patients were identified: CCR7 and CCR10 overexpressions were found to be assocd. with a worse outcome of disease course independent of Breslow's tumor thickness and Clark level, thus representing possible addnl. prognostic markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Jnv8ryd2DrVg90H21EOLACvtfcHk0lhURLsswAR_LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOksbw%253D&md5=51efab7e68b4e3ae4973074fef72453a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs00403-012-1222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-012-1222-8%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChnelt-Leddihn%26aufirst%3DL.%26aulast%3DEisendle%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DZelger%26aufirst%3DB.%26aulast%3DWeinlich%26aufirst%3DG.%26atitle%3DOverexpression%2520of%2520the%2520Chemokine%2520Receptors%2520CXCR4%252C%2520CCR7%252C%2520CCR9%252C%2520and%2520CCR10%2520in%2520Human%2520Primary%2520Cutaneous%2520Melanoma%253A%2520A%2520Potential%2520Prognostic%2520Value%2520for%2520CCR7%2520and%2520CCR10%253F%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D2012%26volume%3D304%26issue%3D3%26spage%3D185%26epage%3D193%26doi%3D10.1007%2Fs00403-012-1222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieramici, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offidani, A.</span></span> <span> </span><span class="NLM_article-title">Potential Role of CCL27 and CCR10 Expression in Melanoma Progression and Immune Escape</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1016%2Fj.ejca.2006.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=1181-1187&issue=8&author=O.+Simonettiauthor=G.+Goteriauthor=G.+Lucariniauthor=A.+Filosaauthor=T.+Pieramiciauthor=C.+Rubiniauthor=G.+Biaginiauthor=A.+Offidani&title=Potential+Role+of+CCL27+and+CCR10+Expression+in+Melanoma+Progression+and+Immune+Escape&doi=10.1016%2Fj.ejca.2006.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DSimonetti%26aufirst%3DO.%26aulast%3DGoteri%26aufirst%3DG.%26aulast%3DLucarini%26aufirst%3DG.%26aulast%3DFilosa%26aufirst%3DA.%26aulast%3DPieramici%26aufirst%3DT.%26aulast%3DRubini%26aufirst%3DC.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DOffidani%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520CCL27%2520and%2520CCR10%2520Expression%2520in%2520Melanoma%2520Progression%2520and%2520Immune%2520Escape%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26issue%3D8%26spage%3D1181%26epage%3D1187%26doi%3D10.1016%2Fj.ejca.2006.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Baruch, A.</span></span> <span> </span><span class="NLM_article-title">Organ Selectivity in Metastasis: Regulation by Chemokines and Their Receptors</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1007/s10585-007-9097-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1007%2Fs10585-007-9097-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=17891505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVSqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=345-356&issue=4&author=A.+Ben-Baruch&title=Organ+Selectivity+in+Metastasis%3A+Regulation+by+Chemokines+and+Their+Receptors&doi=10.1007%2Fs10585-007-9097-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Organ selectivity in metastasis: regulation by chemokines and their receptors</span></div><div class="casAuthors">Ben-Baruch, Adit</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis results from a non-random process, in which organ selectivity by the tumor cells is largely detd. by factors that are expressed at the remote organs that eventually turn into preferred sites of metastasis formation.  These factors support the consecutive steps required for metastasis formation, including tumor cell adhesion to microvessel walls, extravasation into target tissue and migration.  Of the different components that regulate organ selectivity, instrumental roles were recently attributed to chemokines and their receptors.  The present review presents the rationale standing behind the first studies looking at the potential involvement of chemokine-related components in organ selectivity.  Based on these studies and many others that followed, the current paradigm is that chemokines that are expressed at specific organs det. to large extent organ specificity by promoting tumor cell adhesion to microvessel walls, by facilitating processes of extravasation into the target tissue and by inducing tumor cell migration.  Moreover, chemokines can possibly support addnl. steps that are required for "successful" establishment of metastases, such as tumor cell proliferation and survival.  The review focuses on the CXCL12-CXCR4 pair as the role model in our current understanding of chemokine involvement in organ selectivity.  This review also describes the prominent roles played by CCR7 and its corresponding chemokine ligands (CCL21, CCL19) in lymph node metastasis, and of the CCR10-CCL27 axis in melanoma skin survival and metastasis.  Overall, the present discussion describes chemokines as important constituents of the tumor microenvironment at metastatic sites, dictating directionality of chemokine receptor-expressing tumor cells, facilitating their adhesion and extravasation, and eventually contributing to organ selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZX80EGl9CU7Vg90H21EOLACvtfcHk0lhURLsswAR_LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVSqu7c%253D&md5=c85b981d596cde945daea08cf94763ef</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs10585-007-9097-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-007-9097-3%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Baruch%26aufirst%3DA.%26atitle%3DOrgan%2520Selectivity%2520in%2520Metastasis%253A%2520Regulation%2520by%2520Chemokines%2520and%2520Their%2520Receptors%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2008%26volume%3D25%26issue%3D4%26spage%3D345%26epage%3D356%26doi%3D10.1007%2Fs10585-007-9097-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Baruch, A.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Metastasis Formation</span>. <i>Cell Adhes. Migration</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4161/cam.3.4.9211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.4161%2Fcam.3.4.9211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A280%3ADC%252BD1MjovFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=328-333&author=A.+Ben-Baruch&title=Site-Specific+Metastasis+Formation&doi=10.4161%2Fcam.3.4.9211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion</span></div><div class="casAuthors">Ben-Baruch Adit</div><div class="citationInfo"><span class="NLM_cas:title">Cell adhesion & migration</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">328-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The metastatic spread of tumors is a well-coordinated process in which different types of cancers tend to form metastases in defined organs.  The formation of site-specific metastases requires full compatibility between the intrinsic properties of the tumor cells and the tumor microenvironment.  It was recently found that chemokines which are expressed in specific loci promote the adhesion, migration and invasion of tumor cells that express the corresponding receptor(s).  Of the different members of the family, the CXCL12 chemokine and its cognate CXCR4 receptor are the prototypes of this process, although other members of the family (e.g.  CCR7 and CCR10) also play a role in determination of the metastatic spread.  This commentary addresses the fundamental roles of chemokines and their receptors in site-specific metastasis, with emphasis on CXCL12-CXCR4.  The article also describes some of the efforts that were performed thus far in order to identify the intracellular components involved in this process.  The focus is put on the roles played by proteins that regulate adhesion and migration of tumor cells in response to CXCL12, including mainly focal adhesion kinase (FAK), Pyk2/RAFTK and members of the Rho family of GTPases (RhoA, Rac, Cdc42).  This is followed by discussion of open questions that need to be addressed in future research, and of the potential therapeutic implications of the findings that are available to date in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSKpjb2A3ZN2PgL4LrC-0VfW6udTcc2eZd-ABwomc8Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjovFOntQ%253D%253D&md5=7df64d00f52b08934e2f2b01534299a1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.4161%2Fcam.3.4.9211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcam.3.4.9211%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Baruch%26aufirst%3DA.%26atitle%3DSite-Specific%2520Metastasis%2520Formation%26jtitle%3DCell%2520Adhes.%2520Migration%26date%3D2009%26volume%3D3%26spage%3D328%26epage%3D333%26doi%3D10.4161%2Fcam.3.4.9211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+Speed+and+Accuracy+of+Docking+with+a+New+Scoring+Function%2C+Efficient+Optimization%2C+and+Multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljtYfJxOSSogQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520Speed%2520and%2520Accuracy%2520of%2520Docking%2520with%2520a%2520New%2520Scoring%2520Function%252C%2520Efficient%2520Optimization%252C%2520and%2520Multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UIW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UIW','PDB','5UIW'); return false;">PDB: 5UIW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWE','PDB','5LWE'); return false;">PDB: 5LWE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD','PDB','4RWD'); return false;">PDB: 4RWD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03187"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00885">10.1021/acs.jmedchem.8b00885</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Includes NMR tables for brintonamides A–E (<b>1</b>–<b>5</b>) in CDCl<sub>3</sub>; experimental procedures for the synthesis of brintonamides A–E (<b>1</b>–<b>5</b>) and analogues (<b>6</b>, <b>7</b>); results and discussions related to the KLK7 enzyme kinetic studies; effects of brintonamide D on downstream cellular substrates of KLK7 as well as the migration of breast cancer cells; results and discussions related to CCR10 molecular modeling and expressions of CCR10 and other GPCR hits in cancer cells; experimental procedures for KLK7 experiments; relevant references;NMR spectra of brintonamides; HRMS of brintonamides (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates for homology model CCR5 model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UIW">5UIW</a> 4MBS (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates for homology model CCR9 model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWE">5LWE</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates for homology model δ opioid model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a> 4N6H(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_004.pdb">PDB</a>)</p></li><li><p class="inline">molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_005.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_001.pdf">jm8b00885_si_001.pdf (7.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_002.pdb">jm8b00885_si_002.pdb (428.1 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_003.pdb">jm8b00885_si_003.pdb (427.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_004.pdb">jm8b00885_si_004.pdb (428.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00885/suppl_file/jm8b00885_si_005.csv">jm8b00885_si_005.csv (1.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00885&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00885%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00885" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a028a4fbc24bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
